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Abstract 
Heat Shock Protein 90 (Hsp90) is a ubiquitous molecular chaperone linked to the 
maturation and activation of a wide range of 'client proteins'. These include steroid hormone 
receptors, receptor tyrosine kinases and p53. Hsp90 activates ‘clients’ through a series of 
conformational changes driven by the binding and hydrolysis of ATP in the N-terminal domain. 
These changes are thought to facilitate the formation of client protein binding sites and aid 
achieving their functional state.  
The aims of this thesis are to investigate the thermodynamics of nucleotide-based 
ligand binding to the N-terminal domain of Hsp90 and to study the mechanism by which 
conformational changes are induced by ligand binding.  
 Thermodynamic characterization of ligand binding using isothermal titration 
calorimetry was carried out in order to investigate the contribution of the different groups of 
the nucleotide to the binding affinity and determined the importance of the charge state of 
the ligand to binding. Measurements of the change in constant pressure heat capacity induced 
by ligand binding were also performed in order to further investigate previously reported 
unusual heat capacity changes in this system that may correspond to differences in the 
conformational changes induced by ADP vs. an ATP analogue (AMPPNP) . Structural studies by 
NMR of the N-terminal domain reveal a high degree of flexibility and specific conformational 
changes in response to the binding of different ligands to the N-terminal domain of Hsp90. The 
thermodynamics of ligand binding to the full length protein and to the isolated N551 (the first 
551 amino acids) were also investigated and found to have a significant influence over both 
the thermodynamics and the heat capacity measurements compared to the isolated N-
terminal domain. 
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CD  – Circular Dichrosim 
13CHSQC – Carbon edited Heteronuclear single quantum coherence 
DSS  – 4,4-dimethyl-4-silapentane-1-sulfonic acid 
E. Coli  – Escherichia coli 
E64  – L-transepoxysuccinyl-leucylamido-[4-guanidino]butane 
EDTA  – Ethylene-diamine-tetraacetic acid 
EM  – Electron Microscopy 
FRET  – Fluorescence resonance energy transfer 
GHKL superfamily – Gyrase, Histidine kinase, Mut L superfamily 
GndCl  – Guanidinium Chloride 
H/D exchange – Hydrogen/Deuterium exchange 
HEPES  – 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
Hsp90  – Heat shock protein 90 
Hsp90-FL – Full length construct of Hsp90 
IPTG  – Isopropyl-β-D-thiogalactopyranoside 
ITC  – Isothermal Titration Calorimetry 
kDa  – kilo Daltons 
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LB  – Luria Broth 
MES  – 2-(N-morpholino)ethanesulfonic acid 
Mg2+  – Magnesium ions with 2+ charge from MgCl2 
N  – Stoichiometry 
N551  – N-terminal and middle domain construct of Hsp90 consisting of the 
 first 551 amino acids 
15NHSQC – Nitrogen edited Heteronuclear single quantum coherence 
Ni-NTA  – Nickel-charged nitriloacetic acid 
NMR  – Nuclear Magnetic Resonance 
NOE  – Nuclear overhauser effect 
NT  – N-terminal domain of Hsp90 from amino acids 1 - 207 including a  
hexa-his tag 
PDB  – Protein data bank 
PIPES  – Piperazine-N,N′-bis(2-ethanesulfonic acid 
ppm  – parts per million 
SAXS  – Small angle x-ray scattering 
SDS-PAGE – Sodium Dodecyl Sulphate – Polyacrylamide Gel Electrophoresis 
T101I  – N-terminal domain mutant of Hsp90. Residue Thr101 mutated to Ile 
T22I  – N-terminal domain mutant of Hsp90. Residue Thr22 mutated to Ile 
TOCSY  – Total correlation spectroscopy 
TPR  – Tetratricopeptide repeat 
Tris  – Tris(hydroxymethyl)aminomethane 
TROSY  – Transverse relaxation optimized spectroscopy  
UV  – Ultra Violet 
UV-Vis  – Ultra Violet - Visible 
v/v  – volume per volume 
w/v  – weight per volume 
WT  – Wild Type 
ΔCp  – Change in heat capacity 
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ΔG  – Change in Gibbs free energy 
ΔH  – Change in enthalpy  
ΔS  – Change in entropy 
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1 Introduction 
 
The study of heat shock protein 90 (Hsp90) has been, and continues to be, intensively 
investigated. Yet despite the accumulated large body of knowledge, there are still many 
important questions that remain unanswered.  
The protein studied in this thesis was the yeast homologue of Hsp90 from S. cerevisiae, 
otherwise known as Hsp82, however the homology between members of the Hsp90 family and 
the known functional overlap between them is high. Indeed it is known that both yeast and 
human Hsp90 discriminate in a similar way between Hsp70 and its close homologue Kar2[1]. It 
has also been observed that introduction of the human Hsp90 homologue can restore viability 
in yeast when the wild type gene has been knocked out[2]. This establishes the yeast Hsp90 
homologue as a suitable reference for the human chaperone protein. Throughout this thesis, 
and indeed following the example frequently found within the literature, the protein of 
interest will be referred to as Hsp90. 
 
 
1.1 The Hsp90 chaperone molecule 
 The Hsp90 family of proteins are found across all eukaryotic and prokaryotic species, 
with multiple isoforms involved in tissue and organelle specific functions including those within 
the endoplasmic reticulum, mitochondria and chloroplasts. Although the presence of Hsp90 is 
non-essential in bacteria, eukaryotic cell viability requires at least the cytoplasmic version of 
the chaperone[3]. Hsp90 is present in large quantities (up to 1% of the total yeast cell protein) 
under normal conditions, although its expression is increased upon heat shock. 
Hsp90 is a molecular chaperone involved in the stabilisation and activation of a diverse 
range of ‘client’ proteins. Hsp90 does not appear to be involved in de-novo folding, instead it is 
required for the activation of ‘clients’ to a fully competent state. The details of the process of 
activation is one of the remaining mysteries of Hsp90 function but it is known to often involve 
inducing conformational changes within the client or enabling post-translational modification 
such as phosphorylation or dephosphorylation. The diverse set of client proteins is matched by 
an equally varying set of co-chaperone molecules that are required for the function of Hsp90 
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and the specific recruitment of various client proteins. For example the recruitment of the co-
chaperone Cdc37 is required for the activation of protein kinase clients[3]. 
The ‘clients’ that require Hsp90 for function include telomerase, nitric oxide synthase, 
a number of both nuclear hormone receptors and transcription factors and a large array of 
protein kinases. The selectivity for Hsp90 client proteins is such that, although the range of 
proteins classed as requiring Hsp90 for activity is incredibly diverse, it seems to cover very 
specific functional areas (for example, cell signalling) [3]. 
Across the many studies of Hsp90 there are three key features which are consistent. 
The first is that the chaperone activity is controlled by the binding and hydrolysis of ATP. The 
second is that this binding and hydrolysis is coupled to a series of conformational changes 
within the chaperone molecule. The third is that this series of conformational changes is 
inexorably linked to the function of client proteins. 
The link from ligand binding and hydrolysis to conformational changes within the 
Hsp90 molecule is clear (as described in detail later). These conformational changes are key to 
the chaperone activity of Hsp90 and a distinct cycle of conformational changes has been 
observed [4-9]. The Hsp90 chaperone protein functions as a dimer and is comprised of three 
domains: the N-terminal domain, the middle domain and the C-terminal domain. The role of 
these domains within the chaperone cycle and the importance of dimerisation will be 
discussed in detail later. Crystal structures have been solved for the isolated domains [8;10-13] 
and for the full length protein in a ligand and co-chaperone complex [7]. These structures 
however, only provide a ‘snapshot’ of the physical states that correspond to some of the 
stages in the conformational cycle. The accessibility of the remaining states to crystallography 
is extremely limited, and so dynamic methods such as nuclear magnetic resonance 
(NMR)[10;14-19], isothermal titration calorimetry (ITC) [8;17;20;21], fluorescence studies 
[5;9;22] and mutational analysis [23-27] have all been used to probe conformational changes 
within the protein.  
The use of the isolated N-terminal domain of Hsp90 as a model to study the effects of 
ligand binding to the chaperone has been adopted by a number of groups. One reason for this 
is due to the size of the protein while another is the ease with which the N-terminal domain 
constructs have been crystallised. Size limitations of NMR preclude detailed study of proteins 
above 50 kDa; the N-terminal domain of Hsp90 has a molecular weight of 24 kDa and thus falls 
within the working range of NMR spectroscopy while the full length protein in its dimeric state 
is approximately 160 kDa and thus falls outside this accessible range. Another reason is that 
the N-terminal domain alone does not dimerise and thus a single binding event and the 
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corresponding induced conformational changes can be studied in isolation; the complexity of 
the chaperone cycle is evident [5;6;9;22] and thus simplification of the system in order to de-
convolute the events is essential.   
 
 
1.2 Early studies of the Hsp90 molecular chaperone 
 For many years it was believed that Hsp90 was involved in the de-novo folding of 
proteins similar to the previously investigated Hsp70 chaperone. Hsp90’s ability to prevent the 
aggregation of GST under heat stress was seen as evidence of its role in general protein 
stabilisation[28]. It was not until much later that Hsp90’s role in inducing the function of 
proteins rather than de novo folding was identified.  
 For a time the nature of the dimerisation of the Hsp90 chaperone was unknown, with 
early studies, such as that by Maruya et. al.[29], mistakenly attributing an anti-parallel 
arrangement to the homodimer. In hindsight, this is understandable as the degree of extension 
and flexibility actually shown by the dimer is sufficiently large to be mistaken as an anti-parallel 
arrangement. The parallel nature of the dimerisation was later shown by high resolution 
techniques such as crystallography [7;11]. 
Reports of both the existence and the level of ATPase activity of Hsp90 also varied 
dramatically from group to group. The low level ATPase activity that Hsp90 is now known to 
possess was often overwhelmed by the background ATPase activity of contaminants including 
Hsp70, now known to often be present in a chaperone complex with Hsp90. Evidence against 
the binding of ATP to Hsp90 included the failure to photoaffinity label Hsp90 with 8-azido-ADP 
or to bind Hsp90 to an ATP-agarose affinity column[30].  Also as evidence against Hsp90 having 
an intrinsic ATPase activity was its inability to enhance the fluorescence of MABA-ADP in a 
similar fashion to that observed for Hsp70[30]. Initial crystal structures of the N-terminal 
domain alone were solved without any nucleotide present, and showed a deep pocket within 
the molecule. Speculation as to whether this pocket was a binding site for unfolded segments 
of polypeptide chain continued until 1997 when the work of Prodromou et al.[8] resolved this 
issue. This structure was solved in the presence of ADP, clearly showing the ligand bound 
within the N-terminal domain cleft in a ‘kinked’ conformation. Previous studies such as that by 
Jakob et al. [30] used C8 adenine-substituted reagents which would not be able to adopt the 
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‘kinked’ conformation necessary for binding to Hsp90, thus explaining the erroneous 
suggestion that the chaperone had no ATPase activity. 
Early studies in yeast identified distinct domains comprising the N-terminal and C-
terminal ends of Hsp90. These fragments ran from residues 1 – 210 and from residue 262 to 
the extreme C-terminus. Individually these domains were seen to be insufficient for cell 
growth in the absence of full length Hsp90 expression. Moreover in cells with a reduced wild 
type Hsp90 expression these fragments were seen to inhibit Hsp90 function when co-
expressed[25]. In light of more recent knowledge this can now be justified by the formation of 
heterodimers lacking one N-terminal domain. As discussed in detail later, two N-terminal 
domains are required for the full ATPase activity needed for client protein activation. 
 
 
1.3 The role of Hsp90 in genetic capacitance 
One role proposed for the Hsp90 molecular chaperone is as a ‘genetic capacitor’ for 
morphological and phenotypic evolution. A genetic capacitor buffers genetic variation in 
morphogenic pathways. In the same way that a molecular chaperone buffers potentially 
disruptive changes within a single cell over a short time, a genetic capacitor buffers changes in 
a genome across a longer period of time to allow normal development despite destabilising 
effects upon the organism. Hsp90 is known to associate with already predominantly folded 
proteins and its function is to allow the maturation and activation of its ‘clients’. This ability to 
stabilise partially unfolded proteins may suggest a role for Hsp90 in buffering mutational 
variation and promoting evolutionary change. This has been detailed by Lindquist et al. [24-
26;31] under a number of different circumstances. 
 Hsp90 most likely recognises characteristic features common to unstable or unfolding 
proteins rather than sequence specific motifs, thus allowing it to act upon such a large and 
diverse range of ‘clients’. Under stress conditions, such as heat shock, Hsp90 can be diverted 
to associate with a more general subset of unstable proteins to prevent their full denaturation. 
 In a study of Hsp90 mutations in Drosophila melanogaster the degree with which the 
function of Hsp90 was inhibited, either due to mutations within Hsp90 or due to exposure to 
the Hsp90 inhibitor geldanamycin [26], correlated to the spontaneous appearance of 
phenotypically visible mutations. Similar results were observed in A. thaliana [24]. 
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  It was proposed that Hsp90 normally functioned to suppress unstable genetic variation 
when expressed, and that  ‘cryptic genetic variation might be expressed to a greater extent’  in 
the case of Hsp90 inhibition [26]. The studies in A.thaliana also suggested that[24] the 
buffering capacity of Hsp90 may allow added stability against stochastic processes. When the 
buffering capacity of Hsp90 is exceeded by cell stress (increasing the amount of partially 
unfolded protein requiring stabilisation by Hsp90) or inhibited such as with geldanamycin or 
radicicol then otherwise silenced polymorphisms can prevail [24;31]. This buffering ability 
allows the organism to accumulate silent or neutral mutations thus providing a good 
environment in which beneficial or deleterious mutations can occur and be occasionally tested 
during times of environmental stress allowing selection pressure to remove unfavourable 
mutations[24].  Critically a mutation in Hsp90 is not always required, often environmental 
stress will be sufficient to exceed the buffering capacity of Hsp90 [31]. Hsp90 therefore acts as 
a capacitor for mutation allowing otherwise unrealised, and potentially useful, mutations to 
become permanent [26]. In a case where perhaps seven or eight independent determinants, 
such as mutations, are all required for a particular trait to express, this theory states that a 
slightly inhibited Hsp90 activity lowers the threshold of how many determinants are required 
before an altered trait can be expressed by erroneously stabilising the expressed gene product. 
Thus the chance that the lower number of determinants occurs in one gene increases. 
Expression of this multiply mutated protein under Hsp90 inhibited conditions allows selection 
pressure to be placed upon the mutation, which if positive, encourages the gene to gain the 
remaining determinants that allow it to express independently of impaired Hsp90 [26].  
 
 
1.4 The substrate molecules of Hsp90 
 As previously mentioned the chaperone Hsp90 acts upon a diverse but specific set of 
client proteins. Association with Hsp90 allows the activation of many of these client proteins in 
a variety of ways. Six proteins that associate with Hsp90, including co-chaperones and 
substrates, are shown in Figure 1.1. The method by which activation is facilitated however is 
still unclear despite nearly two decades of intensive study [3;32]. Although the Cdc37 co-
chaperone recruits a kinase, which may suggest phosphorylation as an activating mechanism, 
this does not explain the activation of all clients, as Cdc37 is not associated with all client / 
chaperone complexes. Some co-chaperone and client associations are shown in Figure 1.1. 
Even now a full knowledge of which proteins require Hsp90 for maturation is not known and 
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on-going efforts to discover them are regularly revealing new clients [32].  A full and regularly 
updated list of client proteins maintained by Didier Picard can be found at: 
 http://www.picard.ch/downloads/downloads.htm. 
 The ‘clients’ of Hsp90 can largely be broken down into three categories. The first is 
that of the protein kinases, the second is that of transcription factors including nuclear steroid 
receptors, while the third contains structurally unrelated proteins. This third set can loosely be 
categorised into intracellular receptors, viral replication proteins and proteins involved in 
innate immunity[32]. 
 
Figure 1.1 Top: A schematic of the full length Hsp90 chaperone in its open (left) and transiently N-terminal 
dimerised state (right). Bottom: A selection of co-chaperone and substrate proteins to Hsp90 demonstrating the 
range of binding sites across the chaperone molecule. Co-chaperones and clients not to scale. 
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The tyrosine kinase pp60v-src requires Hsp90 for its activation and accumulation[27]. 
Other kinases that require Hsp90 for activation include ASK1 and Akt/PKB. The glucocorticoid 
receptor has been shown to require continual association with Hsp90 to maintain it in a 
hormone-activatable and transcriptionally competent state[27]. Other steroid hormone 
receptors, (including those for estrogen, progesterone, androgen and mineral corticoids) also 
require Hsp90 to enable efficient steroid binding to the receptor[33]. Other proteins that 
require Hsp90 for functionality include eNOS, Bcl-xL and Apaf-1[34]. 
The tumour suppressor protein p53 is known to associate with Hsp90 only in a 
mutated form. It is known that oncogenic mutations of p53 have a lower melting point than 
the wild type p53[16]. This instability leads to partial unfolding of p53 and thus leads to its 
association with Hsp90. This leads to the stabilisation of p53 allowing its persistence within the 
cell. It has been observed by NMR that only unfolded or partially unfolded p53 associates with 
Hsp90 and  that the chaperone does not associate with p53 when it is in its native state[16]. 
Binding of p53 to Hsp90 can therefore only be induced by unfolding of p53 caused by either an 
increase in temperature or mutations that decrease the protein stability. Some NMR data 
suggest that p53 binds to Hsp90 in a predominantly flexible but unfolded state. This 
persistence of an otherwise unstable mutant protein, enabled by Hsp90, can lead to 
uncontrolled cell proliferation and tumourogenesis [16]. This role in protein stabilisation 
makes Hsp90 a good target for potential cancer treatment as inhibition of Hsp90 can prevent 
the stabilisation of otherwise oncogenic proteins. This can lead to the degradation of 
cancerous proteins or identification of the mutation by the cell and subsequently controlled 
cell death. 
 
 
1.5 The chaperone cycle of Hsp90 
Over the course of the last decade, the study of the Hsp90 chaperone cycle has 
advanced dramatically from early work realising that there was a cycle of conformational 
changes associated with ATP binding and hydrolysis, to recent work that has tracked at least 
five steps within the cycle, complete with rate constants for each transition [5;9]. 
Even before the details of the cycle were deduced it was discovered that ADP release 
was not the rate limiting step in the chaperone cycle [35]. Kinetic studies using displacement of 
(Pγ)-MABA-ATP, a fluorescent ATP analogue, from the ATP binding site of Hsp90, revealed that 
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ATP binding can be described as a one-step reversible reaction [35]. The on rate of ATP binding 
also precluded it from being the limiting step in the chaperone cycle [35]. Early studies using 
radio-labelled ATP and a ‘chase’ style experiment with unlabelled ATP revealed that ATP bound 
to the Hsp90 chaperone was committed to hydrolysis, indicating a likely conformational 
change trapping the nucleotide in place. This ‘trapping’ was observed in the full length 
chaperone and truncation mutants containing the middle domain and the catalytic loop, but 
not in the isolated N-terminal domain of Hsp90. Although the larger constructs allowed 
commitment of ATP, none of the truncations regained full ATPase activity [35].  
Transient N-terminal dimerisation was confirmed by introduction of a cysteine residue 
into surface accessible areas of the N-terminal domain and subsequent chemical cross-linking 
under different ligand bound states. Further experimentation with pyrene molecule labelling 
showed that N-terminal dimerisation was far more prevalent in the AMPPNP bound form of 
Hsp90 than the apo or ADP bound states [23] suggesting for the first time that ATP binding 
promoted N-terminal dimerisation while ADP binding did not.  
A series of C-terminal truncation mutations revealed a drastic drop in ATPase activity. 
The link between constitutive dimerisation and ATPase activity was established. It was also 
established that in the longer truncated constructs, the presence of AMPPNP bound to the N-
terminal domain led to dimerisation from an undimerised apo-state. The degree to which 
dimerisation in the presence of AMPPNP occurred also correlated with the ATPase activity of 
the construct [23].  Although the N-terminal domain of Hsp90 alone showed some limited 
ATPase activity, it was observed to be only 1% of the wild type activity and no dimerisation in 
any ligand bound state was observed[23;35]. 
The dramatic decrease in ATPase activity when there is a loss of N-terminal 
dimerisation suggested that there is a cooperative nature to the reaction, that requires both 
N-terminal domains within the dimer for efficient hydrolysis [23].  Further mutation studies 
established that N-terminal domain association between the monomers likely exploited a 
hydrophobic patch exposed by closure of the ATP ‘lid’ region. Mutations designed to stabilise 
the lid ‘closed’ conformation (such as A107N) led to increased N-terminal dimerisation and 
increased ATPase activity. When truncation mutations were used and constitutive dimerisation 
was known to not occur, the presence of the A107N mutation still led to a reduction in ATPase 
activity [23]. 
It is relatively clear now that commitment of the ATP molecule requires 
conformational rearrangement with movement of the ATP ‘lid’ over the nucleotide binding 
site. As described in more detail later this allows the middle domain catalytic loop to contact 
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the γ phosphate. Full ATPase activity requires constitutive dimerisation via the C-terminal 
domain to, in turn, facilitate transient N-terminal domain dimerisation. In order to understand 
the significance of these observations it is necessary to know more about the detailed 
structure of the Hsp90 chaperone and the role of critical key features such as the middle 
domain catalytic loop and the N-terminal domain ATP ‘lid’. 
 
 
1.6 Structural details of the Hsp90 chaperone 
 The intact full length Hsp90 molecular chaperone is a constitutive homodimer. It can 
be subdivided into three domains, the N-terminal domain, the middle domain and the C-
terminal domain. Each domain has a distinct function, however there is a large degree of 
interaction between the domains. The effect of binding and hydrolysis of ATP to the N-
terminal domain can be seen to influence the conformation of the entire protein, while 
binding of co-chaperones can also have a profound influence beyond the domain with which 
they are associated. 
 
1.6.1 Structure of the N-terminal domain 
 
 The N-terminal domain of Hsp90 can be considered to extend from the first amino 
acid residue to residue 216. It contains the ATP binding site[8] but is also the site of both co-
chaperone [7] and client binding. The N-terminal domain of Hsp90 has a high structural 
similarity to the nucleotide binding domain of DNA Gyrase B, a bacterial type II topoisomerase. 
This similarity was only recognised during the CASP2 structural prediction competition of 1997, 
whereupon it was shown that six β strands and five helices had equivalence to the DNA Gyr B 
structure, thus making it part of a gyrase, histidine kinase, and MutL (GHKL) superfamily of 
proteins [36]. 
The N-terminal domain has been crystallised in the presence of ADP  and the structure 
determined to a resolution of 1.85Å[8]  and with ATP to a resolution of 2.0Å[8], revealing 
details of the binding site and some of the contacts formed between the ligand and the protein 
(Figure 1.2). The nucleotide binding site of Hsp90 also shows many similarities to DNA GyrB 
and MutL (a DNA mismatch repair protein) [8]. The crystal structure in the presence of 
nucleotide definitively proved that the Hsp90 chaperone molecule was an ATPase.  
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Several key features of the N-terminal domain have been identified.  The nucleotide 
binding site has been identified as a deep cleft formed by a β-sheet flanked by α helices. The 
existence of an ATP ‘lid’ running from residues 98 to 120 was suggested from homology with 
DNA GyrB. The role of the first 24 residues in enabling ATPase activity has also been 
determined[8]. The importance of each of these features will be discussed in detail. 
 
Figure 1.2  Crystal structure of the N-terminal domain of Hsp90 (ribbons) bound to ADP (atoms as space-filled 
spheres). Structural features are highlighted: the binding pocket is shown in blue (the back of the pocket) and 
yellow (the flanking helices), the N-terminal helix and strand are shown in orange while the ATP lid is shown in 
green – in this instance in the ‘open’ conformation. PDB file 1AMW used for diagram. 
 
The ATP lid 
 Other members of the GHKL family require the movement of an ATP ‘lid’ from an 
‘open’ to a ‘closed’ conformation. This movement results in a covering of the entrance to the 
nucleotide binding site through the rearrangement of a specific loop region. It is probable that 
Hsp90 also requires such a lid movement.  Crystal structures of the yeast Hsp90 homologue 
have now identified the lid in two positions – the ‘open’ state seen in the isolated N-terminal 
domain[8] and the ‘closed’ state over the nucleotide binding site in the full length protein in 
the presence of the co-chaperone p23 [7]. 
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Studies of the lid position of the bacterial Hsp90 molecule suggest that not only does 
the position of the lid affect the binding and hydrolysis of ATP but that it also has an influence 
over the binding and release of client proteins [6]. Heterodimers of wild-type yeast Hsp90 and 
mutants with a lid deletion showed increased ATPase activity on the wild type monomer, 
suggesting that transient N-terminal dimerisation was still occurring despite the absence of the 
ATP lid; indeed analytical gel filtration results suggest that in a dimer comprising two lidless 
mutants the N-terminal dimerisation becomes highly stabilised [10]. 
Combined EM and crystal data suggests that movement of the lid couples ATP 
hydrolysis to the client protein binding and release. Crystallographic and EM studies involving 
the bacterial Hsp90 suggest that in addition to the ‘open’ and ‘closed’ states seen in yeast 
crystal structures [7;8] there may be two further distinct lid conformations. The first of these 
conformations may be a state where prior to nucleotide binding the lid partially occludes the 
binding site and a large amount of exposed hydrophobic surface area is presented to 
encourage client association. This state is observed when the two ‘arms’ of the Hsp90 
chaperone are widely splayed and is incompatible with other known N-terminal and middle 
domain arrangements due to steric clashes. Movement between the two known arrangements 
of the two domains would require rearrangement of the lid region (Figure 1.3). The second 
potential lid state is observed following ATP hydrolysis in the highly compact ADP bound state. 
In this state the lid may arrange itself to bury hydrophobic surface area newly exposed 
following the condensation of the chaperone dimer to a more compact form following 
nucleotide hydrolysis. This may aid in client protein dissociation by reducing accessible 
hydrophobic surface contacts [6].  
 
Figure 1.3 Comparison of the ATP 'lid' open and closed forms. The ‘open’ form is from the crystal structure of the 
isolated N-terminal domain bound to ADP. The ‘closed’ form is a proposed model based upon the full length 
crystal structure of Hsp90 by Ali et al. [7] in the presence of ATP and p23. The same colouring scheme applies as 
in Figure 1.2. PDB file 1AMW used for ‘lid open’ form, same file modified  and used for ‘lid closed’ form. 
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The direct comparisons that can be drawn between the bacterial Hsp90 and the 
eukaryotic yeast Hsp90 are limited, however the ability of the lid to adopt a varied range of 
conformations is likely to apply across species even though the details will likely be different. 
Knowledge that both bacterial and yeast Hsp90 undergo a complex series of conformational 
changes upon ligand binding and hydrolysis, together with the detail resolved regarding the 
bacterial chaperone ATP ‘lid’ conformations, suggests that a similar level of complexity may 
exist in eukaryotic Hsp90 but is not obviously reflected by the two known crystal structures. 
Indeed work by Dollins et al. [4] on the mammalian Hsp90 endoplasmic reticulum isoform of 
Hsp90 (Grp94) suggested the existence of a new ‘ground state’ form. In this form the binding 
of ATP did not induce instant conformational change without further input from clients or co-
chaperones. This ground state prevented the association of the N-terminal domains and thus 
did not favour ATP hydrolysis. The existence of this ‘ground state’ may explain the low ATPase 
rate seen in the Hsp90 chaperone family compared to other ATPase’s in the GHKL family [4], 
and shows similarity to the pre-ligand bound state observed in the bacterial Hsp90 crystal 
structure described previously [6]. 
 
The nucleotide binding site 
 The nucleotide binding site of Hsp90 is shown in detail with ADP bound in the crystal 
structure solved by Prodromou et al. [8]. The binding site described in that paper contains the 
nucleotide and a number of water molecules with the position of the magnesium ion modelled 
in. The nucleotide is bound both directly to the protein and indirectly via water molecule 
contacts that mediate between ligand and chaperone (Figure 1.4). The adenine ring of ADP 
makes direct contact, via a hydrogen bond, from the N6’ atom of the ring to the carboxyl 
group of Asp79. Interactions between the adenine ring and the side chain of Met84 via van de 
Waals forces also occur. Indirect links with the adenine ring include contact between the N1’ 
atom and a water molecule that then contacts Asp79, Gly83 and Thr171. Water-mediated 
contacts are also made between N6’ of the ring and the backbone carbonyl of Leu34, N3’ of 
the ring and Asp92 and N7’ of the ring and Asn37 [8].  The O2’ atom of the ribose of ADP 
makes a direct contact to Asn92. Other water mediated contacts between the ribose and the 
protein include from the O2’ and O3’ atoms to Lys44 and from  O2’ ribose to Asn92, in addition 
to the direct contact also made between these two [8]. 
 The phosphate groups are also involved in both direct and indirect binding contacts to 
the protein. Direct contacts include an oxygen of the α-phosphate to the amide nitrogen of 
Phe124 and the β-phosphate to Lys98. Indirect contacts include the association of the β-
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phosphate to a water molecule at the pocket’s mouth. The phosphate groups are also 
responsible for the contacts to the Mg2+ ion known to be essential for ligand binding. Both α- 
and β-phosphate groups contact the ion which in turn contacts amide oxygen atom of Asn37 
and three further water molecules within the binding site [8]. The location and interaction of 
the terminal phosphate was not present in the ADP bound crystal structures solved by 
Prodromou et al. [8]. The full length crystal structure later solved by Ali et al. [7] did show the γ 
phosphate and revealed a contact between it and residue Arg380 from the middle domain. 
Confirmation of the importance of Arg380 is described later. 
 
Figure 1.4 Contacts within the ATP binding site of the N-terminal domain of Hsp90. Direct and water mediate 
contacts are shown with connecting lines. Van de Waals contacts are shown behind curved lines. Based upon 
data given in Prodoromou et al. (Cell 1997) [8]. The schematic highlights the difference between ADP and 
AMPPNP ligands, the binding of which will be discussed in depth below.  
 Ligand binding is known to lead to conformational changes within the intact Hsp90, 
however H/D exchange mass spectroscopy does not suggest that large structural or dynamic 
changes occur upon ADP binding compared to the apo-state sufficient to alter the exchange 
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rate of protons from the molecule. All that is observed is the stabilisation of amide bonds at 
the back of the binding site pocket [37]. 
 
Residues 1 – 24: The N-terminal helix and strand 
It soon became apparent that the first 24 amino acids played a critical role in 
controlling the ATPase activity of the Hsp90 chaperone[38]. Truncation mutants from the N-
terminal of the chaperone revealed that binding affinity of ADP was unaffected, as were the 
on- and off-rates. It was observed, however that removal of the first 8 amino acids led to an 
increase in ATPase activity above base level, further truncations of 16 and 24 amino acids then 
severely reduced the ATPase activity of the full length protein [38]. Since it is known that 
transient N-terminal dimerisation is required for ATPase activity, the contribution of the N-
terminal strand to this dimerisation was tested by mixing wild-type Hsp90 with the truncation 
mutants. This revealed that the first 24 amino acids were key in forming a transient N-terminal 
dimer to allow efficient ATP hydrolysis. In isolation the crystal structure of the N-terminal 
domain [8] does not reveal why this might be the case. The full length crystal structure [7] can 
explain the observations through interactions made by the two N-terminal domains (Figure 
1.5). Details of these interactions are discussed later in regard to the whole chaperone 
molecule.  
In the presence of ADP the wild-type crystal structure shows a hydrophobic interaction 
between the lid and the helix and loop regions formed by residues 10 – 27, suggesting that this 
‘open’ conformation is stable. Crystallisation of a mutant of the N-terminal domain of Hsp90 
lacking the residues 1 – 24 showed the ATP ‘lid’ to be in a more open conformation than  
previously observed [10]. The association between the lid and residues 10-27 seen in the 
structure by Ali et al. [7] explains why deletion of the N-terminal strand and helix leads to an 
increased flexibility in the lid region observed by Richter et al. [10] and implies that the ATPase 
activity can also be influenced by the lid region as well as the immediate binding site. 
 The relative influence of the lid and the N-terminal 24 residues can be investigated 
using deletion mutations. Removal of the lid led to no change in nucleotide binding properties. 
Removal of the lid and the N-terminal strand, however, did lead to a seven fold increase in 
dissociation rate of the ligand from the binding site and inhibited the ATPase activity [10]. An 
absence of transient N-terminal dimerisation in double mutants  suggests that the influence of 
the N-terminal 24 residues over this conformational change is greater than the influence of the 
lid [10]. 
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Figure 1.5 Diagram showing the N-terminal 24 residues involved in a strand swap event during transient N-
terminal dimerisation from the full length structure by Ali, et. al. [7]. PDB file 2CG9 used for diagram. 
 
1.6.2 Thermodynamics of nucleotide ligand binding 
 
 The thermodynamics of ligand binding are important to record in order to understand 
the nature of ligand binding and how this may influence the conformational changes known to 
occur in Hsp90. Through the use of ITC the enthalpy (ΔH), entropy (ΔS), binding affinity (Kd) 
and stoichiometry (N) of the reaction can all be determined from a single experiment. The 
relationship between these values and how they respond to different conditions (such as a 
change in temperature) can be used to determine something of the nature of the binding site.  
A recent study by Nilapwar et al. [17] demonstrated the need for increased knowledge 
of the relationship between the thermodynamics of ligand binding and associated 
conformational changes within Hsp90. By comparing the thermodynamic properties of binding 
of the adenine based compounds AMPPNP, ADP, cAMP and the Hsp90 inhibitor compound 
geldanamycin and its analogues 17-AAG and 17-DMAG, various interesting facts emerged. 
Geldanamycin and its associated compounds bound with a 20-fold higher binding affinity and 
with a favourable entropy (ΔS) component to the binding. In contrast the adenine based 
compounds bound less tightly with a less favourable ΔS component, but with a similar  
enthalpy (ΔH) component suggesting that the difference in ΔS was responsible for the 
increased affinity.   
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The change in heat capacity (ΔCp) of binding represents the change in enthalpy (ΔH) of 
a reaction with respect to temperature. Contributions towards the ΔCp can include covalent 
bond formation, the burial of surface area and the charge state of the atoms. More detail on 
utilising the recorded ΔCp values are discussed in Chapter 2. The change in heat capacity (ΔCp) 
of binding between the ligands to the N-terminal domain of Hsp90 ranged from positive to 
negative values– a previously un-encountered situation for a single binding site in response to 
different ligands. The ansa-ring compounds have a negative ΔCp, however, in contrast, ADP has 
a ΔCp close to 0, while AMPPNP shows a positive ΔCp [17]. 
A positive contribution to ΔCp by the binding of water molecules to the complex 
interface could not be ruled out by mutation studies, as the mutations knocked out the binding 
capacity of the protein [17]. In predictions, the difference in hydrogen bonding water networks 
around the adenine- compared to the ansa-ring based compounds should lead to a more 
negative value of ΔCp rather than a more positive one. This leads to the conclusion that there 
must be another process affecting the heat capacity [17].  The differences in ΔCp between ADP 
and AMPPNP show that the profiles of each are distinct and that information derived for one 
bound state cannot automatically be applied to the other bound state. This ties in with the 
knowledge that structurally the ADP and AMPPNP bound states appear to be distinctly 
different steps in the chaperone cycle [5;9]. It is therefore important to understand the 
thermodynamics of each state separately. 
 The effects of pH on the binding affinity suggested a single protonation event involved 
in the process of AMPPNP binding. However this appeared to have no effect on the ΔCp which 
remained positive throughout the pH range tested (pH 5 – pH 10). The influence of the ionic 
environment over the ΔCp was ruled out through experiments conducted over a range of 0 – 
200 mM NaCl, which showed no change in ΔCpobs.A full characterisation of the effect of this 
protonation event has not been undertaken, nor has the effect of pH on any other ligand been 
investigated.  
Having ruled out many of the main possibilities that could contribute towards the 
positive heat capacity the paper by Nilapwar et al. [17] concluded that conformational changes 
as the most likely explanation of the positive ΔCp. Crystals structures show the location of the 
binding pocket in the apo-form and the position of ADP within the binding pocket [8].  
Structural differences between the ligand bound states was confirmed by NMR [17]. 
That there are differences in structure between the ligand bound states of the N-terminal 
domain alone is clear from the NMR shifts observed. This ties in with previous studies that also 
suggest conformational changes within the chaperone protein. The presence of ligand bound 
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to the N-terminal domain of Hsp90 led to a number of chemical shifts suggesting a change in 
environment. Figures 1.6 and 1.7 show NMR data collected for this thesis that agree with the 
data previously reported by Nilapwar et al. [17] and Kessler et al. [19] demonstrating the 
chemical shifts induced by ADP and AMPPNP binding respectively.  Since these shifts extend to 
beyond the binding site itself, this suggests a more significant range of conformational 
changes. Overlays of the NMR spectra in the apo and ligand bound states are shown in Figures 
1.6 and 1.7. Residues corresponding to the suspected ATP lid are not visible within the spectra.  
 
Figure 1.6 Overlay of the HSQC spectra for the apo and the ADP bound state of the N-terminal domain of Hsp90 
showing significant differences between the two. Recorded in 20 mM Tris, 5 mM Mg2+, at a concentration of 300 
µM N-terminal domain, 5 mM ADP, pH 8, 700 MHz field strength at 25°C. 
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Figure 1.7 Overlay of the HSQC spectra for the apo and the AMPPNP bound state of the N-terminal domain of 
Hsp90 showing significant differences between the two. Recorded in 20 mM Tris, 5 mM Mg2+, at a concentration 
of 300 µM N-terminal domain, 5 mM AMPPNP, pH 8, 700 MHz field strength at 25°C. 
As discussed below it is known that Hsp90 goes through a series of conformational 
changes driven by the binding and hydrolysis of ATP, however descriptions of each stage of the 
cycle lack atomic resolution. It has already been established that the movement of the lid is 
critical for full Hsp90 activity and that it can influence the overall chaperone cycle [4;6-8;10]. 
Establishing the exact nature of the movement of the lid during the chaperone cycle is 
important to the understanding of the overall function/action of Hsp90.  
 
Ligands and inhibitors 
There are two very well known inhibitors of Hsp90 activity, both of which bind in the 
ATP binding pocket in the N-terminal domain. The first is geldanamycin and its relatives such 
as 17-AAG and DMAG; the second is radicicol which differs in its structure from geldanamycin 
but acts in a similar fashion. It has been known for a long time that geldanamycin, an ansa-ring 
based compound, was an inhibitor of Hsp90 activity. However it was not known how it 
affected the chaperone. With the work of Roe et al.[21] it became apparent that geldanamycin 
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and radicicol bound to the nucleotide binding site, acting to block ATP binding. Both ligands 
are shown in Figure 1.8. 
The crystal structure of geldanamycin bound to the ATP binding site within the N-
terminal domain of Hsp90 shows the ansa-ring of the compound located in the base of the 
binding pocket close to where the adenosine ring of ATP would normally sit. The 
benzoquinone ring of geldanamycin then bends towards the opening of the pocket; this is 
similar to the positioning of the phosphate groups of the native nucleotide when bound. In this 
state geldanamycin is bent significantly compared to its solution state. This ‘bent’ 
conformation is reminiscent of the ‘kinked’ binding conformation adopted by ATP [21]. 
Geldanamycin binding to Hsp90 was established by ITC to have a Kd of 1.2µM in a binding 
interaction that showed an unfavourable entropy. This unfavourable entropic component of 
association can be explained by the minimal release of ordered water molecules upon binding 
[21].   
The crystal structure of radicicol bound to the N-terminal of Hsp90 shows that the 
aromatic ring takes the role of the adenosine group and points towards the bottom of the 
nucleotide binding pocket. The macrocycle and conjugated bond system of radicicol are thus 
left to point towards the top of the binding pocket, with a similar orientation to the phosphate 
groups of the native ligand. The folding of radicicol into the pocket is less dramatic than that 
observed for either geldanamycin or ATP, and is far closer to the free solution structure of 
radicicol. Radicicol binding to Hsp90 was established by ITC to have a Kd of 19nM in a binding 
interaction that showed a favourable entropy. The favourable entropic component of the 
association may well be explained by the displacement of a large number of ordered water 
molecules from the binding site [21]. 
Chemical shift perturbation studies rely upon monitoring the change frequency of a 
given resonance arising from the change in environment of a given group. This change in 
environment can be due to the proximity of a new chemical group such as when a ligand binds 
to a protein via direct contacts. More often it is due to a conformational change which alters 
the environment of the group and thus leads to a shift in the chemical frequency detected for 
that atom pair. 
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Figure 1.8 Diagram of the chemical structures of the ligands ATP/AMPPNP, geldanamycin and radicicol. 
NMR chemical shift perturbation studies revealed distinct shifts for the binding of both 
geldanamycin and radicicol to the N-terminal domain of Hsp90[17;19]. Shifts observed for 
geldanamycin binding were large compared to both nucleotide binding and the binding of the 
inhibitor radicicol. Large shifts were seen at the bottom of the binding pocket in the 
surrounding two α-helices (residues 10 – 22 and 28 – 50). The shifts in this region were similar 
to those seen for radicicol and the nucleotide based ligands. Shifts for the long α-helix 
(residues 28 – 50) show that geldanamycin induces movement similar to the nucleotide based 
ligands, in contrast to radicicol which shows very few shifts in this region [19] compared to the 
regions previously described.  
The pattern of chemical shifts observed for radicicol binding differs significantly from 
that seen for the binding of AMPPNP or ADP to the N-terminal domain. The differences can be 
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explained by consideration of the known crystal structures, where Radicicol is seen to make 
different contacts with Hsp90 to other known ligands. Some shifts due to Radicicol were 
smaller while others were larger than shifts induced by nucleotide binding. Larger shifts 
mapped to the base of the binding pocket [19], which matches the crystal structure observed 
in which the small radicicol molecule inserts more deeply into the binding pocket than the 
nucleotides. Decreased shifts matched the observation that fewer contacts are made in the 
upper region of the binding pocket [21]. When radicicol binding to the full length Hsp90 
chaperone was observed via H/D exchange mass spectroscopy, an increased degree of proton 
protection was observed at the bottom of the binding pocket sufficient to confirm that the 
ligand had bound but insufficient to suggest large scale structural rearrangements [37]. A small 
increase in protection from proton exchange in the ligand binding pocket combined with no 
change in proton exchange rate in the lid region of the N-terminal domain was observed in the 
radicicol bound state compared to the apo state. This suggests that when bound to the 
inhibitor, the chaperone adopts an ‘open’ conformation as is also suggested to be the case in 
the ADP bound and apo states [37]. 
 
1.6.3 Structure of the middle domain 
 
The middle domain extends from residues 262 to 551. Unlike other members of the 
GHKL family, the connection between the N-terminal and middle domains of Hsp90 is not 
formed from a continuous element of secondary structure, but is instead linked by a long 
flexible region of around 50 amino acids. This flexible region varies across species, but includes 
a positively charged region of between 20 – 30 amino acids that is often subject to hydrolysis. 
The crystal structure of the isolated 33kDa middle domain was solved to a resolution of 2.5Å 
by Meyer et al. [12]. From this structure, three main regions can be defined. Initially there is an 
αβα sandwich domain made up of a five stranded β-sheet flanked by a three turn and a six 
turn α-helix (see Figure 1.9). This fold is similar to that found in MutL and GyrB, members of 
the GHKL family to which Hsp90 also belongs [12]. The αβα sandwich is followed by a three 
helix right handed coil followed by a second αβα sandwich motif [12]. This second novel αβα 
sandwich fold is distinct from the second αβα sandwich motif observed in MutL and GyrB, 
although there is still some limited similarity between them [12]. 
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Figure 1.9 Crystal structure of the middle domain of Hsp90 highlighting the key three regions. The αβα sandwich 
followed by the three helix turn followed by the final αβα sandwich. The catalytic loop (approx. location of start 
of loop is starred) containing residue Arg380 is too flexible to be resolved in this crystal but is located in the first 
αβα sandwich. Diagram taken from the PDB file 1HK7. 
It is known that in isolation the N-terminal domain of Hsp90 has a very low ATPase 
activity. Using the homology between MutL, GyrB and Hsp90 it was predicted that a catalytic 
residue was required from the middle domain to facilitate ATP hydrolysis within Hsp90. 
Conserved between Hsp90 and MutL and GyrB is a motif found on the tip of the middle 
domain loop: 377- N(L/I/V)SRExLQ -384. Three residues, Asn377, Arg380 and Gln384, are 
completely conserved in Hsp90 and capable of interacting with the γ phosphate of ATP. 
Mutational analysis revealed that two of these residues, (Arg380 and Gln384 – equivalent to 
Lys337 and Gln335 respectively in GyrB) showed severe retardation of ATPase activity when 
mutated [12].  The crystal structure shows that both Arg380 and Gln384 are in a position that 
is able to interact with the N-terminal domain and this interaction was later confirmed by the 
full-length structure [7] where Arg380 is pointing into the base of the binding pocket. The loop 
in which Arg380 sits is known as the ‘catalytic loop’. H/D mass spectroscopy studies of the 
middle domain suggest that ligand binding influences the degree of secondary structure in the 
catalytic loop. The presence of the inhibitor DMAG (an inhibitor based upon geldanamycin) has 
a destabilising influence over any secondary structural elements within the catalytic loop, thus 
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leading to more proton exchange in this region. How this compares to a nucleotide bound 
state is unclear [37].  
The long linker connecting the N-terminal and middle domains does not prevent 
domain association. Since Arg380 from the middle domain is required for hydrolysis, the 
stability of the interaction must be sufficient to allow this to occur. The surface of the middle 
domain, close to the N-terminal interaction site, contains a hydrophobic ‘patch’ centred on 
Phe349 and close to the catalytic loop already mentioned[12]. H/D exchange mass 
spectroscopy data also suggests interaction between the N-terminal and middle domains of 
Hsp90 centred on this hydrophobic patch[37]. This hydrophobic patch interacts with the 
hydrophobic surface exposed by ATP ‘lid’ closure on the N-terminal domain [7]. This 
interaction was disrupted by mutations in the middle domain hydrophobic patch [12]. Both 
Phe349Ala and Phe349Gln mutants showed a severe retardation of ATPase activity. This 
confirms that association between the N-terminal and middle domains of Hsp90 is required for 
full hydrolysis activity, in order to align the catalytic loop of the middle domain correctly with 
the nucleotide bound to the N-terminal domain [12]. 
The crystal structure reveals a hydrophobic patch on the inside face of the middle 
domain of Hsp90 with respect to the dimer arrangement. This region has been suggested as a 
potential client binding site due to the known association of Hsp90 to partially unfolded 
‘clients’ exposing hydrophobic regions.  The middle domain also contains an amphipathic loop 
with both a positively charged and a hydrophobic face. Mutation studies have established that 
this region is required for the association of the client PKB/Akt to Hsp90, but does not affect 
ATPase activity [12]. The co-chaperone Aha1 associates with the catalytic loop of the middle 
domain and mutations within this loop, such as Glu381Lys, lead to abolition of binding 
between Aha1 and Hsp90 without inhibition of the ATPase activity of the chaperone [12]. 
 
1.6.4 Structure of the C-terminal domain 
The role of the C-terminal domain is to both maintain dimerisation and provide 
binding sites for various co-chaperones and client proteins. The C-terminal domain runs from 
residues 551 to the end and contains both a coiled-coil region, responsible for dimerisation, 
and a ‘MEEVD’ TPR domain binding motif at the extreme C-terminus that is involved in 
interaction with some co-chaperone and client proteins which contain TPR domains.  The 
structure of the isolated C-terminal domain has been solved for the bacterial HtpG homologue 
to a resolution of 2.6Å [11], while the structure of the yeast homologue shows most, but not 
all, of the C-terminal domain in the full length structure already [7]. 
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Both structures agree that the C-terminal domain comprises of a short α-helix followed 
by a three strand anti-parallel β-sheet, within which is a loop region and a short helix involved 
in co-chaperone/client interactions. Beyond the β-sheet are three more helices, with the final 
two forming the dimerisation coiled-coil interface [11]. However, major differences between 
the two crystal structures can also be observed. The full length crystal shows a helix-strand 
protrusion from the C-terminal domain that reaches towards the N-terminal domain and which 
interacts with its equivalent structure from the opposite dimer. In the HtpG structure this 
protrusion is orientated significantly differently to the yeast homologue. 
Constitutive dimerisation via the C-terminal domain of Hsp90 allows the chaperone to 
maintain a high local concentration of the N-terminal domain since the two N-terminal 
domains will be tethered close enough to one another to facilitate their interaction. 
Constitutive dimerisation also provides the correct alignment of each N-terminal domain to 
facilitate transient dimerisation during the chaperone cycle, despite the low affinity for self-
interaction of the N-terminal domain in isolation. As previously mentioned this transient 
dimerisation is critical for full ATPase activity.  
 
Figure 1.10 Ribbon representation of the crystal structure of the yeast C-terminal domain of Hsp90 showing the 
four helix bundle dimerisation site [7]. Diagram taken from PDB file 2CG9. 
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The constitutive dimerisation interface predominantly comprises of two helices from 
the C-terminal domain of each monomer, these four helices associate in a 4-helix bundle [11] 
(Figure 1.10). A third terminal helix provides some additional contact through two hydrophobic 
residues contacting the core four helix bundle (see Figure 1.10). The association of the 
monomers leads to the burial of a large quantity of hydrophobic surface area and as a result 
the dimerisation is highly favoured with a Kd of 60nM in the yeast homologue [13] and 24nM in 
the bacterial HtpG [11].  H/D mass spectroscopy reveals a single amide within the small β-
sheet of the C-terminal domain that becomes completely inaccessible when radicicol is bound 
to the Hsp90 dimer although the identity of the amide is unclear. The interface between the 
middle domain and the C-terminal domain also becomes more protected in the inhibitor 
bound state, with three additional amide bonds protected in comparison to the apo-state. This 
suggests an overall more compact state under some ligand bound conditions [37]. The HtpG 
homologue of Hsp90 naturally lacks the C-terminal ‘MEEVD’ motif [11] and the structure of the 
yeast homologue is disordered in this region [7]. Structural alignment of the bacterial and 
yeast homologues however suggests that if the MEEVD sequence was present it would extend 
away from the dimer interface, accessible to the solvent and binding partners [11]. 
Studies in both human and yeast Hsp90 have suggested that one residue within the C-
terminal domain has a significant influence over the chaperone’s ATPase activity. This residue 
is located in the β-sheet of the C-terminal domain; in the human Hsp90 homologue this 
residue is Cys597, while in the yeast homologue it is Ala577 [39]. The S-nitrosylation of this 
residue in both homologues leads to a decrease in ATPase activity. Mutations in the yeast 
homologue of Ala577 to Cys or Ile enhance the inherent ATPase activity of the chaperone, 
while mutations to Asp or Asn reduce it[39]. Mutations of residues of surrounding Ala577 in 
both sequence and space had little or no effect on the chaperone ATPase activity[39]. Both 
mutations and S-nitrosylation of the key residue lead to a decrease in the ATPase activating co-
chaperone Aha1 associated with Hsp90. FRET analysis of dimer formation and dissociation 
revealed that mutations of the key residue led to a change in dimer affinity. Mutations that 
enhanced the ATPase activity also enhanced the affinity of Hsp90 dimer formation and vice 
versa[39]. Both in vivo and in vitro observations showed that mutations that led to tighter C-
terminal dimer formation also led to a stronger activation of client proteins.  The mutations 
introduced that enhanced dimerisation, ATPase activity and client activation are also known to 
stabilise β-sheet structures while the destabilising mutants also destabilise β-sheets. Since it is 
known that the chaperone cycle of Hsp90 is dynamic and relies upon an equilibrium between 
states, this mutation may well shift the equilibrium towards the ‘open’ state within the cycle. 
As the inhibitory mutations mimic S-nitrosylation, this perhaps indicates a reversible, post-
translational regulation mechanism for the Hsp90 chaperone [39].  
 
45 
1.6.5 Inter and intra-molecular domain interactions of the Hsp90 dimer 
 
Although the individual domains of Hsp90 have been studied in some depth, the 
interaction between the domains is key to understanding the chaperone function. The 
interplay between the domains and their response to both ligand binding and co-
chaperone/client protein interaction is discussed here. 
The idea of a ‘ground state’ has already been discussed, however the molecular details 
of the transition from this ‘ground state’ [4] to the first step in the chaperone cycle and from 
there on to the other known conformations of Hsp90 is still elusive, but clearly involves 
domain rearrangement. Electron microscopy (EM) data for the apo state full length 
mammalian Hsp90 show two distinct conformations of the dimer with a distribution of 90% to 
10% in each form respectively. The first is an elongated so called ‘flying seagull’ structure, 
estimated to be 195 Å x 90 Å using SAXS (small angle x-ray scattering) data where the C-
terminal domains are joined and the N-terminal domains point in opposite directions. The 
second distinct shape is a more compact ‘v’ shape, not detected in the SAXS experiments [40] 
but visible in the EM study. This ‘v’ shape conformer shows a similar C-terminal domain 
arrangement to the more open ‘flying seagull’, however the N-terminal domains are 
orientated differently – both closer to one another and facing in the same direction [40]. A 
transition between the forms would require two rotations, one of 30° and one of 80° in 
orthogonal directions around the dimer’s symmetry axis [40]. The ‘v’ shaped structure may 
represent a transition state from the open to the closed conformation of the Hsp90 chaperone 
cycle, while the extended ‘flying seagull’ may show the extended ‘ground state’ suggested by 
Dollins et al. [4].  
The only crystal of the full length Hsp90 dimer was solved using the yeast homologue 
by Ali et al. [7] and shows the chaperone with transiently dimerised N-terminal domains facing 
each other with the remainder of the protein in a non-compact state. Hsp90 was crystallised in 
the presence of the non-hydrolysable ATP analogue AMPPNP, and the co-chaperone p23/Sba1 
which is a known inhibitor of the ATPase activity [20]. The 3.1Å resolution crystal structure [7] 
shows a dimer of the full length Hsp90 with two copies of p23/Sba1, symmetrically bound on 
either side of the dimer at the N-terminal end of Hsp90.  
The overall architecture of the dimer confirms a parallel arrangement with a left-
handed twist about the central longitudinal axis of the chaperone. An amphipathic loop from 
the middle domain (residues 329 – 339) is observed projecting from the inner face of the 
monomer towards its dimerisation partner[7].  The C-terminal domain and the middle domain 
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of each Hsp90 monomer are linked by an extended loop. The MEEVD sequence at the very C-
terminal of Hsp90 is disordered in this crystal and cannot be seen, although its importance has 
already been mentioned [7].   
Differing from the middle domain/C-terminal domain crystal structure[4],  the 
interface between the middle and C-terminal domains in full-length Hsp90, shows an 
additional ‘flexing’ in the presence of ATP. This ‘flexing’ of the chaperone results in the middle 
domains of each dimer moving 10 Å closer together at the C-terminal end and 20 Å closer at 
the N-terminal end. This movement then leads to a displacement and induction of disorder of 
the C-terminal protrusion previously described. Several temperature sensitive mutations can 
be traced back to this region, showing its significance.  
The full-length crystal structure [7] also shows important detail concerning the N-
terminal /middle domain interface. In the yeast homologue, residues Thr22, Val23 and Tyr24 
on the N-terminal domain form a hydrophobic interaction with residues Leu376 and Leu378 
from the catalytic loop of the middle domain. The interaction of the leucine residues suggests 
that the N-terminal and middle domain interactions aid in the positioning of the catalytic 
residue (Arg380) when ATP, or a suitable analogue, is bound. Another key interaction between 
the two domains of Hsp90 is the packing of Phe200 from the N-terminal domain into a pocket 
formed by the middle domain residues Thr273, Pro275, Trp277, Phe292 and Tyr344.  
Perhaps the most dramatic change in conformation upon AMPPNP binding is the 
dimerisation of the two N-terminal domains of Hsp90 (Figure 1.11). The crystal structure 
provides some explanation for the results of mutational analysis of the N-terminal strand 
discussed earlier. 
The N-terminal β-strand (residues 1 – 9) moves out from the main body of the domain 
and exchanges with its equivalent structure in the dimer partner. The strand then associates 
with the β-sheet of the other N-terminal domain. This ‘strand swap’ is also associated with a 
movement of the first α-helix from residues 13 – 22 to allow the initial strand movement.  This 
strand swap stabilises the transient N-terminal dimerisation and thus the ATPase competent 
state. Removal of this helix would destabilise this state and lead to a decrease in the ATPase 
activity, thus explaining the mutational observations of the same[38]. 
The other significant conformational change within the N-terminal domain is the 
closing of the ATP ‘lid’ region (residues 94 – 125) over the ATP binding pocket. This ‘lid’ 
movement results in the exposure of two hydrophobic patches, one around Leu 15 and Leu 18 
and the other on the back of the lid involving residues 95-97 and Phe120. These exposed 
regions form hydrophobic contacts with their partner areas on the other half of the 
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dimer[7;23]. This association leads to the burial of exposed hydrophobic surface area, which in 
turn leads to the stabilisation of the transient N-terminal dimerisation of Hsp90.  
 
 
Figure 1.11 Crystal structure of the closed Hsp90 dimer bound to AMPPNP[7]. On one monomer the domains are 
highlighted in orange (N-terminal domain), green (Middle domain) and blue (C-terminal domain). PDB file 2CG9 
was used for this diagram. 
The full length crystal structure [7] in the presence of AMPPNP and p23/Sba1 reveals 
elements of the overall arrangement of the Hsp90 dimer that are not evident from the 
individual domains alone. Crystal structures such as those mentioned above [4;7;8;12] give 
some insight into the chaperone cycle under different ligand-bound conditions. The many 
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subtle differences identified between the structures however highlights the importance of 
understanding the entire chaperone cycle in order to understand the complex interplay 
between ligand binding, hydrolysis, co-chaperone influence and ultimately Hsp90’s effect on 
its ‘clients’. 
 
1.7 The influence of co-chaperones on Hsp90 
 Co-chaperones are proteins that associate with the Hsp90 chaperone molecule and 
either enable the recruitment of client proteins, alter the functionality of Hsp90 or facilitate 
specific client protein activation. Binding of a co-chaperone to the N-terminal, middle or C-
terminal domains of Hsp90 are all possible and the location of the binding site often, but not 
always, corresponds to the function of the co-chaperone. Those that bind on or close to the N-
terminal domain of Hsp90 tend to influence the ATPase activity of the chaperone, while those 
that bind on or near the C-terminal domain are more likely to be involved in client protein 
recruitment or activation. Binding of a co-chaperone to the middle domain of Hsp90 may 
indicate a role in either modification of the ATPase activity or client interaction [3].  
 One class of Hsp90 co-chaperones are those that contain a TPR (tetratricopeptide 
repeat) domain that can associate with the TPR binding motif found at the extreme C-terminal 
end of the C-terminal domain. This short peptide sequence – MEEVD – is found on a highly 
flexible region in the final 35 amino acids of the protein and is not visible on the crystal 
structure of the full length Hsp90 [7]. Not all TPR domain-containing proteins are necessarily 
co-chaperones of Hsp90, nor do all co-chaperones containing TPR domains bind via that 
domain. For example the co-chaperone Stg1 does not require its TPR domain to associate with 
Hsp90 [3]. 
Of those co-chaperones that do associate to Hsp90 via their TPR domains, this is often 
the only link between them. The protein WISp39 is involved in client recruitment, while Sti1 is 
involved in recruitment of other co-chaperones. Other TPR domain-containing proteins have 
an active role such as protein phosphatase 5 (PP5), which is a Ser/Thr protein phosphatase or 
CHIP, which is an E3/E4-ubiquitin ligase [3]. 
Another class of Hsp90 co-chaperones are those that influence the ATPase activity of 
the chaperone. These co-chaperones tend to bind to the N-terminal or N-terminal and middle 
domains of Hsp90 close to the ATP-binding site, but even here their influence is not always 
limited to nucleotide binding and hydrolysis. It is known that p23, Sti1 and Cdc37 all inhibit the 
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ATPase activity of Hsp90, however the latter two proteins are also thought to be involved in 
client protein recruitment. Sti1 is also different to the other two co-chaperones in that it 
affects the ATPase activity of the chaperone despite binding to it at the opposite end of the 
protein to the nucleotide binding site. It is thought that it may stabilise Hsp90 in a 
conformation that does not support ATPase activity, but this is not fully confirmed [32]. In 
contrast the co-chaperone Aha1 is known to enhance ATPase activity within Hsp90 [3] binding 
to the N-terminal and middle domains, while Cpr6 enhances ATPase activity by displacing Sti1 
bound to the TPR domain binding motif. 
 
1.7.1 Sba1/p23 
 
 The co-chaperone p23 is known to bind preferentially to the N-terminal domain of 
Hsp90 in the ATP bound state and plays a role in inhibiting ATPase activity [7]. NMR analysis of 
p23’s association with Gallus gallus Hsp90 showed significant peak broadening upon the co-
chaperone, indicating binding to a larger partner, namely the Hsp90 dimer, but only in the 
presence of ATP [14] and it was later found that the co-chaperone p23 does bind to the apo-
Hsp90 molecule, but with a 70-fold weaker affinity than the AMPPNP bound form [20].  The 
binding affinity of p23 to Hsp90 is also known to be reduced when mutations that destabilise 
the transient N-terminal dimerisation of Hsp90 are used. From the binding studies between 
p23 and Hsp90 it can be observed that association of co-chaperone to chaperone requires the 
dimerisation of the N-terminal domains of Hsp90, and is not simply due to the binding of ATP. 
However, since the ATP bound state of Hsp90 favours N-terminal dimerisation, often higher 
affinity binding of p23 to the chaperone is be seen in the presence of ATP [20].  
The full length crystal structure solved by Ali et al. [7] shows two p23 molecules 
associated with the Hsp90 dimer in a symmetrical fashion [7]. The reason for the decrease in 
affinity between P23 and Hsp90 in the absence of dimerisation is evident from the structure; 
p23 binds partially to both N-terminal domains within the Hsp90 dimer (Figure 1.12). Thus any 
effect that decreases the likelihood of transient N-terminal dimerisation, be that mutation or 
lack of nucleotide, will lead to a decreased binding affinity for p23.  
The crystal structure [7] (see Figure 1.12) also shows contacts between p23 and the 
middle domain of Hsp90. NMR also reveals chemical shift changes within the middle domain of 
Hsp90 upon binding of p23 [14]. One possible consequence of this localised association is that 
the binding of p23 to Hsp90 prevents rearrangement of the middle domain catalytic loop. Thus 
the catalytic Arg380 residue cannot be aligned with the terminal phosphate of the bound 
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nucleotide, leading to the inhibition of ATPase activity until p23 dissociates or is displaced by 
another co-chaperone such as Aha1 [14]. 
 
Figure 1.12 The crystal structure of Hsp90 with p23 reveals contacts between p23 and both the N-terminal and 
middle domains of the chaperone molecule. A: Side view shows contacts to N-terminal and middle domains. B: 
Top view shows contacts to the N-terminal domains of both monomers of Hsp90 PDB file 2CG9 used for this 
diagram. 
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1.7.2 Aha1 
 In contrast to p23, Aha1 is known to be an activator of Hsp90 ATPase activity [34]. 
Crystal structures and biochemical studies [41] have shown that Aha1 binds predominantly to 
the middle domain of Hsp90 (see Figure 1.13),  however ITC has revealed that full binding 
affinity is only achieved in the presence of the full length protein [41]. The crystal structure 
shows that Aha1 and the middle domain of Hsp90 associate in a parallel fashion [41]. The 
affinity for Aha1 to the wild type Hsp90 dimer is 0.67µM as determined by ITC [20].   
The importance of the ATP ‘lid’ in the chaperone cycle has already been established [6-
8;10]. The position of the ATP ‘lid’ in Hsp90 can be influenced by particular Hsp90 mutations 
[23]. These ‘ lid-altering’ mutations of Hsp90 were used in concert with Aha1/Hsp90 studies to 
ascertain the influence of Aha1 on role of the lid in the chaperone cycle. It was observed that 
these mutations did not alter the affinity of Aha1 for Hsp90 [20]. The difference in Aha1’s 
influence over the ATPase activity between the wild type Hsp90 and the mutated Hsp90 
molecules were minimal, suggesting that Aha1 acts upon the ATPase cycle at a point following 
closure of the lid, where the mutations no longer influence the cycle [20]. 
 
Figure 1.13 Crystal structure showing that association between Aha1 and Hsp90 is limited to the middle domain 
of Hsp90. 
 
52 
The association of Aha1 with the middle domain of Hsp90 is thought to aid positioning 
of the catalytic Arg380 residue for efficient hydrolysis of ATP. A reorganisation and extension 
of the long helix within the middle domain is observed upon binding of Aha1 to Hsp90. This 
helix extension leads to the movement of the catalytic loop (containing Arg380) away from an 
interaction with Glu353 and Glu355 of Hsp90 and to instead rotate and orientate it towards 
the γ phosphate within the ATP binding site in the N-terminal domain [41]. Mutations in Hsp90 
which alter the interaction between Aha1 and the catalytic loop of the middle domain affect 
Aha1’s ability to enhance the ATPase activity of Hsp90. The change in activation ability does 
not always correspond to the binding affinity of Aha1 for Hsp90, showing that association and 
activation are not coupled [41]. Aha1 has a profound influence on the yeast Hsp90 mutation 
E381K, designed to interrupt the association of the N-terminal and middle domains of Hsp90. 
This mutation alone prevents positioning of the catalytic loop of Hsp90 thus inhibiting the 
ATPase activity. The presence of Aha1 effectively reverses the effect of the mutation allowing 
ATP hydrolysis, and thus suggesting that Aha1 plays a role in formation of the active 
conformation involving the positioning of the middle domain catalytic loop [20]. 
 
1.7.3 Cdc37 
 
 The Hsp90 co-chaperone Cdc37 mediates the interaction between Hsp90 and many 
protein kinases that are known clients of Hsp90. Cdc37 is known to inhibit the ATPase activity 
of Hsp90 through direct interaction with the N-terminal domain of the chaperone, preventing 
ATP lid closure and N-terminal association [42]. NMR chemical shift analysis on the human 
complex of Hsp90 and Cdc37 confirmed two main areas of contact between the two proteins. 
Flanking a hydrophobic patch on human Hsp90, two charged regions within two α helices 
(residues 113-120  and residues 123-134) were identified [18]. The Hsp90/Cdc37 orientations 
correspond well with the known crystal structure of the complex using the yeast homologue of 
Hsp90 and the human homologue of Cdc37 [42] although the interface implied by NMR is 
larger. 
 H/D exchange mass spectroscopy of the full length Hsp90 chaperone in the presence 
of Cdc37 showed a degree of protection from proton exchange expected given the crystal 
structure, where protein/protein interactions lead to the shielding of some regions of the 
Hsp90 N-terminal domain from the solvent. However, some unexpected results were also 
seen.  Specifically the binding of Cdc37 over the lid region of the N-terminal domain of Hsp90 is 
reflected by an expected dramatic decrease in exchange at the tip of the lid in the presence of 
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the co-chaperone [37]. More unexpected is the reduction in exchange across the most C-
terminal strand of the β-sheet region of the Hsp90 N-terminal domain [37]. There is also some 
indication of increased protection in the middle domain/N-terminal domain interface in the 
presence of Cdc37. The H/D exchange data seen by Phillips et al. [37] matches that observed 
for the radicicol and DMAG bound states in the absence of Cdc37. Here the domain interface 
was also stabilised and a more ‘compact’ dimer form assumed for Hsp90 [37]. The H/D 
protection and stabilisation at the domain interface observed could represent a rotation of the 
N-terminal domain with respect to the middle domain to accommodate the co-chaperone 
binding. The similarity of the exchange data seen for Cdc37 binding, and for the inhibitor 
bound complex, suggests that ligand binding and Cdc37 binding may be cooperative [37]. 
 
1.7.4 Hop/Sti1 
 
 The binding of the co-chaperone Sti1 was first identified by Chang et al. [1] in 1994 by 
affinity purification using immobilised yeast Hsp90. Sti1 is strongly associated with Hsp90 and 
is known to be an inhibitor of the chaperone ATPase activity, despite it binding away from the 
nucleotide binding site [1]. It is known to bind to Hsp90 in a 1:1 stoichiometry as determined 
by ITC and this is likely to represent the binding of a dimer to a dimer with an affinity of 
approximately 0.24µM [1]. Later studies showed that independently viable mutations in both 
Sti1 and yeast Hsp90 were lethal when expressed together, confirming a clear connection 
between the two [43]. Co-precipitation studies and pull down analysis confirms that Sti1 is 
found in complex with Hsp90, but while a number of other co-chaperones including Hsp70 are 
seen in these pulldowns , they do not associate directly with Sti1. Sti1 is also not observed in 
complexes with clients of Hsp90. This suggests that the maturation of Hsp90 chaperone client 
proteins requires a number of chaperone complexes of which Sti1 is involved in some, but not 
all, in a transient fashion [43].  
Hsp90 has long been associated with the chaperone Hsp70. In these cases Hsp70 is 
thought to facilitate the folding of client proteins before interaction with Hsp90 leads to their 
activation [3]. Sti1 is also often found in these complexes and is thought to hold together the 
Hsp90/Hsp70 chaperone complex. However some studies suggest that the presence of Sti1 is 
not required for the recruitment of Hsp70, indeed it is seen that Sti1 knock outs do not lead to 
the unfolding of protein due to a lack of an Hsp90/Hsp70 complex. This may indicate a 
transient role for Sti1 or may suggest another role entirely. 
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In addition to inhibiting the ATPase activity of Hs90, Sti1 has also been linked to the 
activation of known Hsp90 client proteins. When mutations of Sti1 were used in vivo, the 
activation of the glucocorticoid receptor was reduced although accumulation of the receptor 
was not. Glucocorticoid receptor activity could then be rescued by introduction of active Sti1 
protein [43]. A similar effect was seen with respect to other Hsp90 clients such as the v-Src 
kinase [43]. Over-expression of Sti1 in a yeast strain containing an inactive Hsp90 gene led to 
the accumulation of the Hsp90 clients, but did not lead to activation of these proteins, showing 
that Sti1 was necessary but not sufficient for client protein activation [43].  
 
 
1.8 The chaperone cycle of Hsp90 
Understanding the chaperone cycle is vital for understanding the functionality of 
Hsp90. The chaperone cycle has been studied using three methods – electron microscopy 
(EM), bulk FRET analysis and single particle FRET analysis. EM allows the direct observation of 
molecular arrangement albeit at a lower resolution than a crystal structure. The advantage of 
EM, however, is that a uniform population is not required and thus different conformations of 
the protein can be observed at the same time. In a system such as Hsp90 where progress 
through the chaperone cycle is based upon shifting equilibrium, the facility to look at mixed 
populations is very important. 
 
1.8.1 The chaperone cycle by electron microscopy 
 
 The use of negative stain electron microscopy (EM) to monitor the chaperone cycle of 
bacterial Hsp90 and its response to nucleotide revealed three distinctly different gross 
conformations of the Hsp90 dimer in the apo-, ADP- and AMPPNP-bound states [6].   
In the absence of ligand a flexible ‘V’ conformation is observed with varying degrees of 
openness. The EM data can be combined with data from a crystal structure of the full length 
apo form of bacterial Hsp90 [6]. Using this approach, the three domains of the chaperone can 
be clearly identified in the EM structure, confirming that the C-terminal domains form the 
dimerisation region with the N-terminal and middle domains extending out from the C-
terminal domain. The degree to which the dimer is ‘open’ is thought to be attributed to the 
rigid body movements of the two monomers with a large degree of flexibility at the C-terminal 
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domain. This variability in openness fits with the ‘ground state’ described by Dollins et al. [4] 
and the presence of two ‘open’ conformations seen by Bron et al. [40] referred to previously 
as the ‘flying seagull’ and the ‘v’ forms.  Detail from the apo-state seen by Shaiu et al. [6] also 
shows residues Phe123 and Gln122 extending into the ligand binding site. This positioning 
would be displaced by ATP binding and could drive conformational changes of the lid [6]. 
Distinct ‘closed’ conformations were observed for ADP and AMPPNP-bound Hsp90. 
The AMPPNP bound Hsp90 dimer as seen by EM has both a similar size and shape to the yeast 
Hsp90 crystal structure solved by Ali et al. [7]. This may suggest that the bacterial Hsp90 can 
achieve the same conformation as the yeast homologue in the absence of co-chaperones.  
In the presence of ADP a third conformation of bacterial Hsp90 is seen with a more 
compact form than observed in the AMPPNP bound state [6]. Dramatic changes in both inter-
domain and inter-subunit interactions are observed in both compact forms compared to the 
apo state. A discrepancy between the EM data and the crystal structure solved by Shiau et al. 
[6] of the ADP compact state was explained as a crystallographic artefact resulting in a 
misalignment of the N-terminal domains of the Hsp90 dimer. An in silico rearrangement of the 
N-terminal domains with respect to the arrangement of the middle and C-terminal domains, 
assuming a flexible linker between them, leads to a form that is consistent with the EM data. 
 
1.8.2 The chaperone cycle by FRET analysis 
 
A study by Hessling et al. [5] used mutations of the yeast Hsp90 molecular chaperone 
designed to allow the attachment of a fluorescent tag to various specific locations. Subsequent 
monitoring by Fluorescence Resonance Energy Transfer (FRET) between two labelled 
molecules could then occur. Two positions, Asp61 in the N-terminal domain and Gln333 in the 
middle domain, were mutated to Cys residues to allow tag binding. These positions were 
chosen for their surface accessibility and low probability that they would affect the activity of 
Hsp90. The neutrality of the mutations was confirmed through the creation of a double 
mutant which was found to complement the essential function of yeast Hsp90 in a knockout 
strain [5].  
Single mutants were purified and labelled with either donor or acceptor fluorescent 
tags. The two populations were then mixed to allow the formation of heterodimers. The FRET 
signal generated by the proximity of the two tags within the heterodimers was then used to 
monitor the distance between the two monomers under various ligand bound conditions. The 
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heterodimer combinations possible with two mutants and two tags allowed monitoring of 
both inter- and intra-monomer distances. The change in FRET intensity across the chaperone 
cycle allowed the calculation of the number of discrete steps within the cycle as well as the 
rate constants for the transition between each step (see Figure 1.14).   
 
Figure 1.14 The proposed states of the five step chaperone cycle as determined using fluorescence studies by 
Buchner et al.[5]. 
The slowest rate detected had a similar kcat to the known ATPase activity of Hsp90, 
suggesting that hydrolysis is the rate limiting step of the cycle. A five step cycle was shown by 
global fitting to be in good agreement with the experimental data collected. A global fit to 
three or four steps did not produce a good fit in comparison. Using a series of truncation 
mutations of Hsp90, the absence of the lid was seen to enhance the rate of the cycle, while the 
excision of the entire N-terminal domain from one monomer led to a very different profile 
where only the initial FRET signal decrease is observed for the first step of the cycle and all 
subsequent slow changes are not detected. This suggests, in keeping with previous data, that 
transient N-terminal domain dimerisation is required for the full active cycle, and that part of 
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that cycle includes the association of the N-terminal and middle domains within a single 
monomer [5]. 
The five stages of the cycle begin with the open conformation of Hsp90 with no ligand 
bound. The first transition is induced by the binding of ATP to the ligand binding site in the N-
terminal domain. The second transition is observed by the FRET analysis but there is no 
evidence for a structural change from other sources. A movement of the ATP lid from the 
‘open’ to the ‘closed’ state could be the root cause of this detected step. The third transition 
leads to an association of the two N-terminal domains within the Hsp90 dimer. The fourth 
transition leads to an association of the N-terminal and middle domains of each monomer, 
which again can be observed by FRET. The rate constant for the reverse transition is far slower 
than the rate of ATP hydrolysis, preventing the back reaction from occurring. ATP hydrolysis 
itself characterises the final transition from the fully closed state to the open state. Within this 
transition is encompassed the release of ADP and free phosphate. Any further distinct 
conformations were intractable to the FRET methodology seen by Hessling et al.[5]. 
ATP hydrolysis is relatively late in the cycle with four previous steps concerning the 
binding of ATP and the conformational changes associated with that prior to hydrolysis to ADP. 
The ‘closed’ state of the Hsp90 dimer does not persist for long, as it occurs following hydrolysis 
until the dissociation of ADP and the free phosphate very shortly after. It is known, however, 
that the presence of various co-chaperones can influence the dwell time in certain positions 
along the cycle. Aha1 is known to accelerate the ATPase activity and from the FRET 
experiments can also be seen to accelerate the association of the N-terminal domains of 
Hsp90. This enhancement of this conformational step is observed even in the absence of 
ligand. In contrast Hop/Sti1 blocks all conformational changes [5]. 
 
1.8.3 The chaperone cycle by single particle FRET analysis 
 
 Observations of the Hsp90 chaperone cycle by single particle analysis allow the ATP 
cycle to be studied without the necessity for bulk averaging and synchronization of the system 
[9]. In the case of Hsp90, where it is clear that there is a complex multi-stage conformational 
cycle, the ability to de-convolute these steps is vital to the overall understanding of the 
process.  
 As was done for the bulk FRET study, single point mutations were made either in the 
N-terminal (D61C) or middle domain (E385C) of the yeast Hsp90 chaperone. These mutants 
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were then labelled with either a fluorescent donor or acceptor and dimerisation was measured 
by increasing FRET signal. The dimers were immobilised onto a surface via either biotinylation 
or a streptavidin tag [9]. 
In the absence of any ligand, this single molecule FRET (smFRET) showed an opening 
and closing of the dimer on a scale far faster than that of the ATPase cycle in the presence of 
ATP. This was repeated in the presence of the slow hydrolysing ATP analogue ATP-γS, ADP and 
AMPPNP [9]. By observing the duration of the ‘open’ and ‘closed’ states, a minimum kinetic 
model was calculated. There were no differences in state distribution between the apo- and 
the ADP-bound states. The introduction of AMPPNP led to an increase in the dwell time within 
the ‘closed’ conformation with no conformational fluctuations on a second timescale.  
A fit of the data led to the conclusion that there were four detectable stages within the 
cycle – two in the open and two in the closed state. Of these four states only two crystal 
structures are known, one in each of the open and closed states. Overall Mickler et al. [9] 
concluded that occupation of the four states by Hsp90 was not ligand binding-dependent and 
that there was no strong coupling between hydrolysis and the conformational cycle. The 
binding and hydrolysis of ATP can increase the rate of transition from one state to another but 
the transition is itself reversible even though ATP hydrolysis is not [9]. The smFRET study  did 
not reveal an ADP bound state and the authors hypothesise that such a state may be short 
lived and not highly populated [9]. 
Overall the single particle study showed similar behaviour to the bulk studies done 
previously [5].  Most evidence suggests that the nature of the chaperone cycle is one of 
equilibria between states rather than distinct and irreversible steps. The study of crystal 
structures or averaged EM images therefore show either a snapshot of one stage in the cycle 
or an average of the bulk behaviour, as biased by various external factors such as ligand 
binding and hydrolysis or co-chaperone association. When the action of the Hsp90 chaperone 
system is considered with regard to understanding client protein activation it is vital to 
remember that the process is one of equilibrium states and not distinct irreversible steps as 
understanding and possible future manipulation of an equilibrium system is very different to 
understanding and manipulation of a cycle of irreversible steps. 
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1.9 Summary 
This thesis primarily focuses on the isolated N-terminal domain of Hsp90, exploring the 
thermodynamics of nucleotide based ligand binding in detail using ITC and observing the 
linkage between ligand binding and conformational change using both NMR and ITC. Some 
investigation into the influence of the full length protein molecule upon the chaperone cycle is 
also undertaken.  
Overall this thesis attempts to provide answers regarding both the structure and the 
function of Hsp90. What is the nature of the ligand binding site and what are the 
conformational changes induced by ligand binding? In particular what is the response of the 
ATP ‘lid’ to the binding of different ligands? What is the influence of the middle domain and 
full length protein on this nucleotide binding, and how can this be related to its function as a 
molecular chaperone? 
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2 Materials and methods 
 
 
The protein studied in this thesis is the yeast homologue Hsp82 of the Hsp90 chaperone 
protein. However throughout the thesis the protein shall be referred to as Hsp90 as is common 
in the literature.  
 All chemicals and reagents were purchased from Sigma-Aldrich, VWR or Melford 
unless otherwise stated. All liquid media were prepared using distilled deionised water. Media 
was sterilised by autoclaving at 123°C for 15 minutes or through filtration through a 0.22 µM 
filter. 
 
 
2.1 Protein Constructs 
 
Five constructs were studied: the N-terminal domain comprising amino acids 1 – 207; 
the N551 construct (residues 1 – 551) encompassing the N-terminal and middle domains; the 
full length protein (residues 1 – 667), the T22I mutant of the N-terminal domain (1 – 207) 
where residue Thr22 was mutated to Ile22; and the T101 mutant of the N-terminal domain 
(residues 1 – 207) where residue Thr101 was mutated to Ile101. All constructs were cloned 
into the NheI site of the pRSETA vector under a T7 promoter inducible with Isopropyl β-D-1-
thiogalactopyranoside (IPTG). All constructs contained a hexa-histadine Tag. E. coli strains 
were used for all studies; E. coli BL21(DE3) cells were used for protein expression while E. coli  
XL1 Blue cells were used for plasmid amplification. All constructs were obtained from Dr. C. 
Prodromou of the Institute for Cancer Research. 
 
Full Length protein: 
 The full length protein runs from residue 1 to 709 with the following sequence: 
 
HHHHHHG 
MASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSL 50 
SDPKQLETEPDLFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSG 100 
TKAFMEALSAGADVSMIGQFGVGFYSLFLVADRVQVISKSNDDEQYIWES 150  
NAGGSFTVTLDEVNERIGRGTILRLFLKDDQLEYLEEKRIKEVIKRHSEF 200 
VAYPIQLVVTKEVEKEVPIPEEEKKDEEKKDEEKKDEDDKKPKLEEVDEE 250 
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EEKKPKTKKVKEEVQEIEELNKTKPLWTRNPSDITQEEYNAFYKSISNDW 300 
EDPLYVKHFSVEGQLEFRAILFIPKRAPFDLFESKKKKNNIKLYVRRVFI 350  
TDEAEDLIPEWLSFVKGVVDSEDLPLNLSREMLQQNKIMKVIRKNIVKKL 400 
IEAFNEIAEDSEQFEKFYSAFSKNIKLGVHEDTQNRAALAKLLRYNSTKS 450  
VDELTSLTDYVTRMPEHQKNIYYITGESLKAVEKSPFLDALKAKNFEVLF 500 
LTDPIDEYAFTQLKEFEGKTLVDITKDFELEETDEEKAEREKEIKEYEPL 550 
TKALKEILGDQVEKVVVSYKLLDAPAAIRTGQFGWSANMERIMKAQALRD 600 
SSMSSYMSSKKTFEISPKSPIIKELKKRVDEGGAQDKTVKDLTKLLYETA 650 
LLTSGFSLDEPTSFASRINRLISLGLNIDEDEETETAPEASTAAPVEEVP 700 
ADTEMEEVD 
 
N Terminal domain: 
 The N-terminal domain construct runs from residue 1 to 207 with the following 
sequence: 
 
HHHHHHG 
MASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSL 50 
SDPKQLETEPDLFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSG 100 
TKAFMEALSAGADVSMIGQFGVGFYSLFLVADRVQVISKSNDDEQYIWES 150  
NAGGSFTVTLDEVNERIGRGTILRLFLKDDQLEYLEEKRIKEVIKRHSEF 200 
VAYPIQL 
 
 
N551 Construct: 
 The N551 construct runs from residue 1 to 551 with the following sequence: 
 
HHHHHHG 
MASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSL 50 
SDPKQLETEPDLFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSG 100  
TKAFMEALSAGADVSMIGQFGVGFYSLFLVADRVQVISKSNDDEQYIWES 150  
NAGGSFTVTLDEVNERIGRGTILRLFLKDDQLEYLEEKRIKEVIKRHSEF 200 
VAYPIQLVVTKEVEKEVPIPEEEKKDEEKKDEEKKDEDDKKPKLEEVDEE 250  
EEKKPKTKKVKEEVQEIEELNKTKPLWTRNPSDITQEEYNAFYKSISNDW 300 
EDPLYVKHFSVEGQLEFRAILFIPKRAPFDLFESKKKKNNIKLYVRRVFI 350  
TDEAEDLIPEWLSFVKGVVDSEDLPLNLSREMLQQNKIMKVIRKNIVKKL 400 
IEAFNEIAEDSEQFEKFYSAFSKNIKLGVHEDTQNRAALAKLLRYNSTKS 450 
VDELTSLTDYVTRMPEHQKNIYYITGESLKAVEKSPFLDALKAKNFEVLF 500 
LTDPIDEYAFTQLKEFEGKTLVDITKDFELEETDEEKAEREKEIKEYEPL 550 
T 
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T22I – N Terminal domain mutant: 
 The T22I N-terminal domain mutant construct runs from residue 1 to 207 with the 
following sequence: 
 
HHHHHHG 
MASETFEFQAEITQLMSLIINIVYSNKEIFLRELISNASDALDKIRYKSL 50 
SDPKQLETEPDLFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSG 100 
TKAFMEALSAGADVSMIGQFGVGFYSLFLVADRVQVISKSNDDEQYIWES 150  
NAGGSFTVTLDEVNERIGRGTILRLFLKDDQLEYLEEKRIKEVIKRHSEF 200 
VAYPIQL 
 
 
T101I – N Terminal domain mutant: 
 The T101I N-terminal domain mutant construct runs from residue 1 to 207 with the 
following sequence: 
 
HHHHHHG 
MASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSL 50 
SDPKQLETEPDLFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSG 100 
IKAFMEALSAGADVSMIGQFGVGFYSLFLVADRVQVISKSNDDEQYIWES 150  
NAGGSFTVTLDEVNERIGRGTILRLFLKDDQLEYLEEKRIKEVIKRHSEF 200 
VAYPIQL 
 
 
 
2.2 Competent cells 
 
A single colony of BL21(DE3), DH5α or XL1 Blue cells were introduced into 10 mL of 
Luria Bertani (LB) media and grown overnight at 37°C while shaking at 200 rpm. No antibiotic 
was used in the production of competent cells. 1ml of overnight culture was used to inoculate 
100mL of LB, which was grown at 37°C while shaking at 200 rpm until an optical density (OD) 
of 0.45 was recorded at 600 nm.  
The cells were then left on ice for 15 minutes before pelleting by centrifugation at 3-
5000 rmp at 4°C for 15 minutes. The supernatant was discarded. The pellet was resuspended 
in 40ml of TFBI buffer (Table 2.1) and kept on ice for a further 30 minutes. The cells were then 
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pelleted at 3-5000 G at 4°C for 15 minutes and the supernatant again discarded. The pellet was 
resuspended in 4 mL TFBII buffer (Table 2.1). The cells were then aliquoted into 50 µl samples 
and frozen immediately at -80°C. 
 
 
TFBI (filter sterile) 30 mM Potassium acetate, 100 mM Rubidium 
chloride, 10 mM Calcium chloride, 50 mM 
Magnesium chloride, 15% (v/v) Glycerol. pH 
5.8 adjusted with acetic acid. 
TFBII (filter sterile) 10 mM MOPS, 10 mM Rubidium chloride, 75 
mM Calcium chloride, 15% (v/v) Glycerol. pH 
6.5 adjusted with Sodium hydroxide. 
Vitamin Stock x 1000 Per 100 mL distilled H2O: 0.04 g Acetylcholine 
chloride, 0.05 g Folic acid, 0.05 g Pantothenic 
acid, 0.05 g Nicotinamide, 0.1 g Myo-inositol, 
0.05 g Pyridoxal HCl, 0.05 g Thiamine HCl, 
0.005 g Riboflavin, 0.1 g Biotin. 
Mineral Sock x 5000 2 mM Na2MoO4, 2 mM H3BO3, 2 mM CoCl2, 2 
mM CuCl2, 2 mM NiCl2, 10 mM ZnSO4, 10 mM 
MnCl2, 50 mM FeCl3 (dissolved in 1:100 
dilution of conc. HCl) 
  
Table 2.1 Summary of solutions required for making competent cells and for addition to minimal media 
 
 
2.3 Growth media 
 
All cells were grown using deionised distilled water (Elga), or deuterated water 
(Cambridge Isotope Laboratories, Cambridge MA). LB liquid media (10 g/L tryptone, 5 g/L yeast 
extract, 5 g/L NaCl) was sterilized by autoclaving[44]. Solid growth media was made up as LB 
with 15 g/L agar and sterilized by autoclaving. Solid media was poured into Petri dishes when 
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cooled but still liquid. If required, filter sterile carbenecillin (250 µg/mL) was added to both 
liquid and solid media[44].  
Minimal media was used to express isotopically enriched proteins for Nuclear Magnetic 
Resonance (NMR). Growth was carried out in M9 media (11.36 g/L Na2HPO4, 2.7 g/L KH2PO4, 1 
g/L (NH4)2SO4, 0.5 g/L NaCl) For expression of 15N labelled proteins (15NH4)2SO4 (Cambridge 
Isotope Laboratories) was used in place of (NH4)2SO4. The solution was adjusted to pH 7.4 and 
sterilized by autoclaving.  
Sterile M9 media was supplemented with 2 mM MgCl2 (from a 1 M autoclaved stock 
solution), 1 mL/L filter sterile  x1000 vitamin stock (Table 2.1), 200 µL/L filter sterile mineral 
stock (Table 2.1), 3 g/L D-glucose and carbenecillin. For 13C-labelled protein 13C D-glucose 
(Cambridge Isotope Laboratories) was used in place of 12C D-glucose. Minimal media was made 
using deionised distilled water when only nitrogen and/or carbon labelling was required. 
Minimal media was made using deuterated water when perdeuteration of the protein was also 
required. 
 
 
2.4 Plasmid purification 
 
One colony of XL1Blue E. coli was picked and used to inoculate 10ml LB with 250µg/ml 
carbenecillin. The culture was grown overnight at 37°C while shaking at 200rpm. The cells were 
harvested by centrifugation at 4000rpm for 15min at 4°C. The supernatant was discarded. The 
plasmid was then extracted from the pelleted cells using a Miniprep kit (Quiagen). 
The Miniprep kit lyses the cells and causes precipitation of the protein and membrane 
components of the cells while the nucleotides are solubilised. The precipitated portions are 
separated from the soluble components by centrifugation and the supernatant is loaded onto 
a Quiagen spin column. The resin in the column retains DNA while other solubilised 
components, such as free nucleotides and RNA, are washed through.  The DNA is then eluted 
from the column by centrifugation in 50µl of deionised water. The purified plasmid was stored 
at -20°C. 
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2.5 E. coli transformations 
 
2 µl of plasmid was incubated on ice with 50 µl of thawed competent cells (BL21(DE3), XL1Blue 
or DH5α) for 30 minutes. The cells were subjected to 45 s of heat shock at 42°C in a water 
bath. The cells were then returned to ice for a further 10 minutes. 1 mL of LB was added to the 
cells which were left at 37°C while shaking at 200 rpm for 1 hour. The cells were then 
centrifuged at 13,400 rpm for 2 minutes and the supernatant discarded. The pellet was re-
suspended in 100 µl of fresh LB and streaked onto a carbenecillin agar plate. The plate was 
incubated at 37°C overnight[44]. 
 
 
2.6 Glycerol stocks 
 
A single colony was picked from an agar plate and used to inoculate 10 mL of LB culture. The 
culture was grown overnight at 27°C while shaking at 200 rpm. 500 µl of cell culture was added 
to 500 µl of glycerol sterilized by autoclaving. The sample was thoroughly mixed in an 
eppendorf tube and stored at -80°C. 
 
 
2.7 Protein expression 
 
The same protocols were used for all constructs.  
 
2.7.1 Small scale expression 
 
Small scale expression was carried out in 20 mL of LB media. A single colony from transformed 
BL21(DE3) or DH5α cells plated on LB agar was used to inoculate a 5 mL culture of LB media 
containing 250 µg/L carbenecillin. The cells were grown overnight at 37°C shaking at 200 rpm. 
200 µl of overnight growth was used to inoculate 20 mL of LB media. The culture was grown at 
37°C while shaking at 200 rpm until an OD600 of 0.6 - 0.8 was reached. Protein expression was 
then induced by the addition of isopropyl-[β]-D-thiogalactopyranoside (IPTG) at a final 
concentration of 1 mM. The cells were left for one hour to allow protein expression before 
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being harvested by centrifugation at 4000 rpm at 4°C for 20 minutes. The supernatant was 
discarded and the pellets freeze thawed and resuspended in 250 µL lysis buffer (50 mM Tris, 
100 mM NaCl, 10% glycerol, pH 8). The sample was lysed by sonication on ice (3 s burst with a 
10 s cooling time repeated three times). The sample was then centrifuged in a 1.5 mL 
eppendorf at 13,200 rpm for 40 minutes. The supernatant was separated from the pellet and a 
gel sample was made from each to run on an SDS polyacrylamide gel to test for protein 
expression. 
 
2.7.2 Large scale expression 
 
A single colony from a plate of transformed BL21(DE3) or DH5α cells or 1 µL from a glycerol 
stock was used to inoculate 100 mL of LB media. The culture was grown overnight at 37°C with 
shaking at 200 rpm. 15 mL of the overnight culture was used to inoculate 1 L of LB media. Cells 
were habitually grown in 5 L batches. 1 L cultures were grown at 37°C at 180 rpm in unbaffled 
2 L flasks until an OD600 of 0.6-0.9 was recorded. The temperature was reduced to 21°C and 
protein expression induced with a final concentration of 1 mM IPTG. Expression was allowed 
to continue overnight before harvesting by centrifugation at 5000 rpm for 15 minutes at 4°C. 
The pellets were stored at -20°C. 
 
2.7.3 Large scale expression of isotope labelled Hsp90 constructs (1) 
 
A single colony from a plate or 1µl of an appropriate glycerol stock was used to inoculate 10 
mL of LB media. The culture was grown for 8 h at 37°C at 200 rpm before being centrifuged at 
4000 rpm for 15 min. The supernatant was discarded and the pellet was re-suspended in 100 
mL of minimal media. This was incubated overnight at 37°C, shaking at 200 rpm. The 100 mL 
culture was centrifuged at 4000 rpm for 15 min in two 50 mL falcon tubes and the supernatant 
discarded. The pellet was re-suspended in 2 mL minimal media and transferred into 1 L of 
minimal media in a 2 L flask. This was then grown at 37°C shaking at 180 rpm until an OD600 of 
0.5-0.7 was recorded. Protein expression was then induced with a final concentration of 1 mM 
IPTG. The temperature was reduced to 21°C and induction allowed to continue overnight. Cells 
were harvested by centrifugation at 4°C at 5000 rpm for 15 min and the pellets stored at -20°C. 
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2.7.4 Large scale expression of isotope labelled Hsp90 constructs (2) 
 
A single colony from a plate or 1 µL of an appropriate glycerol stock was used to inoculate 100 
mL of LB media. The culture was grown overnight at 37°C with shaking at 200 rpm. 15 mL of 
the culture was used to inoculate 1 L of LB media with the addition of 3 g/L D-Glucose to 
suppress 'leaky' expression from the Lac operon. Habitually, 5L of cells were grown in this way  
at a time. 
  
The culture was grown at 37°C while shaking at 180 rpm in 2L unbaffled flasks until an OD600 of 
0.8 - 1.1 was reached. The culture was then centrifuged at 5000 rpm for 15 minutes at 4°C and 
the supernatant discarded. The pellet was re-suspended in 10 mL of minimal media. The re-
suspended cells from 5L of LB media were added to a total volume of 1L of minimal media in 
two baffled 2L flasks. The cells were grown for a further hour at 37°C shaking at 180 rpm prior 
to induction with 1 mM IPTG. The temperature was then reduced to 21°C and expression 
allowed to continue overnight [45]. The cells were then harvested by centrifugation at 5000 
rpm at 4°C for 15 minutes and the cell pellets stored at -20°C. 
 
 
2.8 Protein purification 
 
Protein purification was carried out at 4°C or 21°C (room temperature). The pellets were 
thawed on ice and resuspended in lysis buffer with the protease inhibitors E64 (200 µM), 
Benzamidine (1 mM) and AESBF (10 µM). the resuspended cells were lysed by sonication on ice 
(10 s burst followed by a 50 s cooling period repeated 15 times). 
The lysed cells were centrifuged at 20,000 rpm for 60 minutes to separate the cell debris from 
the cytoplasm. Gel samples were taken from both pellet and supernatant and run on a 10% 
SDS polyacrylamide gel to ensure the presence of the protein in the cytoplasm and absence 
from inclusion bodies in the pellet. All column purification was done using an AKTA purification 
system from Amersham. All buffers used are summarised in Table 2.2. The supernatant was 
loaded onto a pre-equilibrated HisTrap NiNTA column (GE Healthcare, UK) at a rate of between 
0.5 mL/min and 1 mL/min to allow coordination of the His Tag in the constructs with the Ni 
ions on the resin. The column was washed with 5 column volumes (cv) of NiA and 5 cv of  98% 
NiA with 2% NiB to remove non specifically bound protein. Specifically bound protein was 
eluted in a step gradient of 2 - 100% NiB and 2.5ml fractions were collected. The column flow 
through was monitored by UV detection at 280 nm and 254 nm.  
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NiA – Nickel wash buffer 50 mM Tris Base, 100 mM NaCl, pH 8 
NiB – Nickel elution buffer 50 mM Tris Base, 100 mM NaCl, 500 mM 
Imidazole, pH 8 
QA – Anion exchange wash buffer 50 mM Tris Base, 100 mM NaCl, 5 mM EDTA, 
pH 8 
QB – Anion exchange elution buffer 50 mM Tris Base, 2 M NaCl, 5 mM EDTA, pH 8 
Gel filtration buffer. 100 mM Tris Base, 200 mM NaCl, 5 mM EDTA 
pH 8. 
Triple buffer  100 mM ACES, 50 mM Tris base, 50 mM 
Ethanolamine pH 5 – 10, 5 mM Mg2+.  
ITC buffer 20 mM Tris pH 8 
Heat of ionisation buffers 50 mM NaCl, 5 mM Mg2+ 
 20 mM Tris/Bis-Tris/ACES/HEPES/PIPES 
Table 2.2 Buffers used for protein purification and ITC experiments. 
 
The eluted fractions containing protein were concentrated to a volume of no more than 5 mL 
using a spin concentrator (Vivaspin: molecular weight cut off (mwco) of 10 kDa with a PES 
membrane; 3800 rpm for 15 minutes at 10°C repeated as necessary with agitation in between 
runs). The concentrated sample was then loaded onto a pre-equilibrated Superdex 200 gel 
filtration column (GE Healthcare) and run at a rate of 1 mL/min. Fractions (4 mL) were 
collected for 1 cv (100 mL) and the protein content of each fraction monitored by UV.  For the 
purification of the N551 construct and the full length Hsp90 molecule, an additional 
purification step was required between the His-Trap column and the gel filtration column. A Q-
sepharose anion exchange column (GE Healthcare) was used for increased purification. The 
His-trap elution fractions were diluted by a factor of eight to reduce the imidazole 
concentration to 62 mM, to allow binding to the Q-sepharose column. The sample was loaded 
on to a pre-equilibrated Q sepharose anion exchange column at a flow rate of 1 mL/min. The 
column was washed with 5cv of QA buffer before the protein was eluted along a 5cv gradient 
from 100% QA to 100% QB. Fractions (4ml) were collected along the first 50% of the gradient. 
Samples were taken at each step for SDS PAGE gel analysis (Figures 2.1 – 2.5). 
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2.8.1 SDS PAGE Gel analysis 
N-terminal 
 
Figure 2.1 SDS PAGE gel analysis of the purification of the N-terminal domain of Hsp90 
 
N551 Construct 
 
Figure 2.2 SDS PAGE gel analysis of the purification of the N551 construct of Hsp90 
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T22I N-terminal mutant 
 
Figure 2.3 SDS PAGE gel analysis of the purification of the T22I mutant of the N-terminal domain of Hsp90 
 
T101I N-terminal mutant 
 
Figure 2.4 SDS PAGE gel analysis of the purification of the T101I mutant of the N-terminal domain of Hsp90 
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Full length Hsp90 
 
Figure 2.5 SDS PAGE gel analysis of the purification of the full length construct of Hsp90 
 
2.8.2 1D NMR analysis to confirm folding 
As described in more detail later, 1D NMR analysis can be used to determine whether a 
protein contains folded structure. Peaks present above 8.5ppm or below 0ppm are indicative 
of folded protein and as such 1D NMR can be used as a rapid method for determining the 
folded state of purified protein. Figure 2.6 shows 1D NMR data for the N-terminal domain, 
N551 construct and the two N-terminal mutants T101I and T22I. These scans confirm that the 
expressed protein is folded. 
 
73 
 
Figure 2.6 1D spectra for the N-terminal domain, N551 construct and T101I and T22I mutants of the N-terminal 
domain. Peaks above and below the red lines marked are characteristic of a folded protein molecule. 
 
 
2.9 Concentration determination 
2.9.1 Protein Concentration determination 
 
Protein concentration was determined by ultraviolet (UV) spectroscopy. According to the Beer 
Lambert Law, the absorbance of light at a specific wavelength (for proteins this is at 280nm) is 
directly proportional to the concentration of the sample. 
 
            (2.1)  
 
The extinction coefficient (ε) is specific for each protein construct dependent upon its size and 
amino acid composition. A is the absorbance, l is the path length in cm and c is the 
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concentration of the sample in moles. A quartz cuvette was used for all measurements and the 
relevant buffer was used as a reference to subtract an appropriate baseline from all readings. 
An absorbance scan was taken across a range of 340 nm to 190 nm of both buffer and the 
protein solution. If necessary a 1 in 10 or 1 in 20 dilution of protein solution was used so that 
the absorbance was within the working range of the spectrometer (between 0.1 and 1 
absorbance units (AU)). The concentration was then calculated using the appropriate 
extinction coefficient for each construct (Table 2.3) and allowing for a 1 cm path length (l) and 
the relevant dilution factor. Equation 2.1 shows the Beer-Lambert Law where A is the 
absorbance, ε is the specific extinction coefficient, c is the concentration of the sample and l is 
the path length of the light through the sample. 
 
 
Molecule Extinction Coefficient (ε) M-1 cm-1 
AMP-PNP 14600  
ADP 14600 
ATP 14600 
Adenine 13300 
Adenosine 13400 
Hsp90 full length 54050 
N terminal domain (1 – 220) 14440 
Middle domain (245 – 551) 31150 
N551 construct (1 – 551) 44520 
Table 2.3 Summary of the extinction coefficients of the protein constructs and ligands used. Proteins measured at 
280nm. Nucleotide ligands measured at 260nm. 
 
2.9.2 Nucleotide concentration determination 
 
Nucleotide solutions of APMPNP, ADP, adenosine and adenine were used. Nucleotide 
concentration determination was undertaken in the same way as described for protein 
concentration determination by UV spectroscopy. The maximum absorbance was monitored at 
260 nm instead of 280 nm and dilutions of 1 in 100 or 1 in 200 were used. Extinction 
coefficients are summarised in Table 2.3. 
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2.10 SDS Polyacrylamide gel electrophoresis 
  
SDS Polyacrylamide gel electrophoresis (SDS PAGE) allows protein samples to be separated 
according to size. Proteins are denatured by the presence of negatively charged SDS which 
binds to the unfolded proteins such that the negative charge from the SDS is proportional to 
the size of the denatured protein. Movement of protein through the gel matrix is then driven 
by a voltage applied to it. The concentration of acrylamide used determines the 'percentage' of 
the gel and proteins meet a greater resistance passing through a higher percentage gel. The 
'percentage' used defines the effective resolution for different molecular mass proteins on any 
given gel. A high percentage gel allows resolution of small proteins, while a low percentage gel 
gives better resolution for larger proteins.  All gels used were 10% SDS PAGE gels unless 
otherwise specified. 0.75 mm thick gels were cast using frames, flat plates and 10 well combs 
from Biorad. Stacking and resolving gel mixtures are shown in table 2.4. All gel recipes and 
protocols adapted from Sambrook and Russell [44]. In all cases TEMED was added last, prior to 
pouring, to induce crosslinking of the acrylamide. 3.5 mL of resolving gel was used per gel and 
the top levelled off before setting by the addition of water which, was later removed after the 
resolving gel had set. The stacking section of the gel was cast and the well comb inserted 
before it set. The comb was removed immediately prior to running the gel. 
Gel samples were prepared with 2:1 ratio of sample to x2 loading dye (Table 2.4) in an 
eppendorf and heated for 5 minutes at 100°C before loading 10 µL aliquots onto the gel. 
All gels were run using 'gel running buffer' (Table 2.4) at 120 V for 1 h 15 min. Gels were 
stained with Coomassie staining dye following 20 s heating in a microwave followed by 1 – 4 h 
in stain solution while shaking gently. Background dye was removed by immersion in destain 
solution (Table2.4) after 20 s heating in a microwave. Gels were stored in dH2O and 
photographed using gel doc’ equipment and 'genesnap' software (both by Syngene, Frederick, 
MD). 
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Stacking Gel 500 µL 30% Acrylamide 
2 mL H2O 
1 mL 3 M Tris pH 8.8 
40 µL 10% SDS 
100 µL 10% Ammonium persulfate. 
5 µL Temed 
10% Resolving Gel 1.7 mL 30% Acrylamide 
2.55 mL H2O 
625 µL 3 M Tris pH 8.8 
50 µL 10% SDS 
37.5 µL 10% Ammonium persulfate. 
10 µL Temed 
Coomassie Staining solution 40% Methanol, 10% Acetic acid, 50% dH20, 0.5 
g/L Coomassie brilliant blue. 
Coomassie Destaining solution 40% Methanol, 10% Acetic acid, 50% dH20 
X2 Loading Dye 25% SDS, 25% Glycerol, 62.5 mM Tris-HCl (pH 
6.8), 0.01% Bromophenol blue. 
Running Buffer 14.4 g/L Glycine, 3.03 g/L Tris base, 1 g/L SDS. 
Table 2.4 Solutions used in SDS PAGE gel pouring and running. 
 
 
2.11 Circular dichroism 
 
All spectra were measured using a circular dichroism spectrometer (Aviv Instruments Inc.) and 
all data was plotted using Microsoft Excel. Circular dichroism (CD) spectroscopy is used to 
monitor the difference in absorption of a molecule of left-handed and right-handed plane 
polarized light at wavelengths across the near and far UV range. A difference in absorption 
results in elliptically polarised light. For there to be a difference the molecule must contain a 
chiral centre or be within an asymmetric environment. The absorption difference was 
measured either in units of the difference in molar absorbance Δε = εl-εr ∙cm-1 ∙dmol-1, or in 
terms of the mean residue ellipticity ( [θ]mrw. λ) in deg ∙cm2 ∙dmol-1. Where mrw = mean 
residue weight [mass/no. amino acids], θ = observed ellipticity in degrees. d= path length (cm), 
c = conc. in g/mL. This is calculated by: 
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[θ]mrw. λ= mrw[θ]/ 10d.c        (2.2) 
 
The two units are related by the relationship: 
 
 [θ]mrw = 3298 Δε.        (2.3) 
 
 
The absorption difference of these chiral molecules, such as amino acids, is characteristic at 
certain wavelengths. The same is also true for distinct chiral structures such as α-helices and β-
sheets. These structures, found to varying degrees in folded proteins, display characteristic 
absorption minima at different wavelengths; α-helices absorb at 222 nm and 208 nm while β-
sheets absorb preferentially at 216 nm. The intensity of the signal is dependent upon the 
amount of each secondary structure in the protein, the concentration of protein and the width 
of the cuvette used. From the overall signal due to all secondary structure within a protein, 
and knowing the protein concentration, the proportion of α-helices and β-sheet can be 
calculated.  
 
Scans were taken across a range of 270 – 195 nm using either a 0.5 or 0.1 mm quartz cuvette. 
Readings were taken at 3 s intervals, 0.5 nm apart. Each scan was repeated and the average of 
the two readings was plotted. Identical runs using buffer to provide a blank scan were carried 
out for each sample. Buffers containing high concentrations of Cl- ions and Tris base showed 
high absorbance below 195 nm, thus making accurate readings below 195 nm impossible. 
Temperature denaturation was measured as a function of disappearance of secondary 
structure monitored at 222 nm. Melting curves of the change in secondary structure with 
respect to temperature were created from measurements recorded using a 1 mm quartz 
cuvette at temperature intervals of 1°C. 
 
For wavelength scans a protein concentration of 50 µM was used. For denaturing curves a 
lower protein concentration of 10 µM was used in order to reduce the possibility of 
aggregation of the unfolded protein. 
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2.12 Isothermal titration calorimetry  
 
All titrations were carried out using a VPITC (Microcal, Northampton, MA) instrument and 
analysed using origin 5.0 software (OriginLab, Northampton MA). Isothermal titration 
calorimetry (ITC) can be used to monitor the change in heat of a solution upon injection of a 
small quantity of another solution, such as a ligand injected into a protein sample (Figure 2.7). 
The change in enthalpy can correspond to a chemical reaction or a molecular reorganisation. 
With knowledge of the volume and concentration of both the reactants, the heat measured 
upon mixing of the two can be related directly to the extent of reaction in the sample cell. In a 
protein/ligand binding experiment a series of injections leading towards the saturation of the 
protein in the sample cell can be used to determine the change in enthalpy (ΔH), binding 
affinity (kA) and stoichiometry (n) of the binding reaction. From these parameters the change 
in both entropy (ΔS) and Gibbs free energy (ΔG) can be calculated using the equations 2.4 – 
2.7. Over a series of temperatures the change in heat capacity (ΔCp) can also be calculated as 
dΔH/dT. 
 
∆  ∆	 
 ∆         (2.4) 
∆  
 ln        (2.5) 
           (2.6) 
Equations 2.4 to 2.6 show  the relationship between the Gibbs free energy and the 
entropy and enthalpy of a reaction (2.4) and the link this then has to the dissociation constant 
of a reaction (2.5). Also shown is the inverse relationship between the association and 
dissociation constants of a reaction (2.6). Shown here, G is the Gibbs free energy, R is the gas 
constant taken as 8.314 J.K-1.mol-1, T is the temperature in Kelvin, S is the entropy, H is the 
enthalpy, Ka is the association constant of the reaction and Kd is the dissociation constant of 
the reaction. 
 The accuracy to which ITC is able to measure the Ka of an interaction is dependent 
upon the strength of the interaction as measured by a value called 'c', a unit-less parameter 
that is the product of the total concentration of the sample (Ptot) and the Ka. Values of c that 
are between 1-1000 allow accurate determination of the thermodynamic parameters 
described above by ITC. Values of c lying outside of this range are not readily accurately 
measured by ITC. 
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Figure 2.7 ITC trace showing the raw heats (top) and the integrated heats (bottom) of the reaction of the N-
terminal domain of Hsp90 (100 µM) with ADP (1 mM).  20 mM Tris, pH 8 15°C. 
  
 
80 
 
For a single site binding interaction, titrations are fitted to a curve by Origin software following 
the equation:  
  ∆ 1    	  1    		  

  (2.7) 
 
Where Q is the total heat, V0 is the active cell volume, Mt is the bulk concentration of the 
protein, Xt is the bulk concentration of the ligand.  Over a series of injections this equation can 
be fitted and the value of Q adjusted for the increased volume due to the injection of ligand 
into the cell, from this  n (the number of binding sites), ΔH (the enthalpy of the reaction) and K 
(the binding constant) can be determined[46].  
 
All experiments were carried out under a constant temperature and pressure to measure the 
enthalpy and binding affinity of a variety of ligands and binding partners to all or part of Hsp90. 
A purified protein sample was transferred into an appropriate ITC buffer by serial dilution; 
Triple buffer (Table 2.2) at every half pH unit from pH 5 - 10, 20 mM Tris pH 8, 50 mM Tris 50 
mM NaCl pH 7.5 were all used. All buffers contained 5 mM MgCl2. Titrations were done every 
5°C from 10°C to 30°C.  
 
1.5 mL Hsp90 full length, N terminal or N551 was loaded into a clean sample cell using a 2 mL 
syringe (Hamilton, Nevada) according to microcal instructions. The sample cell was allowed to 
equilibrate with the reference cell at the relevant temperature before the titration was 
started. 
 
The ligand used (AMPPNP, ADP, adenosine or adenine) was dissolved in the same buffer as the 
protein at a 10 fold higher concentration than the protein. The ligand solution was adjusted for 
pH if necessary to match the protein. 300 µL from a reservoir of 500 µL ligand was loaded into 
a clean ITC syringe according to microcal instructions. The contents of the syringe was purged 
and refilled twice to remove air bubbles. Residual ligand was removed from the syringe tip 
with a kimwipe prior to inserting the syringe into the cell. All experiments were carried out at 
reference power of 15 µcal/s with a series of 20 injections. The first injection had a volume of 2 
µL with a delay of 120 s before the second injection. All subsequent injections had a volume of 
15 µL with a delay of 240 s between each. A constant stirring speed of 300 rpm was used in all 
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cases. For each set of experimental conditions a heat of dilution experiment was run with 
ligand injected into buffer in the cell without protein. This was then used to adjust the final 
results so only heats of interaction were used in the final calculations. 
 
2.12.1 Heat capacity 
 
What is a heat capacity change? 
 The change in constant pressure heat capacity, or ΔCp, of a protein can be simply 
defined as the change in the enthalpy (ΔH) of a process (ligand binding or protein unfolding for 
example) with respect to temperature. However this simplistic definition does not describe the 
many processes that contribute to the ΔCp value. A change in heat capacity results from a 
change in the degrees of freedom within a system from the transition from the free to the 
bound state. This change in freedom  can be induced by either the unfolding or folding of a 
protein [47], by the binding of another molecule to the protein, a change in hydration of a 
protein[48] and displacement of water molecules, or a conformational change[49]. A change in 
the degrees of freedom will in turn alter the energy required to raise the temperature of the 
system. Gomez et al. [47] described three main contributions to the ΔCp; the first arises from 
the covalent structure of the protein including contributions from vibrational motions due to 
bond stretching and internal rotations; the second is due to non-covalent interactions due to 
secondary and tertiary structure; the third is due to the hydration of the molecule including 
the overall buried surface area and the solvent accessible polar and non-polar surface area. 
These three factors can be further classified as being either intrinsic to the molecule (such as 
the first two) or extrinsic involving the surrounding solute (the third) and the total heat 
capacity classified below:   ,  ,,,   (2.8)   ,,,   (2.9) 
Equations (2.8, 2.9) show contributions to the heat capacity from various sources[47], where 
Cp,bond is the heat capacity due to the atomic and covalent interactions, Cp,nonbond is the heat 
capacity due to non-covalent interactions, Cp,hydration is the heat capacity due to the hydration of 
the protein molecule and  Cp,protonation is the heat capacity due to the protonation state of the 
side chains within the protein. When a process involving a single protein is considered then the 
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term Cp,bond remains the same both before and after the event and so the equations is 
simplified to equation (2.9). 
Hydration changes of protein surface groups and non-covalent interactions, however, 
have a small influence on the total heat capacity of a protein compared to the primary heat 
capacity (Cp,a, equation 2.8)[47]. However, when changes in heat capacity on going from one 
state to another with respect to a single protein are considered, the primary heat capacity 
contributions are identical, and as such small influences from hydration change and non-
covalent interactions account for most of the ΔCp associated with any given process[47] and 
thus the simplified equation (2.9) can be used.  
This summation towards the overall heat capacity allows for a varied and unequal 
contribution from each source. The exact relative influence over the overall ΔCp from each of 
these sources is widely contested however the agreement is that the influence is small[47;50]. 
 
What contributes to the heat capacity and what can these tell us about a physiological 
process? 
 The Cp of an unfolded protein over a physiological temperature range of 0°C – 50°C is 
known to change linearly with respect to temperature [48]. The ΔCp of a protein actively 
unfolding over a physiological temperature range of 0°C – 50°C is not linear, but instead fits to 
a second order polynomial equation [47]. The exposure and hydration of non-polar surface 
area during protein unfolding is known to lead to a positive ΔCp [47], while the hydration polar 
groups lead to an opposing ΔCp change. The non-linear change in the ΔCp of unfolding is due to 
hydration exposure of polar and non-polar groups responding differently to a change in 
temperature, and thus the sum of the two contributions changes in a non-linear fashion with a 
maximum to the curve at around 50°C [48].  
 However as previously mentioned a change in heat capacity is not only associated with 
protein unfolding but also with ligand binding. Indeed, a large negative ΔCp is thought to be 
characteristic of site-specific binding between two molecules due to the associated removal of 
exposed non-polar surface area and the restriction of freedom of the associated polar surface 
area.[49;51;52].  
The influence over the heat capacity of a protein due to a change in non-covalent 
interactions is small compared to the change in solvation due to surface area burial. It is well 
known that a good approximation of the heat capacity change due to hydration can be 
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calculated from changes in polar and non-polar solvent accessible surface area[47;51;53]. 
From experimental data this contribution has been quantitatively assessed[51;54].  ∆  1.34  0.04∆  0.59  0.04∆    (2.10) ∆  1.874∆  0.711∆   1.097∆     (2.11) 
Equation 2.10 calculates the change in heat capacity (ΔCp) from the change in non 
polar (ΔAnp) and polar (ΔAp) surface area[51]. Equation 2.11 also calculates the change in heat 
capacity but includes a term allowing for the change in hydration of the protein (ΔAoh). Both 
equations are valid depending on the number of variables under consideration. For most 
purposes equation 2.10 is sufficient while equation 2.11 allows for the small influence the 
change in hydration will have over the heat capacity. 
Conformational changes will often lead to a change in exposed surface area and so one 
might expect them to also contribute to the ΔCp of a process. Observations of ΔCp associated 
with a protein complex formation, frequently cannot be accounted for by models which 
assume ‘rigid body’ association. This discrepancy is only resolved if a conformational change is 
also assumed to result from binding[49;51]. A variety of examples have confirmed the idea 
that an ‘anomalous’ ΔCp can be used to investigate conformational changes induced by 
binding.  Using the measured ΔCp of a binding interaction and the calculated change in surface 
area associated with rigid body binding, it is therefore possible to assess whether a 
conformational change is likely to be coupled to the binding[51;55]. If conformational changes 
are expected or hypothesised to occur then predictions of the ΔCp based upon the expected 
change in surface area can be compared to the recorded ΔCp. This can then be used to confirm 
the predicted conformational changes or look for other effects influencing the ΔCp.  
Positive heat capacity changes are anticipated within cooperative systems where 
‘order to disorder’ transitions occur, such as during protein unfolding or subunit dissociation 
and water network disruption. The decrease in the water molecules ‘soft’ vibrational modes 
through the formation of H-bond networks can lead to a more negative ΔCp, thus the 
disruption of such a network would mitigate the heat capacity effect due to H-bond 
networks[52;55]. Sometimes disruptions can lead to the reduction for freedom of water 
molecules within a binding interface and the associated negative ΔCp change[52].  
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2.12.2 Proton linkage 
 
The measured enthalpy of a binding event can be used to determine the proton 
linkage of the binding if the experiment is repeated across a pH range. The following 
explanation is based upon Bradshaw et al. 1998 [56].    
If a protonation is required for binding then the linkage scheme can be described as 
shown in figure 2.8. 
 
Figure 2.8 Interaction profile for a single proton linkage binding between a ligand and a macromolecule. L = 
ligand. M = macromolecule. H = proton. Subscripts: p = protonation, b = binding. Superscripts 1 = binding 
deprotonated, 2 = binding protonated ligand. Superscripts f = protonation of free ligand, b = protonation of 
bound ligand. 
 
The relationship between the binding constant of the macromolecule for both the 
protonated (2Kb) and deprotonated (1Ka) and the proton binding constants of the free (fKb) and 
bound (bKp) ligand can be expressed thus: 
 
  	       (2.12) 
 
The proton binding constants can be related to the proton acid dissociation constants by a 
simple inverse relationship: 
 	  1  	          (2.13) 
   1            (2.14) 
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Linkage theory then shows that the association constant of the interaction (Kobs) as a function 
of pH is equal to the product of a reference equilibrium constant (1Kb) and the quotient of the 
subpartition functions for binding of protons to the bound and free forms of the ligand (Zb and 
Zf). 

             (2.15) 
 
For a single protonation event Zb and Zf can be described thus: 
  1  10         (2.16) 
	  1  10        (2.17) 
This is derived using the relationship: 
  log          (2.18) 
	  log  	        (2.19) 
Therefore for a single protonation event Kobs as a function of pH can be described as: 

     
	
  
 	
        (2.20) 
 
Experimental data fit to this equation can then be used to determine the binding constants of 
the proton in both the bound and free state and the binding constant of the unprotonated 
ligand to the macromolecule. 
 
The enthalpy of binding can also be used to assess the proton linkage of an interaction 
between a ligand and a macromolecule. The ΔHobs recorded by ITC comprises of both the 
intrinsic enthalpy of a binding event (ΔH°b) and the enthalpy associated with the ionization 
enthalpy of the buffer used. These relate to each other in the following manner[57]: 
 
∆	  ∆	  ∆	
        (2.21) 
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Where ΔHb  is the intrinsic enthalpy of the interaction accounting for buffer effects, ΔHion is the 
enthalpy of ionisation of the buffer used and n is the number of protons absorbed upon ligand 
binding to the macromolecule. Thus at any given pH the number of protons taken up in an 
interaction can be determined if the enthalpy is recorded under different buffer conditions 
with different heats of ionisation. The gradient of a plot of ΔHobs vs. ΔHion should reveal the 
number of protons taken up. If ligand binding is dependent upon protonation of the ligand 
then n can be described thus: 
    
  	         (2.22) 
Where bf and ff refer to the fractional saturation of protons at a given pH for the bound and 
free ligand respectively. These fractions can then be expressed in terms of the pKa of the 
ligand and the solution of the pH. 
   	
  	
         (2.23) 
 	  	
  	
         (2.24) 
The enthalpy of the binding process (ΔHb) can then be determined using equation 2.20 and the 
following expression where T is the temperature and R is the gas constant: 
 
  ⁄   
 ∆          (2.25) 
This then gives: 
∆	   ∆	   ∆	 
  		∆	     (2.26) 
Where ΔHb is described in terms of the enthalpy of the deprotonated ligand (1ΔHb) and the 
enthalpies of the bound (bΔHp) and free (fΔHp) ligand and the proton saturation fraction of the 
bound (bf) and free (ff) ligand.  
As also described by Baker et al. [57] the ΔHobs, ΔHion and the pH can all be related to one 
another through the following expression combining equations 2.26 and 2.21: 
∆	
   ∆	   ∆	 
  		∆	  ∆	
   (2.27) 
 
This expression describes all the single proton linkage parameters in terms of the solution pH 
and the ΔHion of the buffer used allowing these parameters to be derrived by experimentation 
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at different pH values and different ΔHion values. This can be globally fit to determine the pKa 
values in the bound and the free states. 
 
2.13 Nuclear Magnetic Resonance 
 
2.13.1 Facilities 
 
Nuclear magnetic resonance (NMR) spectrometers at the UCL Biomolecular NMR facility and at 
the MRC Centre for biomedical NMR at Mill Hill were used for this study.  
UCL  Biomolecular NMR facility:  Three spectrometers were used during this study; a Varian 
Inova operating at a Lamour frequency of 600 MHz with a 5 mm 1H, 13C, 15N cryoprobe and 
cooled 1H  pre-amplifier; a Bruker Advance III operating at a Lamour frequency of 700 MHz 
with a 5 mm 1H, 13C, 15N cryoprobe with cooled 1H and 13C preamplifiers; and a Bruker Advance 
III operating at a Lamour frequency of 500 MHz with a 5 mm 1H, 13C, 15N room temperature 
probe. 
MRC Centre: Three spectrometers were used during this study; A Varian Inova operating at a 
Lamour frequency of 800 MHz with a 5 mm 1H, 13C, 15N cryoprobe; a Bruker Advance III 
operating at a Lamour frequency of 700 MHz with a 5 mm 1H, 13C, 15N cryoprobe; and a Varian 
Inova operating at a Lamour frequency of 600 MHz with a 5 mm 1H, 13C, 15N cold probe and a 
31P X-detect probe. 
 
2.13.2 Acquisition of data 
 
Varian spectrometers were controlled using VNMR software, Bruker spectrometers were 
controlled using Topspin software. All experiments were performed at 25°C unless otherwise 
stated.  Each sample contained between 5% - 10% (v/v) D2O to allow a frequency lock to 
adjust for drift in the magnetic field over the time course of the experiments. All samples 
contained 0.02% sodium 2,2-dimethyl-2-silane-pentane-5-sulphonate (DSS) (v/v) to allow for 
referencing recorded spectra to one another. Most experiments were run using 5mm Shigemi 
tubes (Shigemi co. Ltd.) with exceptions noted using 5mm standard NMR tubes (Wilmad Glass 
co. Inc.). Water signals were suppressed using the ‘watergate’ or ‘presaturation’ methods. The 
details used for each experiment are noted in Table 2.5, including the spectral width and the 
number of points. 
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2.13.3 Processing and analysis of NMR data 
 
Processing of the free induction decay (FID) data from both Varian and Bruker 
spectrometers was carried out using NMRPipe spectral processing and analysis system [58] 
and viewed using NMRDraw.  The direct proton time-dimension data were treated with a 
solvent suppression function (SOL) followed by a squared sine-bell apodisation function (SP) 
and zero filled. The treated data was then Fourier transformed and phased as required. This 
process was repeated for the second and third dimensions if applicable. The last dimension, 
either the second for 2D datasets or the third for 3D datasets was linear predicted before 
being processed in a similar way to the first proton dimension. Baseline correction (POLY) was 
applied following phase correction to all dimensions, using either first or second order 
polynomial correction as required. 
 
Processed data were then converted to AZARA format and analysed using the 
Collaborative Computing Project for NMR (CCPNMR) Analysis software v.2.1.3 [59]. Chemical 
shifts were referenced to DSS. Peaks were picked either automatically using CCPN software 
and subsequently edited by hand or picked by hand entirely.   
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2.13.4 NMR experiments 
  1H   D2   D3  Mix 
(ms) 
Experiment SF SW   
(Hz) 
NP Nuc SW (Hz) NP Nuc SW  
(Hz) 
NP  
1H-1D 500 8012.82 32768        
1H-1D 600 10000 8192        
1H-1D 700 8012.82 32768        
31P-1D 600   31P 20000.0 10000     
15N-HSQC (wt 
apo and H/D 
exchange) 
500 2652.774 815 15N 1750.01 512     
15N-HSQC (wt 
AMPPNP and 
H/D exchange) 
700 9455.00 1024 15N 4525.000 128     
15N-HSQC (wt 
ADP and H/D 
exchange) 
700 3860.044 1805 15N 2150.019 256     
15N-HSQC 
(mutants) 
700 3830.178 512 15N 2100.565 903     
15N-HSQC 800 10999.6 4096 15N 3243.98 512     
15N-TROSY 700 12626.263 2048 15N       
CT-13C-HSQC 700 8741.259 2084 13C 12437.15 1024     
13C-HSQC 
(folded) 
800 10999.58 1100 13C 8000.00 160     
HCCH-TOCSY 
(apo) 
700 8741.258 2048 1H 5952.38 256 13C 12437.15 256 100 
HCCH-TOCSY 
(ADP/AMPPNP) 
700 5606.192 1364 1H 7002.801 256 13C 12333.46 256 100 
CCH-TOCSY (all) 700 5605.469 1148 13C 12435.45 256 13C 12435.45 256 100 
Table 2.5 Summary of NMR parameters used for all experiments. 
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One Dimensional NMR 
One dimensional (1D) scans of the protein constructs were recorded prior to all other 
experiments on each sample. This was done to ensure consistent nature of the sample as 
peaks below 0ppm are characteristic of the folded protein in each state. It also allowed 
referencing and calibration of the water suppression using the Watergate method. 
 
Two Dimensional NMR 
Various different two dimensional (2D) experiments were undertaken on the protein 
constructs. Heteronuclear Single Quantum Correlation (HSQC) experiments were performed in 
order to detect resonances from H-N and NH2 groups from both the protein backbone and 
amino acid side chains (Figure 2.9). A 15N-HSQC observes one proton from a one bond 
correlation between 15N - 1H and requires a sample of 15N-labelled protein. Magnetisation from 
the proton can be transferred to the nitrogen and the spin allowed to evolve during a t1 
relaxation period, where it acquires a frequency label according to the offset of the nitrogen 
atom. The magnetisation is then transferred back onto the proton where it is observed but 
retains the frequency label from the nitrogen atom in addition to the frequency of the proton 
itself. 
Signals from protons which are unconnected to a nitrogen atom can be suppressed, 
using a 90° pulse to invert all magnetisation on the nitrogen atom that will only affect the spins 
in antiphase. This means only spins in the 15N – 1H situation are inverted. If this experiment is 
repeated in the inverse dimension then again only the 15N – 1H spins will be inverted. If these 
two signals are subtracted from one another, then any resultant signal will be due to the 
correct 15N-1H correlations with all other proton signals cancelled out[60-62]. 
 
A TROSY experiment is designed to observe the resonances between 1H-15N pairs on 
protein backbones (side chain 1H-15N are not observed with this experiment). The signals 
detected from the 1H-15N pair are subject to two methods of relaxation: dipole-dipole 
interactions and chemical shift anisotropy (CSA). These two methods of relation affect the four 
peaks of the multiplet (1H-15N) differently with one generally being an intense narrow peak and 
the others being shallower, broader, peaks. The local magnetic fields generated – one from the 
CSA and the other from the dipole – either reinforce one another or cancel one another out, 
depending on whether the spins are in the same, or opposite, states. Also unlike an HSQC 
experiment where the multiplet peak splitting is collapsed to a single peak, the asymmetrical 
nature of the peaks is exploited in a TROSY to detect just the intense narrow peak, thus 
increasing the signal to noise ratio when the peak narrowing outweighs the loss of ¾ of the 
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peaks, i.e. for large proteins. Compared to the HSQC pulse sequence, the TROSY pulse 
sequence lacks a 180° pulse applied to the proton during the t1 phase and lacks decoupling of 
the 15N nucleus. This leads to detection of a multiplet separated by JHN. The degree of splitting 
is dependent upon the degree of peak asymmetry due to the cross correlation. Detection of all 
the peaks would lead to a crowded spectrum however spectra are simplified by suppression of 
all but the wanted peak.  
 
The different peaks arise from transitions between the different energy levels 
associated with the cross correlation effects being either in phase or anti-phase with respect to 
each nuclei. Different transitions can be suppressed with a specific low radiofrequency 180° 
pulse that will select only for the unwanted transitions but will not affect the wanted peak [60-
62]. 
 
 
Figure 2.9 Transfer of magnetisation that occurs during a 15N-HSQC and a 15N-TROSY experiment. All transfers are 
within a single amino acid. 
 
A 13C-HSQC observes one proton from a one bond correlation between 13C - 1H and 
usually requires a 13C labelled sample of protein (Figure 2.10). Magnetisation from the proton 
can be transferred to the carbon and the spin allowed to evolve during a t1 relaxation period 
where it acquires a frequency label according to the offset of the carbon atom. The 
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magnetisation is then transferred back onto the proton where it is observed but retains the 
frequency label from the carbon atom in addition to the frequency of the proton itself. This 
will allow the detection of protons involved in 13C - 1H bonds on the backbone from Cα to Hα 
and from all 13C - 1H bonds along the side chains. When multiple protons are attached to a 
carbon atom each 13C - 1H bond will generate a separate signal however signals may be 
degenerate. In the case of CH2 groups, each proton may be in a different environment and so 
two 13C - 1H bonds will be recorded. In the case of a methyl group the rotation of the group is 
sufficiently fast that each 13C - 1H bond is in an equivalent environment to the others and so a 
single averaged peak will be detected for the three 13C bonded protons [60]. 
 
 
 
Figure 2.10 Transfer of magnetisation that occurs during a 13C-HSQC. All transfers are within a single amino acid. 
 
 Two experiments were recorded to aid in the assignment of the 13C - 1H resonances 
from the side chains, both require a 13C labelled sample of protein and the experiment is best 
undertaken in deuterated buffer to minimise the water solvent signal in the spectrum. The 
H(C)CH and (H)CCH TOCSY experiments work in a very similar way to one another (Figure 
2.11). The TOCSY experiment generates cross-peaks between spins that are either directly 
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connected or that are connected by an unbroken chain of couplings. This allows the detection 
of couplings across an extended network such as an amino acid side chain by coherence 
transfer of magnetisation. The transfer of magnetisation along the network is dependent upon 
the mixing time of the experiment and the coupling constant between the two nuclei. The 
magnetisation transfer reaches maximum intensity in a time roughly equal to 1/(2J) where J is 
the largest coupling constant between the two spins in the system being observed. Thus when 
the system extends to beyond one coupling, the time required for magnetisation transfer is 
increased. This necessitates using a longer mixing time in the experiment. The experiment can 
be set up to label the magnetisation with the frequency of the detected proton, the carbon 
directly connected to it and a second carbon that is connected to it through an unbroken chain 
of couplings; this is a (H)CCH-TOCSY experiment. Alternatively the experiment can be set up to 
label the magnetisation with the frequency of the detected proton, the carbon directly 
connected to it and a second proton connected to a carbon that is connected to the first 
carbon through an unbroken chain of couplings. The second carbon does not label the 
magnetisation but merely provides a connection to the second proton. This is known as a 
H(C)CH-TOCSY experiment [60]. 
 
Figure 2.11 Transfer of magnetisation occurring in an (H)CCH or H(C)CH TOCSY experiment within a single amino 
acid. 
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2.13.5 Hydrogen/Deuterium exchange experiments 
 
NMR samples of the N-terminal domain of Hsp90 labelled with 15N were prepared as 
previously described in this chapter. A 300 µL sample of 600 µM protein was prepared in 20 
mM Tris, 5 mM MgCl2, Ph 8 using protonated distilled water. A sample of matching buffer (20 
mM Tris, 5 mM MgCl2, pH 8) was made using deuterated distilled water. 
Initial NMR calibration for the experiment was undertaken using a 600 µL sample 
consisting of a 1:1 ratio of deuterated and protonated buffer without protein to act as a ‘blank’ 
sample. Immediately prior to the experimental start, the 300 µl  protein sample was quenched 
with 300 µl of the matched deuterated buffer used for the blank calibration. Rapid calibration 
was undertaken using the previous ‘blank’ calibration to minimise the duration of this step. 
Subsequently HSQC spectra were recorded every 15 minutes for the first 10 h 30 min. The 
number of scans was then doubled and 30 min spectra were recorded for 11 h 30 min. The 
number of scans was then doubled again and 1 h spectra were recorded for 25 h. This 
experiment was repeated in the presence of a final concentration of 3 mM AMPPNP or 3 mM 
ADP. The spectra were processed as detailed in section 2.13.3 and the change in peak height 
intensity analysed using NMRPipe software[58]. 
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3 The thermodynamics of N-terminal ligand 
binding and conformational flexibility 
 
As has previously been detailed (see Chapter 1) the binding and hydrolysis of ATP to the 
N-terminal domain of Hsp90 is required for the function of the protein. The conformational 
changes induced by the ligand extend not only to the N-terminal domain but are observed 
across the entire protein. The control of the Hsp90 chaperone cycle therefore rests in 
interaction with the ligand, and thus a full understanding of the nature of the binding site is 
important for any future inhibitor design of the Hsp90 chaperone function. Once the binding of 
the isolated N-terminal domain is understood then its potential influence on the rest of the 
protein can be investigated. 
In order to fully understand the binding of a ligand to the N-terminal domain it is 
important to know the thermodynamic parameters and any conformational changes 
associated with binding. The affinity (Kd), enthalpy (ΔH) and entropy (ΔS) of a binding event can 
all provide important information on the nature of the binding process as described in Chapter 
1. Crystal structures of the N-terminal domain of Hsp90 in complex with ADP [8] and for the 
full length protein bound to p23 and AMPPNP[7] have been solved. This reveals two potential 
structures of the molecule, in the product (analogue)- and substrate-bound states respectively. 
Other studies, using fluorescence resonance energy transfer (FRET) to monitor the rate of 
conformational change induced by binding and hydrolysis of ATP, determined five distinct rate 
constants associated with the cycle of reactant binding, hydrolysis and product release[5]. It is 
clear that there is structural information missing between the five rate constants detected and 
the two known conformations. Such a dynamic process of binding, hydrolysis and induced 
conformational changes requires more information to fully understand than that provided by 
static crystal structures alone. 
The nature of the binding site has been investigated using both ITC and NMR. The work 
falls into two main categories. First, binding of different nucleotide-based ligands was 
investigated using ITC. All errors shown for the ITC are taken from the fit of the titration 
determined by the Origin software. Following this the influence of pH on the binding of 
AMPPNP and ADP was investigated and revealed a significant difference in behaviour between 
the two ligands. This change was believed to be due to a protonation event which was then 
further investigated using both 1H/15N NMR and 31P NMR. 
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The remainder of the chapter concerns the change in heat capacity (ΔCp) upon ligand 
binding to the N-terminal domain of Hsp90. The different ligands binding to the same site 
within the N-terminal domain of Hsp90 have ΔCp values of opposite signs (positive ΔCp for 
AMPPNP binding compared to a negative ΔCp for ADP binding). One of the many factors that 
can have a significant influence over the ΔCp of binding is conformational change and 
consequent change in solvent exposed surface area. The ΔCp was used to investigate possible 
changes in conformation of the ‘ATP lid’ region of the N-terminal domain of Hsp90 (residues 98 
– 120). Mutations of the N-terminal domain of Hsp90 designed to stabilise the lid in either an 
open or closed conformation were used to investigate the influence on the binding constants 
and the ΔCp associated with ligand binding. 
 
 
3.1 The binding of ADP to the N-terminal of Hsp90 shows 
significant differences to the binding of AMPPNP to the same 
domain 
 
3.1.1 Dissection of the thermodynamics of binding of AMPPNP to the N-terminal 
domain of Hsp90 reveals a destabilising effect of the γ-phosphate group on 
binding affinity 
 
In order to understand the binding of AMPPNP to the N-terminal domain of Hsp90 the 
ligands ADP, adenosine and adenine were used to dissect the contributions of the chemical 
components of AMPPNP to its binding thermodynamics. The relationships of these molecules 
to each other are shown in Figure 3.1. By observing the thermodynamic profile of these 
substructures it begins to be possible to look at the contributions to binding of the different 
structural regions. 
ITC titrations were performed for the interactions between the N-terminal domain and 
ADP, AMPPNP, adenine and adenosine across a temperature range from 10°C – 30°C. 
Additionally experiments were also performed with ADP and AMPPNP across a pH range of pH 
10 – 5.  
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Figure 3.1 The ATP molecule (analogous to AMPPNP shown in red) highlighting the smaller ligands adenine, 
adenosine and ADP within the ATP structure. 
Results for the nucleotide-based ligands are summarised in Table 3.1. ITC titrations 
initially undertaken in 20 mM Tris with ADP showed a binding affinity (Kd) of 19.6 µM at 15°C. 
Both entropy and enthalpy were negative with the process of binding being enthalpically 
driven with a favourable ΔG value of around -26 kJ∙mol-1.  The binding of ADP is enthalpically 
driven similar to many other natural ligand binding situations[63]. While this binding is 
relatively weak, ADP has three times greater affinity than the binding of AMPPNP to the NT 
domain whose Kd is 74.6 µM at 15°C.  Results are shown at 15°C due to very small enthalpy 
values at 25°C making the ITC data for adenine too difficult to fit.  
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N-terminal w/  Kd  
(µM)  
Error (Kd) ΔH  
(kJ mol-1)  
Error  
(ΔH) 
TΔS  
(kJ mol-1)  
ΔG  
(kJ mol-1)  
Adenine  101.5  ±18.0 -10.1  ±0.8 +12.3 -22.4  
Adenosine  67.2 ±1.7 -45.9 ±1.3 -22.9  -23.0  
ADP  19.6  ±0.9 -74.7 ±1.0 -48.8 -25.9  
AMPPNP  74.6   -  -35.9  ±0.3 -13.1  -22.8  
Table 3.1 Thermodynamic parameters of binding of ligands adenine, adenosine, ADP and AMPPNP as determined 
by ITC at 15°C in 20 mM Tris, 5 mM Mg2+ pH 8. (AMPPNP data from Nilapwar et al. 2009[17]). 
 
 
Figure 3.2 The ΔH TΔS and ΔG values for the four ligands adenine, adenosine, ADP and AMPPNP binding to the N-
terminal of Hsp90 as determined by ITC at 15°C in 20 mM Tris, 5 mM Mg2+ pH 8. 
The binding of adenosine shows a similar affinity to that of AMPPNP at around 70 µM with a 
free energy of -23.0 kJ∙mol-1. It also shows a similarly enthalpically driven thermodynamic 
profile. The adenine moiety contributes most of the binding affinity of the nucleotide based 
ligand with a Kd of around 100 µM. Adenine also shows an entropically driven profile very 
different to that seen by the other ligands. The binding of AMPPNP is less favourable than the 
binding of the product ADP. The binding of the product more tightly than the substrate is 
unusual given the need for removal of the product from the binding site. This may indicated 
that the remainder of the protein plays a role in ATP turnover. 
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A paper by Nilapwar et al. [17] showed that the binding of AMPPNP to the N-terminal of Hsp90 
changed dramatically with respect to pH. Although this effect was noted it was not fully 
explored within the paper. This response could indicate presence of a protonation event upon 
binding. As has already been stated, one way to investigate the nature of the binding site is to 
look at the binding of the chemical components of ATP to the N-terminal domain of Hsp90. 
Given that there is a significant difference between the binding affinities of ADP and AMPPNP 
to the N-terminal domain of Hsp90 at pH8, the next logical step would be to investigate 
whether the binding of ADP responded to a change in pH in a similar way to that of AMPPNP. 
Then confirmation of whether the effect is the result of a protonation event or not can be 
investigated. 
 
3.1.2 Nucleotide based ligand binding to the N-terminal of Hsp90 
 
The thermodynamics of ligand binding to the N-terminal domain of Hsp90 can be 
considered with respect to the binding of increasingly extending ligand molecules, from 
adenine to AMPPNP. In this context it is possible to see some interesting features emerging. 
The dissociation constant of adenine is within the µM range suggesting that the adenine 
moiety contributes most to the binding affinity. This is a view supported by the packing of the 
adenine ring against the β-sheet of the NT binding domain as seen in the crystal structure. The 
binding of adenosine is comparable to the binding of AMPPNP. This suggests that the addition 
of the ribose ring leads to a stabilisation of the binding as seen by the lower dissociation 
constant. The contacts made by the ribose ring include one direct contact with Asn92[8] and a 
number of contacts made with the water molecules within the binding site. It is interesting to 
note that despite the presumable trapping of water molecules within the binding site upon the 
binding of adenine the entropy is still favourable. This favourable entropy is probably caused 
by the displacement by adenine of additional water molecules within the binding site that 
counteracts the trapping of water. In contrast the addition of the ribose group then leads to an 
unfavourable entropy. This may indicate that additional water molecules are trapped by the 
ribose moiety that cannot be fully counteracted by the initial displacement of water. 
The addition of the two phosphate groups in ADP has the most stabilising effect 
beyond the initial adenine ring, reducing the Kd to 19.6 µM. These two phosphate groups are 
thought to mediate contacts between the ligand and several residues via a water molecule 
network and one direct contact with Lys98 [8]. It is also thought that it mediates several 
contacts to a magnesium ion known to be essential for ATP, AMPPNP and ADP binding. The 
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thermodynamic profile also changes quite dramatically with both increased entropy and 
enthalpy values compared to adenosine.  
The addition of the third phosphate group with AMPPNP appears to have a 
destabilising effect upon the binding affinity as it is reduced from 19.6 µM to 74.6 µM, close to 
that of the base adenosine molecule. The values of ΔH and TΔS are slightly less negative than 
those recorded for adenosine. These subtle changes in enthalpy and entropy may well be due 
to the trapping and release of additional water molecules within the binding site by the 
terminal phosphate group as well as any direct contacts between the γ-phosphate and the 
closed lid seen in crystal structure of the full length protein [7]. The degree of change of the 
binding affinity suggests that the number of water molecules affected by the γ-phosphate is 
roughly equal to the number of water molecules affected by the α and β-phosphates but with 
opposing influence. It is known that ATP (and presumably thus AMPPNP) must adopt a kinked 
conformation within the binding site – the presence of the terminal phosphate may well allow 
the final structural rearrangements of the ligand that is likely to put it under strain that might 
make binding less favourable. This combined with any stabilisation of the ‘lid closed’ state may 
put the remainder of the domain under strain not seen under other ligand bound states. 
 
3.1.3 ITC reveals distinctly different pH dependencies of binding affinity for ADP 
and AMPPNP 
 
A comparison set of data looking at the binding of ADP with respect to pH was 
collected at 15°C in the same triple buffer conditions (See Table 3.2 and Figure 3.2).  
From Table 3.1 and Figure 3.2 it can be seen that although there is some variation in 
the binding affinity of ADP to the N-terminal  domain of Hsp90, the changes are negligible 
compared to those observed for AMPPNP where the Kd varied by a factor of 10 from ≈20 µM 
to ≈200 µM across the entire pH range (Figure 3.3).  
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pH N 
Stoichiometry 
Kd  
(µM) 
Error  
(Kd) 
ΔH  
(kJ mol-1) 
Error  
(ΔH) 
TΔS 
(kJ mol-1 K-1) 
ΔG  
 
(ΔH-TΔS) 
pH10 1.05 18.8 ±1.1 -71.8 ±1.0 -43.7 -28.1 
pH9.5 1.01 24.0 ±1.5 -76.7 ±1.4 -50.9 -25.8 
pH9 1.05 14.5 ±0.8 -84.6 ±1.3 -57.9 -26.7 
pH8.5 0.95 15.6 ±1.3 -82.3 ±2.1 -55.9 -26.4 
pH8 1.00 19.6 ±0.9 -74.7 ±1.0 -48.7 -26.0 
pH7.5 1.06 6.4 ±0.3 -70.3 ±1.8 -41.7 -28.6 
pH7 1.00 8.6 ±0.6 -70.6 ±1.3 -42.7 -27.9 
pH6.5 0.98 9.9 ±0.9 -69.4 ±1.8 -41.8 -27.6 
pH6 1.10 11.1 ±1.2 -73.2 ±2.7 -45.8 -27.4 
pH5.5 1.04 10.5 ±0.7 -55.7 ±1.3 -28.2 -27.5 
pH5 1.09 15.9 ±1.8 -75.4 ±3.6 -49.0 -26.4 
Table 3.2 pH dependence of ADP binding to the N-terminal domain of Hsp90 by ITC at 15°C in 20 mM Tris 5 mM 
Mg2+.  
 
 
Figure 3.3 The pH dependence of AMPPNP and ADP binding to the N-terminal domain of Hsp90 binding 
determined by ITC at 15°C in 50 mM Ethanolamine, 100 mM ACES, 50 mM Tris Base, 5 mM Mg2+ (AMPPNP values 
were taken from Nilapwar et al. [17]). 
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 A fit of the Kd to equation 3.1  describing one event upon ligand binding  across a range 
of pH9.5 - pH5 gave pKa values for the protonation of the free (pH 6.5) and bound states 
(pH8.0) [64] (See Figure 3.4).  
  
 
	
      (3.1) 
Equation 3.1 Single proton linkage (Kobs) as a function of the bound and the free pKa values for the protonation 
event as described by Bradshaw et at.[65] 
 
Figure 3.4 A single protonation fit of the Kd data of the binding between AMPPNP and the N-terminal domain of 
Hsp90 by ITC across a pH range. The corresponding Monte Carlo results show the range of values possible for 
both the bound and free pKa of the protonation event. Single protonation fitting and Monte Carlo analysis 
undertaken by Dr. Mark Williams – Birkbeck College London. 
 
3.1.4 Uncovering the number of protonation events associated with binding of 
ADP and AMPPNP to the N-terminal of Hsp90 using the heats of ionisation of 
different of buffer solutions 
 
ITC has been used to probe the binding affinity of ADP and AMPPNP with respect to pH 
and has identified a potential protonation event at pH7. A single protonation event associated 
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with binding has been assumed, however data fitting alone cannot exclude the possibility of 
multiple protonation events. Further characterisation of this protonation event is possible 
exploiting the differing heats of ionisation of a variety of buffers as described in the 
Introduction chapter.  
The heats of ionisation can be used to confirm the number of protons involved in a 
binding event [64-66] as previously only a single protonation event was assumed. A series of 
ITC experiments were carried out in five different buffers with both ADP and AMPPNP at 
pH7.5. This pH is approximately midway between the bound and free pKa’s and should give the 
maximum change in enthalpy arising from the change of protonation state. The results are 
summarised in Tables 3.3 and 3.4. A plot of the specific enthalpy of ionisation of each buffer 
against the ΔH value can be used to determine the number of protons involved in a 
protonation event as described by Baker et al. [64] and detailed in chapter 2 (also see Figures 
3.5 and 3.6). 
 
Buffer Stoichiom
etry (N) 
Kd 
(µM) 
Error 
(Kd) 
ΔH  
(kJ 
mol-1) 
Error 
(ΔH) 
TΔS  
(kJ 
mol-1)  
ΔG 
(kJ mol-
1) 
Heat of 
ionization 
(kJ mol-1) 
Hepes 1.1 35.9 ±0.7 -95.7 ±0.8 -70.4 -25.4 21.0 
Hepes 1.0 21.9 ±0.8 -59.7 ±0.6 -33.1 -26.6 21.0 
Pipes 0.9 34.7 ±1.1 -95.1 ±1.3 -69.7 -25.5 11.5 
Pipes 0.9 34.2 ±1.1 -93.8 ±1.4 -68.3 -25.5 11.5 
Tris 1.1 35.7 ±1.8 -91.2 ±2.2 -65.8 -25.4 47.3 
Tris 1.1 44.5 ±6.0 -92.3 ±6.7 -67.4 -24.8 47.3 
Bis Tris 1.1 43.5 ±2.6 -77.5 ±2.3 -52.5 -24.9 28.2 
Bis Tris 1.1 39.8 ±2.2 -72.6 ±1.8 -47.5 -25.1 28.2 
ACES 1.0 33.6 ±1.6 -75.0 ±1.5 -49.5 -25.5 31.3 
ACES 1.0 53.0 ±8.2 -72.8 ±4.7 -48.3 -24.4 31.3 
Table 3.3 The binding of the N-terminal domain of Hsp90 to ADP by ITC at 25°C, pH 7.5 in 50 mM buffer, 20 mM 
NaCl, 5 mM Mg2. The heats of ionisation for each buffer are shown. 
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Buffer Stoichiom
etry (N) 
Kd 
(µM) 
Error 
(Kd) 
ΔH  
(kJ 
mol-1) 
Error  
(+/-) 
TΔS  
(kJ 
mol-1) 
ΔG 
(kJ mol-
1)  
Heat of 
ionization 
(kJ mol-1)  
ACES 1.0 60.4 ±3.4 -29.5 ±1.6 -5.4 -24.1 31.3 
ACES 1.0 61.8 ±4.3 -31.0 ±2.2 -7.0 -24.0 31.3 
Pipes 1.0 80.5 ±4.7 -47.5 ±3.7 -24.2 -23.4 11.5 
Pipes 1.0 76.2 ±2.2 -41.8 ±1.4 -18.4 -23.5 11.5 
BisTris 1.1 70.3 ±2.8 -39.7 ±1.8 -15.9 -23.2 28.2 
Hepes 1.0 87.5 ±2.3 -54.6 ±1.4 -31.5 -23.1 21.0 
Hepes 1.0 90.3 ±1.4 -56.3 ±2.4 -33.2 -23.7 21.0 
Table 3.4 The binding of the N-terminal domain of Hsp90 to AMPPNP by ITC at 25°C, pH 7.5 in 50 mM buffer, 20 
mM NaCl, 5 mM Mg2+. The heats of ionisation for each buffer are shown. 
 
 
Figure 3.5 The enthalpy of the binding of ADP to the N-terminal domain of Hsp90 determined by ITC plotted 
against the ionisation enthalpy constants of the buffers the titrations were performed under. ITC was carried out 
at 25°C, pH 7.5 in 50 mM buffer, 20 mM NaCl, 5 mM Mg2+. 
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Figure 3.6 The enthalpy of the binding of AMPPNP to the N-terminal domain of Hsp90 determined by ITC plotted 
against the ionisation enthalpy constants of the buffers the titrations were performed under. ITC was carried out 
at 25°C, pH 7.5 in 50 mM buffer, 20 mM NaCl, 5 mM Mg2+. 
Figures 3.5 and 3.6 show a clear difference in the proton linkage of the two ligands 
ADP and AMPPNP in their binding to Hsp90 at pH 7.5. ADP shows close to 0 (1 d.p.) protons 
taken up/released upon binding in comparison to 1 (1 d.p) proton taken up/released upon 
binding to AMPPNP thus confirming a single protonation event associated with the binding to 
the N-terminal domain of Hsp90 at pH7.5. This is consistent with the fit of the binding affinities 
as described previously to a single protonation event. However the information this provided  
still does not reveal whether the protonation event is on the protein or the ligand.  
 
3.1.5 Variation in the Kd of AMPPNP binding to the N-terminal of Hsp90 compared 
to the binding of ADP to the same with respect to a change in pH 
 
The strong pH dependence of binding AMPPNP but not ADP, to the N-terminal domain 
of Hsp90 suggests that the sensitivity to pH originates in the interaction of the terminal γ-
phosphate of the molecule. The destabilising effect of the γ-phosphate is only apparent at pH 
values of 7 and above which suggests that a protonation event may be occurring that affects 
binding, i.e. in the physiological range. Although the most likely source of this protonation is 
the γ-phosphate itself this cannot be verified by ITC alone. 
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From what is known about the properties of the isolated ligands ADP and ATP, the 
fitted pKa value for the free state in the AMPPNP/Hsp90 interaction coincides with the 
transition of ATP from an ATP-3.Mg2+ state to an ATP-4.Mg2+state [67]. The assumption is made 
that AMPPNP behaves in a similar way to ATP. At low pH values both ADP and ATP are in a -3 
charge state and both show similar binding affinities to the N-terminal of Hsp90 of around 
19µM. As the pH increases the binding affinity of AMPPNP decreases however the affinity of 
ADP does not change. Co-incident with this as the pH increases the charge state of AMPPNP 
changes to -4 through deprotonation of the γ-phosphate while ADP remains in a -3 charge 
state. This implies that the -3 charge state is the preferred state for binding.  
 
 
3.2 pH dependence of NMR spectra of the apo and AMPPNP 
bound states of the Hsp90 N-terminal domain  
 
NMR can be used to observe the behaviour of individual amino acids directly in 
response to changes in environmental conditions. If a change in the protonation state of an 
amino acid residue occurs this will not only induce changes in chemical shift for that amino 
acid but also to others nearby due to a local environmental change. 
 A series of HSQC spectra were collected at each half pH unit from 5 to 9.5 for both the 
apo and the AMPPNP bound state of the NT domain. Peak shifts induced by the pH change 
were used to identify whether or not a protonation event occurred on the protein.  
In addition, in order to directly observe the phosphorus groups on the AMPPNP 
molecule by NMR, a series of 1D spectra were collected using a 31P phosphorus probe. Spectra 
across the pH range 5 – 10 were recorded to observe the ligand directly to identify a 
protonation event occurring across this range. 
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3.2.1 Observation of change in chemical shifts by 2D protein NMR identified 
residues affected by the protonation event across the pH5 – 10 in the apo 
state. 
 
 Initially 15N NMR HSQC spectra of the NT domain in the apo-state were collected 
across the pH range 5 – 10 at every half pH unit. Peaks where changes in chemical shift 
(hereafter referred to as ‘chemical shifts’ or ‘shifts’) were induced by a change in pH were 
identified using the backbone assignments [15]. Shift differences between pH5.5 and 6.5, 6.5 
and 7.5, 7.5 and 8.5 and 8.5 and 9.5 were identified and quantified. The magnitude of the 
overall shift for each pH unit interval was calculated based upon the relationship between 
proton and nitrogen shifts given by: 
 
Combined H/N shift = Proton shift + (nitrogen shift/6.4)      (3.2) 
(Taylor J. PhD Thesis UCL. 2006 – Internal lab results.)  
Equation 3.2. Calculation of the combined proton and nitrogen shift used to compare peak shifts. 
This equation allows for direct comparison of the range of shifts in the proton and 
nitrogen dimensions. It accounts for the greater scale over which the nitrogen shifts are 
observed compared to the proton shifts. Thus the contribution of the proton shift is equal to 
the contribution of the nitrogen shift in the calculated values for the overall shift. 
Residues with shifts < 0.01 (combined H/N ppm) in at least one pH unit range were 
considered to be unaffected and not analysed further. No significant shifts were observed 
between pH 5 and pH 5.5. From the analysis of the peaks significant shifts can be identified 
across each pH range (Figures 3.7 and 3.8) and each shift compared between residues and 
across the pH range (see Figure 3.9). 
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Figure 3.7 pH dependent peak shifts of selected peaks from the N-terminal domain of Hsp90 in the apo state. 15N 
labelled sample at 300 µM in triple buffer. Colouring of peaks runs from high pH (red) to low pH (purple) through 
the spectrum. 
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Figure 3.8 pH-dependent peak shifts of selected peaks from the N-terminal domain of Hsp90 bound to AMPPNP. 
15N labelled sample at 300 µM in triple buffer. Colouring of peaks runs from high pH (red) to low pH (purple) 
through the spectrum. 
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Figure 3.10 Chemical shifts of the apo N-terminal domain of Hsp90  induced by a change in pH are shown here on 
the crystal structure taken from PDB file 1AMW of the ADP bound domain. It is assumed that the apo state and 
the ADP state are structurally similar. Residues highlighted in red indicate large shifts while residues highlighted 
in orange indicate smaller shifts. 
is fairly distant from the pH5.5-6.5 range observed however it is possible that the location of 
Asp161 within the folded protein might alter the pKa value to closer to the range being 
observed however this cannot be easily confirmed here as observations are not directly of the 
side-chain but of the backbone. The shifts observed for Ile82 and Gly83 may be influenced by 
Asp161 as they are relatively close however this is unconfirmed.  
 The second set of observed shifts is at a slightly higher pH within the range 6.5 – 7.5. 
These residues include Asp43, Tyr47, Thr159, Val158 and Ala2. On the structure these five 
residue fall into two groups – The first includes Thr159, Val158 and Ala2 are all in close 
proximity and may be linked to the same cause. The involvement of the N-terminal strand in 
this set may suggest that flexibility of this strand in the apo state may be somewhat pH 
dependent. The second set includes Asp43 and Tyr47 which are at one end of the long helix 
and fairly exposed to the solvent. 
 
 3.2.2 Observation of chemical shifts by 2D protein NMR identified residues 
affected by the protonation event across the pH5 
state. 
 
A second set of NMR spectra were obtained across the same pH range however these 
were done in the presence of AMPPNP. Shifts were detected and analysed in the same way to 
the apo-dataset with the following shifts identified (see Figur
across the range of pH5 to 6.5 and then every unit from 6.5 to 7.5, 7.5 to 8.5 and 8.5 to 9.5 
were identified and the same selection criteria as for the apo dataset 
magnitude of the overall shift for each 
the apo-data (equation 3.2). In this case pH5 data were included, since in the presence of 
ligand shifts were observed between pH5 and pH5.5. 
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been mapped onto the crystal structure for the N-terminal domain of Hsp90[8] with shifts 
between pH 5 – 6.5 in red, shifts between pH 6.5 – 7.5 in orange and shifts from pH 7.5 – 9.5 in 
blue (see Figure 3.12).  
 
 
Figure 3.12 Chemical shifts on the AMPPNP bound N-terminal domain of Hsp90 induced by a change in pH are 
shown here on the crystal structure taken from the PDB file 1AMW. Residues highlighted in red indicate shifts 
observed in the low pH range (pH5 – 6.5). Residues highlighted in orange indicate shifts observed between pH6.5 
– 7.5. Residues highlighted in dark blue indicate shifts observed between pH7.5 – 9.  
 In the AMPPNP bound state, three events occur at distinct pH ranges. The first low pH 
event involves Asp161, Leu207, Tyr203, Ala202, Val201, Glu187 and Lys188. The first four 
residues were also implicated in the apo state as changing with respect to pH however this was 
previously thought to be due to the protonation of His197. In this case Arg32 (acting as a 
reporter for His197) does not show a shift until pH 6.5 – 7.5.  This may suggest that the set of 
residues that move at the C-terminal end of the N-terminal domain move independently of 
 
114 
His197. Residues Glu187 and Lys188 were not implicated previously in the apo state however 
their proximity to the other residues of the C-terminal end of the N-terminal domain may 
explain the shifts. The presence of AMPPNP may alter the conformation such that they are 
now subject to the influence of the C-terminal tail of the N-terminal domain. 
 As mentioned the shift observed in Arg32 has moved to a higher pH. In this construct a 
backbone resonance cannot be observed for His197 however the response of Arg32 may 
suggest that the presence of AMPPNP bound to the N-terminal domain has led to an increase 
in the pKa of the His197 side chain. This shift however still does not fall at the correct range for 
that predicted for the pKa of the bound protonation event detected by ITC. It was also 
observed in the apo state albeit at a lower pH. This suggests that His197 is not the protonation 
event detected by ITC. The two other shifts observed at this pH range are Gly153 and Gly154. 
 The final set of shifts observed are Ser39, Asp43, Asp79, Asn135, Lys139, Thr157, 
Ile172 and Phe174. With the exception of Asp43, all these shifts are unique to the AMPPNP 
bound state. These shifts are also the only significant shifts observed in the pH7.5 – 9 range 
which is where the expected protonation event detected by ITC is predicted to occur. All of 
these higher range shifts are also located on the back of the binding site in the β-sheet or on 
the long helix that flanks the binding site, suggesting that the binding of AMPPNP may exert an 
influence over them at this pH range. None of the shifts identified belong to residues that have 
titratable groups in this region, nor do any of the peaks look significant enough to suggest a 
protonation event on it. Although this does not confirm that the protonation event is on the 
ligand it strongly suggests that it is not on the protein. 
The protonation of the γ-phosphate of AMPPNP would change the charge state and 
significantly affect the electrostatic interactions of the phosphate with the surrounding protein 
environment. This change could force the rearrangement of the ligand within the binding site, 
inducing movement and displacement of water within the binding site to accommodate the 
newly positioned ligand and thus changing the overall environment of the binding site. An 
alternative would be a change in the ring currents on the Adenosine moiety of the AMPPNP 
molecule causing shifts at this pH range upon their interaction with the amino acids in the 
binding pocket. Protonation on the ligand however cannot be confirmed by protein NMR.  
 Both sets of low pH shifts observed in both the apo state and the AMPPNP bound state 
are located at the periphery of the protein and are some distance from the nucleotide binding 
domain. The binding of AMPPNP appears to influence the number of residues that shift with 
respect to pH, however, it is already known that the binding of nucleotide ligand causes some 
structural rearrangement to the N-terminal domain of hsp90. The differences between the apo 
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and bound state suggest that these rearrangements reach to the periphery of the protein. The 
lack of shifts seen in Thr159, Val158 and Ala2 may suggest that AMPPNP binding stabilises the 
N-terminal strand thus reducing the influence of pH over it. The binding of AMPPNP also 
influences residue His197 leading to a change in its pKa value as reflected by the change in 
shift of Arg32. 
 
3.2.3 Investigation of the protonation of the γ-phosphate of AMPPNP by 31 
phosphorous NMR 
 
Direct observation of the phosphate groups of the ligand is possible using 31P NMR 1D 
spectra. Due to the simplicity of the molecules involved, i.e. each has only two or three 
phosphate groups, 1D NMR can be used to monitor each group and detect any shift induced by 
pH in both free AMPPNP and when bound to the N-terminal domain of Hsp90. 
31P NMR studies of ADP and ATP have been undertaken in the past and the 
assignments of these spectra will be of use in assigning those of AMPPNP, the effect of the 
protein upon the NMR signals of the bound ligand are unknown.  
Spectra were recorded for ADP, ATP and AMPPNP at both high (pH9) and low (pH5) pH 
values, with and without magnesium (Figure 3.14). A comparison of the spectra and the data in 
papers by Cohn et al. [68;69] allowed peak assignment of ADP, ATP and AMPPNP. Subsequent 
experiments were then recorded for AMPPNP with Mg2+ both in the absence and presence of 
the N-terminal domain of Hsp90 (Figures 3.15 and 3.16). 1D spectra were recorded at each half 
pH unit in each case. All experiments were done in triple buffer with ligand concentrations at 
400µM.  
 
3.2.3.1 Assignment of the 31P phosphate peaks of AMPPNP 
 
Previous studies [68;69] of 31P spectra with ATP and ADP under various pH and 
magnesium bound conditions identified the resonances of ATP by the characteristic splitting 
patterns arising from spin-spin interactions as described above. The γ-peak showed a doublet 
due to its interaction with the neighbouring β-phosphate. The β-phosphate showed a triplet 
pattern due to its interaction with both γ- and α-phosphate groups both across oxygen atoms. 
The α-phosphate showed a less distinct splitting pattern due to its interaction with both the β-
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phosphate and the influence of the neighbouring ribose ring. Cohn[69] also demonstrated that 
as pH decreased, the peak due to the terminal phosphate shifted towards the α-phosphate 
peak. The apparent pKa of this shift corresponds with the pKa of the transition to either the 
ADP3- or ATP4- state respectively[68]. The β-peak of ATP showed limited movement over this 
range. The addition of Mg2+ to ATP was seen to cause a shift in the β- and γ-phosphate peaks 
however no shift was observed on the α-phosphate. This suggests that the Mg2+ ion contacts 
predominantly the terminal two phosphates in ATP. With ADP shifts were observed with both 
the β-phosphate and α-phosphate peaks suggesting that Mg2+ contacts both phosphate groups 
in the smaller ligand. 
 
 
Figure 3.13 Assignment of the phosphate peaks of AMPPNP using the peak splitting patterns identified in the 1D 
spectrum. 
Turning to the AMPPNP spectra, the peak splitting pattern observed for each of the 
three phosphate groups is distinct and allows for their initial identification. The α-peak shows a 
symmetrical doublet splitting pattern caused by the presence of two phosphorus atoms linked 
by one oxygen atom. The β-peak should show a four peak split as it is bound on one side 
through an oxygen to another phosphorus atom and on the other side by a nitrogen to the 
third phosphate. Due to this asymmetrical structure the splitting pattern is not as predictable 
and here results in the superposition of the split peaks leading to a more intense peak with a 
broad shouldered base. The γ-peak should show a doublet pattern but the splitting across a 
nitrogen atom, while symmetrical, will not be identical to the α-phosphate. This is shown in 
Figure 3.13 with a slightly broader peak suggesting less significant separation between the split 
peaks but with a similar intensity to the α peak. Further confirmation of the peak identification 
was undertaken by monitoring the peak behaviour with respect to pH in the unbound state 
using the known behaviour of the peaks of ATP as a guide. 
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The AMPPNP spectra recorded across the pH range shows clearly that at pH9 the 
terminal phosphate has moved away from the α-phosphate as anticipated compared to the 
spectra recorded at pH5. In this way AMPPNP behaves like ATP. When AMPPNP is observed 
without Mg2+ at low pH one large peak is seen corresponding to the α- and γ-phosphates with 
a second peak which can be attributed to the β-peak.  At pH 9 three peaks are seen – the α- 
and γ- peaks as previously described and the β-peak which has shifted slightly in response to a 
change in pH as anticipated. At both high and low pH this β-peak is very far distant from the β 
peaks observed for ATP but can be explained when considered in relation to the modification 
made to AMPPNP to negate hydrolysis of the terminal phosphate. Instead of being linked by 
an oxygen atom, the β- and γ-phosphates are linked by a nitrogen atom which appears to have 
profoundly affected the position of the β peak, yet its behaviour under changing pH and the 
behaviour of the other peaks confirms their identities. The β peak of ADP behaves in a similar 
fashion to the terminal phosphate of ATP and AMPPNP. 
 The effect of the magnesium, again as expected, has caused a shift in both the β- and 
γ-phosphates in all cases (Figures 3.14). At low pH the peaks are very much broader causing 
the β to disappear completely when magnesium is added with both ADP and ATP. As with ATP, 
an increase in pH caused the movement of the γ peak away from the α peak with a small effect 
on the β-peak. Addition of Mg2+ (see Figure 3.14) shows a small movement of the β- and γ-
peaks from their positions without Mg2+ however the gross differences between ATP and 
AMPPNP are maintained. 
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Figure 3.14  Control 31P 1D spectra collected for ADP and ATP, with and without 5 mM Mg2+, and at pH 5 and pH 9 
in each case. 31P 1D spectra collected for AMPPNP without Mg2+ at pH 5 and pH 9. Spectra in 50 mM 
Ethanolamine, 100 mM ACES, 50 mM Tris Base. Ligands at 400 µM concentration. 600 MHz field used. 
 
3.2.4 Titration data for both free and bound AMPPNP reveals a chemical shift 
transition as pH changes. 
 
Using free AMPPNP 1D NMR spectra were recorded using a 31P probe in the triple 
buffer across the pH range used for previous ITC and NMR experiments. The ligand was used at 
400µM concentration. A Mg2+ concentration of 5 mM was used. Protonation of any phosphate 
group will introduce an extra electron thus increasing the shielding of the nucleus and leading 
to a reduction in chemical shift. 
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Figure 3.15  The pH dependence of 31P 1D spectra of free AMPPNP at a concentration of 400 µM. Buffer 
conditions 50 mM ethanolamine, 100 mM ACES, 50 mM Tris Base, 5 mM Mg2+. 600 MHz field used. 
 
Observations of the ligand while bound to the N-terminal domain of Hsp90 are 
important to understand how the ligand interacts with the protein. The binding of a small fast 
tumbling ligand to a larger slower tumbling protein may act to slow the tumbling time of the 
ligand thus leading to faster relaxation of the phosphorus signal from the ligand phosphates 
and peak broadening of any signals detected. This may reduce the intensity of the overall 
signal. 
1D NMR spectra were recorded using a 31P probe in triple buffer across the pH range 
used for previous ITC and NMR experiments (Figure 3.15). The ligand was used at 400 µM 
concentration with equimolar N-terminal Hsp90. A Mg2+ concentration of 5 mM was used. 
Titrations were conducted from pH 6 – pH 10 for the protein bound scans as at the 
concentrations used the N-terminal domain of Hsp90 precipitated.  
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Figure 3.16 31P 1D spectra of a pH dependent titration of AMPPNP bound to equimolar concentrations of the N-
terminal domain of Hsp90 at concentration of 400 µM. Buffer conditions: 50 mM ethanolamine, 100 mM ACES, 
50 mM Tris Base, 5 mM Mg2+. 600 MHz field used. 
 
 Assignment of all three peaks for AMPPNP bound to the N-terminal domain of Hsp90 is 
as seen in the free AMPPNP spectra from pH 10 – 8, (see Figure 3.16) During the transition 
from pH 8 - 7 both the α- and β-peaks are visible and show a clear movement from one pH to 
the next with some slight movement. The γ-peak over this range however decreases in 
intensity before disappearing completely. The appearance of a fourth peak at pH 7.5 at -0.9 
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ppm however and its subsequent increasing intensity from pH 7.5 to pH 6 correlates to the 
disappearance of the γ peak. This suggests that this is indeed the γ-phosphate peak having 
undergone a radical chemical shift upon an event, possibly protonation, at pH 7.5. The 
presence of both peaks, both at a low intensity, suggest a mixed population of both the 
protonated and un-protonated γ-phosphate of AMPPNP at this pH. The intensity increase as 
pH decreases would then be as the population moved away from a mixed population to a 
single charge state. 
 
3.2.5 Analysis of titration data for both the free AMPPNP ligand and AMPPNP 
bound to the N-terminal domain of Hsp90 
 
 
Figure 3.17 Chemical shift changes with respect to pH of the three phosphate groups of free AMPPNP as 
determined by 31P NMR. 
 The shifts for AMPPNP in the presence of the N-terminal domain of Hsp90 are 
summarised in Figure 3.18. 
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Figure 3.18 Chemical shift changes with respect to pH of the three phosphate groups of AMPPNP bound to the N-
terminal domain of Hsp90 as determined by 31P NMR. 
A plot of the shifts for the free AMPPNP ligand (Figure 3.17) shows clearly that both 
the γ and β peaks are both responding to a protonation event between pH 6.5 – 7. The effect 
on the γ peak shift is of a greater magnitude than that observed on the β-peak suggesting that 
a protonation event is occurring on the γ-phosphate. When this is compared to the results of 
the 1H/15N NMR pH titration (Figure 3.11) and the ITC data (Figure 3.3) it can be seen that this 
corresponds to the pKa value calculated for the ‘free’ event.  
A plot of the shifts for the bound AMPPNP ligand (Figure 3.18) shows different results 
to that of the free ligand. Unlike in the free ligand the β-peak shows a very slight shift in 
response to pH change suggesting that being bound to the protein acts to stabilise the β-
phosphate group. In contrast the effect on the γ-phosphate is very pronounced. A slight shift is 
seen between pH 10 – 8 however at pH 7.5 the intensity of the peak decreases and as 
previously mentioned a new peak appears and increases in intensity. A possible interpretation 
is that as pH decreases, the terminal phosphate becomes protonated and that this protonation 
profoundly changes its chemical shift. This transition occurs at a higher pH than in the free 
ligand corresponding to the ‘bound pKa’ calculated by the ITC data shown previously. This 
suggests that the presence of the protein acts to alter the pKa of the terminal phosphate to 
between pH 7 – 8. Unlike the free ligand, a transition is observed for the α-phosphate however 
the transition is small compared to the γ phosphate suggesting that, like the β-phosphate in 
the free ligand, the chemical shift change is due to neighbouring groups rather than any direct 
effect. It is already known that the protonation event described leads to a wide spread range 
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of chemical shifts across the N-terminal domain of Hsp90 (Figure 3.12), this may well explain 
why protonation of the γ-phosphate leads to a change in the environment of the α phosphate 
and subsequent chemical shifts, due to effects transferred via the ligand binding site.  
When the transition for the γ-phosphate in the bound state is compared to the 
previous protein NMR titration data and the ITC data it can be seen that the shift in peak 
position occurs in the same pH range as shifts observed previously.  It can be concluded that 
the protonation event observed on the γ-phosphate of bound AMPPNP is the same as the 
protonation event observed by protein NMR and ITC. Therefore when combined with the 
knowledge of ATP protonation [68;69] linking the γ peak movement to the formation of an 
ATP-4 form, this suggests that the protonation of AMPPNP on the γ peak is as AMPPNP moves 
from a -3 to -4 charge state. This transition corresponds to a change in binding affinity as 
previously seen. This, combined with the knowledge that ADP remains in a -3 charge state 
across the pH range without altering its binding affinity, suggests that binding in the -3 charge 
state is more favourable than the -4 charge state.  
 
3.2.6 Summary of NMR pH titration data 
 
 The ITC studies of the N-terminal domain of Hsp90 binding to AMPPNP in triple buffer 
at different pH values are consistent with a single protonation event with a free pKa of 6.5 and 
a bound pKa of 8. A single protonation event is confirmed by a value of 0.7 protons released at 
pH7.5 i.e. between the free and bound pKa values. No protonation event is associated with 
ADP binding to the N-terminal domain of Hsp90.  
With the combination of the 2D 15N-HSQC  pH titration data and the 31P 1D pH titration 
data it can be confirmed that there is a protonation event that occurs at pH7 and that this is 
limited to the terminal γ-phosphate of the AMPPNP ligand and does not map to the 
protonation of any amino acid within the NT domain. This pH range corresponds to the 
transition of AMPPNP from the AMPPNP-3 to the AMPPNP-4 state, assuming similar behaviour 
to ATP [67] as the pH increases.  
As previously described the binding affinity dramatically decreases at around pH7 with 
AMPPNP but not ADP. At low pH when both ligands bind with a similar affinity both ligands are 
in the -3 charge state. The weakening in binding of AMPPNP coincides with the pH of the 
known transition of ATP from the -3 to the -4 charge state. Assuming a similar behaviour for 
AMPPNP this may indicate a de-protonation of the AMPPNP γ-phosphate as observed by 31P 
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NMR. In contrast the ADP binding affinity does not vary with pH, nor does the charge state of 
the ligand [67]. This reveals that the -3 charge state of both ligands is preferable for binding to 
the NT domain of Hsp90. Additionally the spread of the shifts observed on the protein 
associated with this change in charge state across the binding site suggests that it is not one 
functional group responsible for an increased binding affinity but a less specific effect 
influencing the entire binding site. 
 This knowledge has important ramifications for future drug molecule design as it is 
clear that the charge state of the ligand has a profound effect upon the binding affinity while 
not clearly corresponding to any one specific side chain or functional group. 
 
 
3.3 The ΔCp values found by ITC upon binding of ligands ADP, 
AMPPNP, adenine and adenosine to the N-terminal of Hsp90 
suggest conformational changes are occurring 
 
 It is known that Hsp90 goes through a series of conformational changes in response to 
the binding to and hydrolysis of ATP at the NT domain [5;10;20;22;23;35;38;70]. Many of these 
conformational changes are not limited to the NT domain but have long ranging effects 
throughout the chaperone. The crystal structures of the N-terminal domain alone and of the 
full length Hsp90 protein bound to AMPPNP  and the co-chaperone p23, [7;8] suggest that a 
key conformational change is the movement of the ATP lid over the ligand binding site upon 
complex formation. This conformational change appears to be very important in the overall 
nucleotide hydrolysis cycle, however detailed information on how hydrolysis is linked to this 
conformational change is not clear. 
 
3.3.1 ΔCp data was collected for the binding of ADP and AMPPNP to the N-terminal 
domain of Hsp90 across a pH range from pH 5 – 10 
 
 As has been previously described in Chapter 1, the change in heat capacity of a 
reaction can be used to identify large changes in conformation because it is a measure of the 
change in degrees of freedom of a system on going from a free to bound state, which is often 
largely dictated by the displacement of water molecules from protein surfaces and changes in 
 
125 
the rotational and vibrational degrees of freedom. Thus if a conformational change results 
from the binding of the N-terminal of Hsp90 to ADP and/or AMPPNP then this may be 
reflected in the change in heat capacity of the binding reaction. 
 ITC can be used to determine the change in heat capacity of a protein/ligand 
interaction by recording the ΔH values of binding at different temperatures. These 
experiments have been undertaken from 10°C to 25°C, across the pH range 10 – 5 every half 
pH unit for ligands binding to NT. These data are summarised in Tables 3.5 and 3.6. 
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Protein:  N-Terminal Ligand: ADP pH: 10 ΔCp: -1.72  kJ mol-1  K-1 
Temp (C) Stoichiometry 
(N) 
Error ± Kd (µM) Error (µM) ± ΔH (kJ mol-1) Error (±) TΔS (kJ mol-1)  ΔG (kJ mol-1) 
10 0.99 0.01 10.66 0.92 -68.03 1.17 -41.11 -26.92 
15 1.05 0.01 18.76 1.07 -71.76 1.02 -45.69 -26.06 
20 1.06 0.01 33.11 1.50 -77.95 1.19 -52.86 -25.08 
25 1.00 0.02 62.11 3.30 -94.56 2.58 -69.11 -25.45 
 
Protein:  N-Terminal Ligand: ADP pH: 9.5 ΔCp: -3.21 kJ mol-1  K-1 
Temp (C) Stoichiometry 
(N) 
Error  ± Kd (µM) Error (µM) ΔH (kJ mol-1) Error (+/-) TΔS (kJ mol-1) ΔG (kJ mol-1) 
10 0.95 0.02 10.72 0.73 -69.37 1.16 -42.41 -26.96 
15 1.01 0.01 23.98 1.46 -76.65 1.43 -50.85 -25.80 
20 1.05 0.02 43.80 2.86 -91.80 3.14 -67.29 -24.51 
25 0.97 0.02 81.50 3.18 -117.74 3.93 -94.37 -23.37 
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Protein:  N-Terminal Ligand: ADP pH: 9.0 ΔCp: -1.33 kJ mol-1  K-1 
Temp (C) Stoichiometry 
(N) 
Error  ± Kd (µM) Error (µM) ΔH (KJ mol-1) Error (+/-) TΔS (KJ mol-1) ΔG (kJ mol-1)  
10 0.99 0.01 6.94 0.57 -78.70 1.23 -50.74 -27.96 
15 1.05 0.01 14.49 0.79 -84.60 1.25 -57.92 -26.68 
20 1.11 0.01 24.49 1.17 -90.08 1.51 -64.15 -25.93 
25 1.13 0.01 41.81 1.51 -98.78 1.70 -73.78 -25.01 
 
Protein:  N-Terminal Ligand: ADP pH: 8.5 ΔCp: -2.44 kJ mol-1  K-1 
Temp (C) Stoichiometry 
(N) 
Error  ± Kd (µM) Error (µM) ΔH (KJ mol-1) Error (+/-) TΔS (KJ mol-1) ΔG (kJ mol-1) 
10 0.91 0.01 7.75 0.70 -73.64 1.37 -45.94 -27.70 
15 0.95 0.02 15.57 1.30 -82.34 2.09 -55.88 -26.46 
20 0.99 0.02 30.01 1.71 -93.01 2.20 -67.61 -25.40 
25 0.98 0.02 75.30 6.17 -110.71 3.72 -86.27 -24.43 
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Protein:  N-Terminal Ligand: ADP pH: 8.0 ΔCp: -0.95 kJ mol-1  K-1 
Temp (C) Stoichiometry 
(N) 
error Kd (µM) Error (µM) ΔH (KJ mol-1) Error (+/-) TΔS (KJ mol-1) ΔG (kJ mol-1) 
10 1.00 0.01 8.76 0.80 -68.57 1.22 -41.15 -27.43 
15 1.00 0.01 19.60 0.93 -74.73 1.04 -48.73 -26.00 
20 1.06 0.02 35.93 2.01 -80.42 1.78 -55.48 -24.94 
25 1.15 0.02 42.88 3.12 -82.51 2.42 -57.58 -24.93 
 
Protein:  N-Terminal Ligand: ADP pH: 7.5 ΔCp: -0.95 kJ mol-1  K-1 
Temp (C) Stoichiometry 
(N) 
error Kd (µM) Error (µM) ΔH (KJ mol-1) Error (+/-) TΔS (KJ mol-1) ΔG (kJ mol-1) 
10 1.01 0.01 3.85 0.13 -67.74 0.49 -38.38 -29.36 
15 1.06 0.01 6.37 0.27 -70.33 0.80 -41.71 -28.62 
20 1.05 0.01 10.68 0.50 -76.23 1.29 -48.33 -27.91 
25 1.04 0.02 19.78 1.19 -81.55 2.24 -54.51 -27.03 
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Protein:  N-Terminal Ligand: ADP pH: 7.0 ΔCp: -0.84 kJ mol-1  K-1 
Temp (C) Stoichiometry 
(N) 
error Kd (µM) error ΔH (KJ mol-1) Error (+/-) TΔS (KJ mol-1) ΔG (kJ mol-1) 
10 1.01 0.01 6.21 0.29 -50.88 0.45 -22.63 -28.25 
15 1.00 0.01 8.62 0.62 -70.58 1.34 -42.68 -27.91 
20 1.01 0.01 12.76 0.60 -73.43 1.10 -46.00 -27.44 
25 1.01 0.01 20.45 1.05 -78.95 1.73 -52.14 -26.81 
 
Protein:  N-Terminal Ligand: ADP pH: 6.5 ΔCp: -0.69 kJ mol-1  K-1 
Temp (C) Stoichiometry 
(N) 
error Kd (µM) error ΔH (KJ mol-1) Error (+/-) TΔS (KJ mol-1) ΔG (kJ mol-1) 
10 1.01 0.01 5.50 0.53 -63.85 1.26 -35.30 -28.54 
15 0.98 0.02 9.90 0.88 -69.41 1.76 -41.84 -27.58 
20 1.01 0.02 13.23 0.93 -71.30 1.64 -43.91 -27.39 
25 1.05 0.02 21.83 1.75 -74.73 2.55 -48.15 -26.57 
30 1.03 0.09 59.52 0.53 -98.74 12.78 -74.20 -24.54 
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Protein:  N-Terminal Ligand: ADP pH: 6.0 ΔCp: -0.81 kJ mol-1  K-1 
Temp (C) Stoichiometry 
(N) 
error Kd (µM) error ΔH (KJ mol-1) Error (+/-) TΔS (KJ mol-1) ΔG (kJ mol-1) 
10 1.05 0.01 6.33 0.40 -68.58 1.10 -40.40 -28.18 
15 1.10 0.03 11.12 1.24 -73.22 2.66 -45.81 -27.41 
20 1.09 0.03 12.89 1.38 -76.07 2.81 -48.57 -27.49 
25 1.09 0.05 27.55 3.42 -81.09 5.61 -55.01 -26.07 
 
Protein:  N-Terminal Ligand: ADP pH: 5.5 ΔCp: -0.83 kJ mol-1  K-1 
Temp (C) Stoichiometr
y (N) 
error Kd (µM) Error ΔH (KJ mol-1) Error (+/-) TΔS (KJ mol-1) ΔG (kJ mol-1) 
10 1.00 0.01 6.17 0.38 -53.76 0.88 -25.47 -28.29 
15 1.04 0.02 10.52 0.66 -55.69 1.25 -28.21 -27.48 
20 1.01 0.04 20.33 2.05 -60.71 3.18 -34.34 -26.37 
25 1.02 0.08 40.10 5.66 -65.94 7.37 -40.82 -25.12 
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Protein:  N-Terminal Ligand: ADP pH: 5.0 ΔCp: -0.23 kJ mol-1  K-1 
Temp (C) Stoichiometry 
(N) 
error Kd (µM) Error ΔH (KJ mol-1) Error (+/-) TΔS (KJ mol-1) ΔG (kJ mol-1) 
10 1.10 0.01 10.88 0.57 -70.88 1.19 -43.95 -26.93 
15 1.09 0.03 15.87 1.84 -75.44 3.58 -48.95 -26.49 
20 1.28 0.08 19.34 4.86 -67.32 6.73 -40.84 -26.48 
25 1.15 0.08 40.32 6.42 -77.45 8.63 -52.39 -25.05 
Table 3.5 Summary of binding data including errors of the binding of the N-terminal of Hsp90 to ADP across the pH range pH10 - 5 across a temperature range of 10°C to 25°C. 
  
 
132 
A summary of the calculated ΔCp values for the N-terminal of Hsp90 binding to ADP is 
shown in Table 3.6.  
pH 
ΔCp (kJ mol-1 
K-1) 
Error (+/-)  
(kJ mol-1 K-1) 
10 -1.72 0.01 
9.5 -3.20 0.16 
9 -1.33 0.1 
8.5 -2.44 0.16 
8 -0.95 0.11 
7.5 -0.95 0.08 
7 -0.84 0.08 
6.5 -0.69 0.12 
6 -0.81 0.20 
5.5 -0.83 0.21 
5 -0.23 0.34 
Table 3.6 The pH dependence of the ΔCp values for the binding of ADP to the N-terminal domain of Hsp90 as 
determined by ITC. A temperature range of 10°C - 25°C was used. Buffer conditions: 50mM ethanolamine, 
100mM ACES, 50mM Tris Base, 5mM Mg2+.  
The ΔCp of the binding of AMPPNP was determined by Nilapwar et al.[17] and is summarised in 
Table 3.7.   
pH 
ΔCp  
(kJ∙mol-1∙K-1) 
Error (+/-)  
(kJ∙mol-1∙K-1) 
10 0.28 0.04 
9.5 0.50 0.10 
8.7 0.24 0.08 
8 0.15 0.08 
7 0.23 0.02 
6 -0.01 0.02 
5 0.03 0.03 
Table 3.7 The pH dependence of the ΔCp values for the binding of AMPPNP to the N-terminal domain of Hsp90 as 
determined by ITC by Nilapwar et al. [17] Buffer conditions: 50mM ethanolamine, 100mM ACES, 50mM Tris Base, 
5mM Mg2+. 
A comparison of the ΔCp data for both ADP and AMPNP binding to the N-terminal of 
Hsp90 across a physiological pH range is summarised in Figure 3.19.  
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Figure 3.19 The pH dependence of ΔCp of the binding of ADP and AMPPNP to the N-terminal domain of Hsp90. 
 
3.3.2 The ΔCp values for ADP and AMPPNP binding to the N-terminal domain of 
Hsp90 show a significant variation to each other 
 
A cursory glance at the numbers in Table 3.6 shows that the ΔCp for ADP binding to the 
N-terminal of Hsp90 is predominantly negative with a more negative value at the higher pH 
values gradually decreasing towards zero as the pH decreases. This effect must be 
independent of the Kd since no change in Kd is observed with the change in pH with ADP. A 
negative heat capacity in relation to the binding of a protein is not unexpected since this 
usually represents the burial of hydrophobic/apolar surface area caused by the binding of 
ligand to the protein binding site. However contributions towards this heat capacity can come 
from many other sources [66;71]. 
It is also clear to see that the ΔCp values previously reported for AMPPNP differ 
significantly to those recorded for ADP, i.e. the ΔCp’s for AMPPNP are predominantly positive 
and decrease to zero as pH decreases.  
This large variety in ΔCp values involving similar ligands at the same binding site is an 
unusual phenomenon suggesting that the binding must involve a complex series of events as 
has been suggested previously in this chapter. It is also noteworthy that the magnitude of the 
ΔCp values between ADP and AMPPNP differ significantly. 
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The effect of pH on the ΔCp alone has been described by Baker and Murphy.[64] and 
under constant buffer conditions the ΔCp across a pH range should reveal minima and maxima 
at both the pKa of the free and bound state as well as showing the ΔCp for the protonation of 
free protein upon ligand binding  described as ΔCp.p. From plots of the ΔCp values against pH 
for ADP and AMPPNP (Figure 3.19) it is clear to see that this simple pattern is not evident 
suggesting other factors are affecting the ΔCp.  
 
3.3.3 The ΔCp values for the binding of ADP and AMPPNP to the N-terminal of 
Hsp90 can be used to predict conformational changes 
 
 Large negative ΔCp values are often associated with site specific ligand/protein binding 
events[71] as ligand binding often results in the burial of surface area and the displacement of 
water molecules. Conformational changes caused by ligand binding may also displace water 
molecules and contribute to the ΔCp. The ΔCp value is comprised of several components 
including both polar and apolar surface area burial, atomic and covalent bond contributions 
and the protonation state of the side chain. Some of these factors, such as surface area burial, 
have a greater influence over the ΔCp value than others such as atomic bond contributions[71]. 
The result of this dominance is that changes in the surface area burial and conformational 
changes are reflected in the ΔCp and thus the ΔCp can be used as an indication that these 
events are occurring. From the ΔCp a rough estimate of the surface area burial can be 
calculated. Should this differ from that expected by structural modelling then a conformational 
change associated with binding may be inferred[51]. Due to the many factors contributing to 
ΔCp the calculations only take surface area burial under consideration and are therefore no 
more than an indication as to the existence and rough scale of any changes. However since the 
dominant contribution to the ΔCp value is the burial of surface area the equation is still a valid 
indicator of structural rearrangement. Using the crystal structures [7;8] as a starting 
reference the anticipated ΔCp was calculated by Nilapwar et al.[17] (Table 3.8) as described 
below [71;72]. Although there is no crystal structure of the AMPPNP bound state of the NT 
domain alone, a prediction of this state was made from  the full length crystal bound to p23[7].  
There was a difference between the calculated ΔCp based upon the crystal structure 
and models and the actual observed ΔCp for both AMPPNP and ADP. 
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NT Hsp90 ligand ΔCp obs (J mol-1 K-1) ΔCp calc (J mol-1 K-1) 
(eq. 3.3) 
ΔCp calc(J mol-1 K-1)  
(eq 3.4) 
ADP  -840 -140 -190 
AMPPNP (open) +230 -150 -170 
AMPPNP (closed) +230 +600 +680 
Table 3.8 Comparison of the observed and calculated ΔCp for ADP and AMPPNP binding to the N-terminal domain 
of Hsp90 at pH7. Predictions for the ADP bound protein are based on the N-terminal crystal structure while 
predictions for the AMPPNP bound protein are based from the ADP bound N-terminal structure (assuming a ‘lid 
open’ conformation as in ADP binding) or modelled assuming a ‘lid closed’ position using information from the 
full length AMPPNP bound Hsp90 in complex with p23. AMPPNP data from Nilapwar et al. [17] 
 The two equations used were taken from Bergqvist et al.[54] and derived from work by 
Freire et al. [47] and Luque et al.[72]. They are summarised in Equations 3.3 and 3.4. 
ΔCp = 1.34ΔAnp – (0.59 ± 0.04)ΔAp J mol-1 K-1      (3.3) 
ΔCp = 1.874ΔAnp + 0.711ΔAoh – 1.097ΔAp J mol-1 K-1     (3.4) 
Above are the equations used to calculate the predicted ΔCp for the binding of ADP 
and AMPPNP to the N-terminal of Hsp90 and applied to the N-terminal crystal structure bound 
to ADP and the predicted model for the N-terminal of Hsp90 bound to AMPPNP based on the 
full length crystal structure and the N-terminal crystal structure as previously detailed. Both 
equations are valid with the first taking just polar and non-polar surface area under 
consideration while the second adds in the influence of change in hydration. For the work 
presented here the first equation only was used. 
This difference between observed and predicted results is most likely attributed to the 
differential movement of the ATP lid upon binding of the different ligands. The conformational 
change associated with the lid-closed conformation exposes a large amount of hydrophobic 
surface area on the back of the lid thus providing a major contribution to the ΔCp. It is possible 
that disruption of the extensive hydrogen bond network within the binding site might also 
influence the ΔCp as binding would displace water within the binding site and reduce the water 
trapped between the binding interfaces. It was also theorised by Nilapwar et al. that 
replacement of the flexible hydrogen bonding network with a more rigid ligand within the 
binding site might weaken the stability of the overall protein domain structure ‘creating 
additional vibrational modes within the protein both locally and globally’[17]. Although this is 
rather speculative it is somewhat supported by the NMR titration data where binding is seen 
to influence a large number of residues even far from the binding site. 
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 The expanded results for the ΔCp of ADP show that the ΔCp value is more negative than 
previously thought. The ΔCp calculated at low pH is close to that predicted in the absence of 
conformational change (around -100 J∙mol-1∙K-1) however as pH increases the ΔCp decreases 
dramatically to around -1000 J∙mol-1∙K-1.  
3.3.4 Explaining the heat capacity observed in reference to movement of the ATP 
lid upon ligand binding 
 
It is clear that there is a significant difference between the predicted and observed values for 
the ΔCp associated with both ADP and AMPPNP binding to the N-terminal of Hsp90. The 
difference between the predicted values and the observed values for ADP could be explained 
by considering the position of the ATP lid (residues 98 – 120) at various points within the 
nucleotide binding and hydrolysis cycle.  The various positions of the lid are shown in Figure 
3.20.
 
Figure 3.20 The various possible lid positions of the N-terminal domain of Hsp90 during ligand binding are shown. 
A: Shows the apo state with the lid in an open conformation. B: Shows the apo state with the lid neither in the 
fully open or fully closed state. B: Shows the apo state with the lid in a closed conformation. D: Shows a ligand 
bound state with the lid in the open conformation. E: Shows a ligand bound state with the lid in the closed 
conformation. 
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 ADP binding to the N-terminal domain of Hsp90 is thought to favour an ‘open’ 
position[8] for the ATP lid as shown in Figure 3.20D. If we assume movement of the lid from a 
position of not being fully open (Figure 3.20B) to a fully open position (Figure 3.20D) upon 
ligand binding, the ΔCp is therefore based upon the change in exposed non-polar surface area 
as the back of the lid contacts the main body of the protein. Table 3.9 shows a ΔCp value of -
840 J∙mol-1∙K-1 for ADP binding which can be interpreted as arising from the burial of a large 
amount of non-polar surface area that was not anticipated in the prediction. If ADP binds 
when the lid is already in the open position (from A to D) then binding will not induce any 
further conformational changes, only the displacement of water molecules from within the 
binding site. There will be no change in surface area burial and as such no major contribution 
to a change in ΔCp. If however the lid does not start in the fully ‘open’ position then the 
binding of ADP may induce full opening of the lid leading to the burial of surface area along the 
back of the lid. 
 However as pH increases the ΔCp value observed for the binding of ADP becomes more 
negative until it is greater than that predicted from any model involving ADP.  If an increase in 
pH caused the starting position of the apo protein to resemble Figure 3.20B more than Figure 
3.20A, then upon ADP binding opening of the lid would now result in the burial of surface area 
between the back of the lid and the main body of the protein. This suggests that in the apo 
state at higher pH, the ATP ‘lid’ of the protein is not in the fully open position but is more likely 
to be in an equilibrium between open and closed as shown in Figure 3.20B. 
 AMPPNP binding to the N-terminal domain of Hsp90 is thought to favour a ‘closed’ 
position of the lid as shown in Figure 3.20E. Calculations were made assuming induction of 
either a ‘closed’ or ‘open’ conformation of the lid. Predictions for the ΔCp of an ‘open’ lid while 
bound to AMPPNP were close to that predicted for ADP. Predictions for the ‘closed’ lid 
conformation give a large positive ΔCp. Closure of the lid results in the occlusion of some 
exposed surface area on the inside of the lid but also the exposure of a large area of non-polar 
surface area on the back of the lid and the main body of the protein. This exposure of surface 
area has led to a prediction of a large positive ΔCp for the binding of AMPPNP to the N-terminal 
domain of Hsp90.  
The experimental results show a positive ΔCp favouring AMPPNP inducing a lid closed 
conformation however the results show a far less positive ΔCp than expected. This suggests 
that the difference in surface area exposed between the free and bound states is less than 
anticipated. This again supports the idea that in the apo state the lid of the N-terminal of 
Hsp90 is closer to Figure 3.20B than Figure 3.20A.  
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The calculated figures give a difference between the predicted fully ‘open’ state (ADP 
bound) and the fully ‘closed’ state (AMPPNP bound) of the lid as being 850 J∙mol-1∙K-1. The 
experimentally determined figures give the difference between the ADP and the AMPPNP 
bound states as being 1100 J∙mol-1∙K-1. This shows a discrepancy of 250 J∙mol-1∙K-1 between the 
prediction and the experimental data. This may suggest an additional influence, such as a 
conformational change, on the ΔCp that is independent of the lid but dependent upon ligand 
binding.  
As the pH increases the discrepancy increases while at lower pH the ΔCp difference 
between the two ligand bound states is reduced. At pH five there is a difference of only 260 
J∙mol-1∙K-1 however at pH10 there is a difference of closer to 2700 J∙mol-1∙K-1. This suggests a pH 
dependence to the conformational changes induced by ligand binding that extend beyond the 
lid region alone. The NMR results from the pH titration with AMPPNP show a series of subtle 
yet extensive chemical shift changes predominantly across the binding site as described earlier 
as well as a number of pH dependent but ligand independent chemical shifts. This may indicate 
an overall shift in the domain as theorised in Nilapwar et al. [17]. 
 
3.3.5 Binding of adenosine and adenine to the N-terminal domain of Hsp90 and 
associated ΔCp values 
 
 As has already been established the binding of adenine-based ligands to NT Hsp90 
reflects something of the nature of the binding site. Adenine binds more weakly than 
adenosine and in turn adenosine binds less tightly than ADP. AMPPNP is then seen to bind less 
tightly again than ADP, with a similar affinity to adenosine. Previously in this chapter it has 
been detailed why this might be the case based on the influence of the protonation state of 
the ligand in relation to the binding of the ligand. Now we consider the ΔCp of the binding of 
adenine and adenosine to the NT Hsp90 domain and what information this provides. 
 From previous NMR experiments [17] it is known that the shifts induced by the 
adenosine or adenine binding are far fewer than those observed for ADP or AMPPNP 
suggesting that there is less rearrangement and conformational change associated with 
binding even accounting for the reduction in contacts due to the smaller molecule. The 
titration data is shown in Table 3.9. The heat capacity for binding of both adenosine and 
adenine were calculated at pH8 in 20mM Tris as shown in Figures 3.21 and 3.22. 
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Protein:  N-Terminal Ligand: Adenosine pH: 8.0 ΔCp: 0.65 kJ mol-1  K-1 
Temp (C) Stoichiometry 
(N) 
error Kd (µM) Error ΔH (KJ mol-1) Error (+/-) TΔS (KJ mol-1) ΔG (KJ mol-1) 
10 0.96 0.11 79.9 11.8 -69.0 10.2 -46.8 -22.2 
10 1.04 0.03 49.9 1.5 -57.4 2.1 -34.1 -23.3 
15 0.98 0.01 67.2 1.7 -45.9 0.8 -22.9 -23.0 
15 1.03 0.04 82.3 2.1 -60.3 2.7 -37.7 -22.6 
20 1.06 0.01 111.6 1.6 -50.4 0.7 -28.1 -22.3 
20 0.97 0.04 116.1 2.0 -56.4 2.1 -34.3 -22.1 
25 0.84 0.03 174.3 5.6 -46.3 1.7 -24.8 -21.5 
25 1.10 0.22 169.2 17.1 -46.6 10.6 -25.0 -21.6 
Protein:  N-Terminal Ligand: Adenine pH: 8.0 ΔCp: -0.23 kJ mol-1  K-1 
Temp (C) Stoichiometry 
(N) 
error Kd (µM) Error ΔH (KJ mol-1) Error (+/-) TΔS (KJ mol-1) ΔG (KJ mol-1) 
10 1.00 0.04 202.9 13.8 -15.7 0.9 4.3 -20.0 
15 1.02 0.07 101.5 17.5 -10.1 1.3 12.3 -22.4 
20 1.05 0.05 124.1 18.2 -7.2 0.6 14.7 -21.9 
25 1.06 0.09 243.7 32.4 -16.5 2.0 4.1 -20.6 
30 0.97 0.04 161.4 16.4 -8.4 0.5 13.6 -22.0 
Table 3.9 Summary of binding data including errors of the binding of the N-terminal of Hsp90 to adenosine and adenine at pH 8, 20 mM Tris, 5 mM Mg2+ across a temperature range of 10°C to 
25°C or 30°C.  
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Figure 3.21 The ΔCp associated with the binding of adenine to the N-terminal domain of Hsp90 showing a slight 
positive heat capacity as determined by ITC; 20 mM Tris, pH 8. The calculated ΔCp ≈ 160 J∙mol-1∙K-1. 
 
 
Figure 3.22 The ΔCp associated with the binding of adenosine to the N-terminal domain of Hsp90 showing a 
positive heat capacity as determined by ITC; 20 mM Tris, 5 mM Mg2+, pH 8. The calculated ΔCp ≈ 650 J∙mol-1∙K-1. 
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 From the calculated ΔCp values (+1000 ±220 J∙mol-1∙K-1  for adenosine and +160 ±80 
J∙mol-1∙K-1 for adenine) we can see that both adenosine and adenine have positive heat 
capacities however the ΔCp for adenosine is greater than that of adenine and AMPPNP at pH8. 
The value of +1000 J∙mol-1∙K-1 exceeds the calculated value for the closing of the lid suggesting 
that there is an additional effect occurring to explain the increased positive heat capacity 
change. This could include an interaction with water molecules that would be displaced using 
any large chemical compound. Earlier in the chapter, the binding of the adenosine ring has 
already been shown to be one of the major contributors to the binding affinity of the 
nucleotide based ligands. Since the adenosine ring is common to both ADP and AMPPNP it is 
likely that any changes induced solely by adenosine will not include any movement where ADP 
and AMPPNP show opposing effects, such as in the movement of the ATP lid. The positive ΔCp 
indicates however that there are additional processes occurring to the movement of the ‘lid’ 
that may contribute to the discrepancy in differences between the ΔCp values described 
previously. The exact nature of these processes however cannot be easily determined by the 
methods described here and may be the culmination of a number of complex events. 
 
3.3.6 Mutations in the N-terminal of Hsp90 stabilise the ‘lid open’ and ‘lid closed’ 
conformations of the domain 
 
From the experiments described above it is clear that the response of the N-terminal 
domain to the binding of nucleotide is more complex than a simple lid open/lid closed 
situation. It may include a number of intermediate positions in equilibrium. Two mutant 
constructs of Hsp90 were used to probe the binding of ligands to the NT domain with the lid 
region stabilised or destabilised in each case to explore the equilibrium by attempting to bias 
the position of the lid to either open or closed. Both mutants were obtained from C. 
Prodromou from Imperial College London.  
Two mutant proteins were made. The T101I mutant is close to the base of the lid 
region and mutation of this residue to an isoleucine strengthens the contacts between the 
back of the lid and the domain, thus favouring the open conformation and hence stabilising 
the open state. In contrast the T22I mutant is on the main body of the NT domain facing out 
towards the end of the back of the lid (see Figure 3.23). The mutation of residues 22 from 
Threonine to Isoleucine interferes with hydrophobic contacts between it and the back of the 
lid with residues such as Val114, thus destabilising the ‘open’ conformation and favouring the 
closed form. 
  
Figure 3.23 The position of the T101I and T22I mutants (red) s
domain of Hsp90. The ATP 'lid' region is highlighted (green). 
Tables 3.10 and 3.11 show a summary of the binding data for the ligand ADP, AMPPNP 
and adenosine to both the T22
Differences between the binding parameters of the wild type and the mutants can be 
interpreted using the knowledge of how the mutants affect the ATP lid region. 
 
hown on the crystal structure of the N
Diagram taken from PDB file 1AMW.
I and T101I mutants of the N-terminal domain of Hsp90. 
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A       ΔCp   -2.05  kJ∙mol-1∙K-1 
Temp (C) Stoichiometry (N) Error (N) Kd (µM) Error (Kd) ΔH (kJ mol-1) Error (ΔH) TΔS (kJ mol-1) ΔG (kJ mol-1) 
10.00 1.00 ±0.02 15.90 ±1.18 -73.51 ±2.28 -47.51 -26.01 
10.00 1.00 ±0.01 4.39 ±1.18 -67.36 ±2.28 -38.27 -29.10 
15.00 1.03 ±0.02 8.33 ±0.48 -71.13 ±1.42 -43.04 -28.09 
20.00 0.99 ±0.04 18.08 ±4.18 -85.31 ±8.80 -58.63 -26.68 
20.00 0.91 ±0.06 50.76 ±4.18 -101.0 ±8.80 -76.90 -24.14 
25.00 0.82 ±0.09 60.24 ±6.72 -97.61 ±14.34 -73.48 -24.14 
B       ΔCp -0.79  kJ mol-1 K-1 
Temp (C) Stoichiometry (N) error Kd (µM) Error (Kd) ΔH (kJ mol-1)  Error (ΔH ) TΔS (kJ mol-1) ΔG (kJ mol-1) 
10.00 1.01 ±0.04 102.44 ±2.29 -57.36 ±2.80 -35.72 -21.64 
15.00 0.95 ±0.13 143.47 ±8.16 -50.71 ±7.48 -29.53 -21.18 
20.00 1.04 ±0.21 188.22 ±10.57 -59.75 ±13.00 -38.83 -20.92 
25.00 0.90 ±0.62 252.27 ±40.63 -67.57 ±50.21 -47.05 -20.52 
C       ΔCp   -5.9 kJ mol-1 K-1 
Temp (C) Stoichiometry (N) error Kd (µM) Error (Kd) ΔH (kJ mol-1) Error (+/-) TΔS (kJ mol-1)  ΔG (kJ mol-1) 
10.00 0.98 ±0.02 72.93 ±2.96 -55.73 ±1.71 -33.29 -22.44 
10.00 0.97 ±0.22 48.31 ±8.79 -63.64 ±1.65 -40.28 -23.36 
15.00 1.02 ±0.03 110.62 ±3.72 -58.62 ±1.89 -36.77 -21.85 
20.00 1.06 ±0.15 258.40 ±15.08 -124.9 ±20.41 -104.87 -20.07 
Table 3.10 Binding data for the mutant T22I to the ligands ADP (A) AMPPNP (B) and adenosine (C) as determined  by ITC in 20 mM Tris, 5 mM Mg2+ at pH 8. 
 
144 
A      ΔCp -610  J mol-1 K-1  
Temp (C) Stoichiometry (N) error Kd (µM) Error (Kd) ΔH (kJ mol-1) Error (+/-) TΔS (kJ mol-1)  ΔG (kJ mol-1) 
10.00 1.01 0.01 3.47 ±0.17 -69.12 ±0.43 -39.55 -29.57 
15.00 1.06 0.01 6.53 ±0.26 -72.26 ±0.45 -43.64 -28.61 
20.00 1.04 0.01 12.30 ±0.80 -75.31 ±1.05 -47.75 -27.56 
25.00 1.07 0.01 20.24 ±1.59 -78.32 ±1.63 -51.53 -26.79 
B       ΔCp   -1290  J mol-1 K-1 
Temp (C) Stoichiometry (N) error Kd (µM) Error (Kd) ΔH (kJ mol-1) Error (+/-) TΔS (kJ mol-1)  ΔG (kJ mol-1) 
10.00 1.04 0.02 45.03 ±2.64 -35.43 ±0.79 -11.66 -23.77 
15.00 1.04 0.02 74.85 ±3.67 -38.17 ±0.97 -15.41 -22.76 
20.00 1.00 0.04 165.87 ±9.91 -48.33 ±2.66 -27.13 -21.19 
C       ΔCp   -1360  J mol-1 K-1 
Temp (C) Stoichiometry (N) error Kd (µM) Error (Kd) ΔH (kJ mol-1) Error (+/-) TΔS (kJ mol-1)  ΔG (kJ mol-1) 
10.00 0.99 0.02 53.76 ±2.39 -53.22 ±1.55 -30.09 -23.14 
15.00 1.06 0.03 72.46 ±3.15 -51.00 ±1.69 -28.09 -22.84 
20.00 1.08 0.02 116.60 ±2.88 -54.43 ±1.41 -32.38 -22.07 
25.00 1.00 0.14 194.20 ±16.86 -74.68 ±12.51 -53.52 -21.19 
Table 3.11 Binding data for the mutant T101I to the ligands ADP (A) AMPPNP (B) and adenosine (C) as determined  by ITC in 20 mM Tris, 5 mM Mg2+ at pH 8. 
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The data in Tables 3.10 and 3.11 can be used to calculate the ΔCp values for the 
binding of ADP, AMPPNP and adenosine to both the T22I and T101I mutants of the N-terminal 
domain of Hsp90. The graphs for the ΔCp values are shown in Figures 3.24 - 3.26 and 
summarised in Table 3.9. 
 
Figure 3.24 The ΔCp associated with the binding of ADP to the mutants T101I and T22I of the N-terminal domain 
of Hsp90 as determined by ITC at pH 8, 20 mM Tris, 5 mM Mg2+. 
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Figure 3.25 The ΔCp associated with the binding of AMPPNP to the mutants T101I and T22I of the N-terminal 
domain of Hsp90 as determined by ITC at pH 8, 20 mM Tris, 5 mM Mg2+. 
 
 
Figure 3.26 The ΔCp associated with the binding of adenosine to the mutants T101I and T22I of the N-terminal 
domain of Hsp90 as determined by ITC at pH 8, 20 mM Tris, 5 mM Mg2+. 
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3.3.7 Analysis of the binding of ADP, AMPPNP and adenosine to the mutants T22I 
and T101I of the N-terminal of Hsp90 can be used to inform upon the 
position of the ATP lid region and its response to the binding of different 
ligands 
 
Table 3.12 summaries the binding constants as determined by ITC for each mutant and 
the wild type of the N-terminal domain of Hsp90 with ADP, AMPPNP and adenosine.  The 
binding affinity differences between the mutant forms can be explained with the knowledge of 
how the mutants affect the ATP lid region.  
 
Construct and ligand 
used.  Kd (µM)  
ΔH  
(kJ mol-1)  
TΔS  
(kJ mol-1)  
ΔG  
(kJ mol-1)  
WT w/ ADP  35.93 -80.42 -55.48 -24.94 
T22I w/ ADP 18.08 -85.31 -58.63 -26.68 
T101I w/ ADP 12.30 -75.31 -47.75 -27.56 
WT w/ AMPPNP [17] 105.00 -39.70 -17.40 -22.30 
T22I w/ AMPPPNP 188.22 -59.75 -38.83 -20.91 
T101I w/ AMPPPNP 165.86 -48.33 -27.13 -21.19 
WT w/ adenosine 111.63 -50.42 -28.15 -22.27 
T22I w/ adenosine 258.40 -124.93 -104.87 -20.07 
T101I w/ adenosine 116.60 -54.43 -32.38 -22.07 
Table 3.12 A summary of the binding parameters associated with binding of ADP, AMPPNP and adenosine to the 
wild type and T22I and T101I mutants of the N-terminal domain of Hsp90. Data shown from ITC titrations at 20°C, 
pH 8.  
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3.3.8 ADP binding in both the T22I and T101I mutants of the N-terminal domain of 
Hsp90 
 
The T22I mutant stabilises the ‘lid closed’ conformation. This is the conformation that 
is favoured upon AMPPNP binding to the N-terminal domain of Hsp90. The binding of ADP to 
the T22I mutant appears to be more favourable than the wild type (Table 3.12). It can be seen 
that the Kd is lower for binding of ADP to the T22I mutant than the wild type and that both the 
ΔH and TΔS are slightly more negative however the ΔG value is very close for the two.  
The T101I mutant stabilises the ‘lid open’ conformation. The ΔH and TΔS value are 
slightly less negative than in the wild type however not by much.  It is interesting to note then 
that binding of ADP both mutants is tighter than the wild type. The T101 ‘lid open’ mutant 
mimics the ADP bound form and so this is not surprising however it is also the case for the ‘lid 
closed’ T22I mutant that should be closer to the AMPPNP bound state.  
This suggests that although binding of ADP induces an opening of the ATP lid this is not 
the only route leading to an increase in affinity. If the ATP binding and hydrolysis cycle of 
Hsp90 is considered then ATP binds, induces a lid closure and is then hydrolysed to ADP. There 
is then a conformational change induced by this hydrolysis that leads to lid opening, other 
conformational changes across the protein, and release of ADP and the free phosphate. Thus 
initially ADP and free phosphate are present in the lid closed position. It is possible that the lid 
closed conformation is more stable for the binding of ADP with free phosphate than the lid 
open conformation and that the conformational change leads to a destabilisation of the bound 
ADP ligand allowing it to dissociate. Normally however ADP binding causes the lid to open so 
that ADP binding to the lid closed state is never observed. It is also impossible to observe the 
ADP with free phosphate as there is no way to mimic the presence of both ADP and the free 
phosphate in the immediately post hydrolysis state. The T22I mutant may have allowed the 
conformational changes induced by ADP to be overcome by the destabilisation of the open lid 
conformation and has allowed the domain to retain elements of the ‘lid closed’ state (Figure 
3.27). 
 Figure 3.27 Schematic representation of the binding of ADP to both T22I and T101I mutants of the N
Hsp90 showing the possible conformational changes induced by ligand binding.
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-terminal of 
-terminal 
AMPPNP 
 despite 
and thus it 
 Figure 3.28 Schematic representation of the binding of AMPPNP to both T22I and T101I mutants of the 
terminal of Hsp90 showing the possible conformational changes induced by ligand binding.
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3.3.11 Analysis of the ΔCp of the mutant NT Hsp90 domains 
 
 The ΔCp was determined for both mutants with both ADP and AMPPPNP at pH8. These 
are shown in Figures 3.24 – 3.26 and summarised in Table 3.13.  
Construct of NT Hsp90 ΔCp with ADP  
(kJ∙mol-1∙K-1) 
ΔCp with AMPPNP 
(kJ∙mol-1∙K-1)  
ΔCp with adenosine 
(kJ∙mol-1∙K-1)  
WT -0.95 +0.15  ref:[17] +0.65 
T22I mutant (lid ‘closed’) -2.05 -0.79 -5.90 
T101I mutant (lid ‘open’) -0.61 -1.29 -1.36 
Table 3.13 A summary of the ΔCp data for ADP, AMPPNP and adenosine comparing the wild type, T22I and T101I 
mutants of the N-terminal of Hsp90 at pH 8. 
The ΔCp obtained for the T101I mutant with ADP is smaller and less negative than that 
determined for the WT although the binding constants are very different. In contrast the ΔCp 
value for the T22I mutant is 1.0 kJ∙mol-1∙K-1 more negative than the wild type with ADP. This 
suggests that the mutations alter the equilibrium position of the lid between open and closed. 
The T22I mutation favours lid closing while ADP induces a ‘lid open’ state thus when the 
overall the lid equilibrium shifts towards the ‘fully open’ state it does so from closer to the 
‘closed state’ thus leading to more burial of surface area upon binding. In contrast the T101I 
mutant is working with the influence of ADP binding and thus the lid equilibrium shifts more 
towards the ‘lid open’ state upon ligand binding, but since it is already closer to being ‘open’ to 
begin with there is less burial of surface area and thus a smaller heat capacity change. This also 
suggests that the influence of the nucleotide is stronger than the influence of the T22I 
mutation over the lid conformation since the lid does appear to still close in the presence of 
ligand. 
The ΔCp obtained for the T101I and T22I mutants with AMPPNP are both more 
negative than for the wild type binding to AMPPNP. The negative ΔCp value determined for the 
binding of AMPPNP to the T101I mutant suggests that the ligand is less able to overcome the 
influence of the mutation and thus the lid does not shut in response to AMPPNP binding. The 
binding of AMPPNP to the T22I mutant does not appear to be sufficient to give a positive ΔCp 
that would be expected if the lid were closed. This suggests that the destabilising of the lid 
open conformation and the addition of the AMPPNP ligand does not lead simply to the ‘lid 
closed’ conformation. The destabilisation of the ‘lid open’ conformation may lead to more 
wide ranging conformational effects beyond the lid its self that influence the ΔCp values 
observed. 
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The ΔCp values associated with adenosine binding to the mutant constructs of Hsp90 
are both very negative in contrast to the positive ΔCp displayed by the wild type. As has already 
been discussed it is likely that the ΔCp due to adenosine binding to the wild type N-terminal 
domain is not solely due to the lid movement. In combination with the effects the mutations 
have on the protein, it is likely that the disruption causing the large negative ΔCp values is, in 
addition to any movement of the lid region, also due to numerous other conformational 
changes. 
 
3.3.12 NMR of the mutants T22I and T101I of NT Hsp90 
 
 In order to look at the mutant NT domains in more detail 15N-HSQC spectra were 
collected in the apo state and when bound to AMPPNP and ADP (Figures 3.29, 3.30 and 3.31). 
These spectra were then compared to the wild type 15N-HSQC spectra obtained previously for 
the three states described and shifts due to the mutations identified for each state. The 
complete list of shifts for each mutant and the shifts common to each mutant are shown 
plotted onto the crystal structure in Figure 3.32. Shifts unique to each mutant were identified 
and plotted onto the known crystal structure of the ADP bound form (PDB file 1AMW) [8] as 
shown in Figure 3.33. 
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Figure 3.29 Overlays of the wild type (black) and mutant forms of Hsp90 (T22I – top red, T101I – bottom blue) in 
the apo state. Spectra recorded in 20 mM Tris, 5 mM Mg2+, pH 8 at 700 MHz field strength. 
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Figure 3.30 Overlays of the wild type (black) and mutant forms of Hsp90 (T22I – top red, T101I – bottom blue) in 
the AMPPNP bound state. Spectra recorded in 20 mM Tris, 5 mM Mg2+, pH 8 at 700 MHz field strength. 
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Figure 3.31 Overlays of the wild type (black) and mutant forms of Hsp90 (T22I – top red, T101I – bottom blue) in 
the ADP bound  state. Spectra recorded in 20 mM Tris, 5 mM Mg2+, pH 8 at 700 MHz field strength. 
 There are a number of distinctive differences both between the mutants and the wild 
type and between the mutants themselves in each state. The shifts associated with each 
mutant in the apo state can be seen to map to one side of the protein with subtle differences 
between the two constructs (See fig. 3.32).  
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Figure 3.32 Diagrams for the shifts of the T22I and T101I mutants of the N-terminal domain of Hsp90 in the apo 
state. ATP lid is shown in orange. A: Shows the shifts associated with both mutant constructs. B: shows all shifts 
associated with the T101I construct. C: shows all shifts associated with the T22I. Position of the ligand ADP shown 
only for the purpose of comparison with other figures. Diagram taken from PDB file 1AMW. 
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The shifts common to both mutants of the N-terminal of Hsp90 (Figure 3.32A) map to 
the lid region, the β-sheet which forms the back of the binding pocket and the two α helices 
that contact the back of the lid. Shifts that are unique to each mutant are highlighted in Figure 
3.33. 
 
Figure 3.33 Diagrams for the unique shifts of the T22I and T101I mutants of the N-terminal of Hsp90 in the apo 
state. ATP lid is shown in orange. A: Shows the shifts only associated with the T101I mutant construct only. B: 
Shows shifts associated with the T22I mutant construct only. Diagram taken from PDB file 1AMW. Locations of 
mutant residues labelled in red. 
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The T22I mutant (Figure 3.32 C all shifts and Figure 3.33 B unique shifts) shows a 
number of shifts unique to it at the base of the binding pocket on the β-sheet structure that 
forms the back of the binding pocket. The only shifts that are not located within this region are 
Glu162, Gly168 and Arg169 which are located on a loop at the top of the β-sheet. Two shifts 
are observed within the lid region itself, these are Ala107 and Gly118 while two shifts are seen 
close to the mutation site but also close to the two shifts observed in the lid – these also are 
the only two shifts not observed within the β-sheet. Ala107 is opposite a shift in Asn21 which is 
also directly next to the mutation T22I itself. Gly118 is opposite a shift in Leu31 which is also 
close to the original mutation. The collection of shifts around the base of the binding pocket 
(Val130, Ala131, Arg133, Gly154, Thr157, Leu175, Lue177 and Leu182) is likely to alter the 
nature of the binding site significantly around the region where the adenine ring system sits. 
As has already been established, it is the adenine ring that provides much of the binding 
affinity and disruptions to these contacts is likely to affect the binding affinity of the ligands. 
This is supported by the reduced binding affinities observed for both ADP and AMPPNP. 
The T101I mutant (Figure 3.32 B showing all shifts and Figure 3.33 A showing unique 
shifts) shows a number of shifts on the periphery of the binding site on the edges of the β-
sheet and the long helix with few shifts observed in the lid itself and in close proximity to it. 
The β-sheet shifts (Ile64, Val74, Ile77 on one side and Gly153, Gly 154, Thr157 and Glu7 on the 
other) flank the bound nucleotide and may well represent an overall movement in the domain 
as suggested by the ΔCp values discussed previously. Within the lid itself residues Gly118 and 
Val122 show shifts although why this should be in a ‘lid open’ conformation is unclear. Shifts 
seen in Glu33, Leu89 and Leu93 are at the mouth of the ligand binding site. The former is on 
the long helix while the later two are part of a smaller helix, both regions however would be 
impacted by closure of the lid. Shifts observed in Gly123 and Ser126 are close to the terminal 
phosphate of the ligand thus showing additional alteration of the binding site which will 
contribute to the altered binding constants as previously seen. 
The large number of residues seen to show chemical shifts upon mutating either T22I 
or T101I suggests that each has a significant effect upon the protein beyond the region of the 
mutation (either the lid or the helix adjoining the lid). Although shifts are observed in this 
region, shifts are also observed across the base of the binding pocket in the β-sheet and in a 
number of surrounding helices.  However ITC confirms binding and the NMR 15N-HSQC spectra 
show a very similar set of results to the wild type suggesting a large number of small changes 
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rather than drastic ones. It is already known that ligand binding induces a large number of 
shifts beyond the binding site alone suggesting an inherent flexibility in the N-terminal domain 
of Hsp90. The large number of shifts observed for both mutants suggests that there is an 
overall adjustment of the domain and subsequently the binding site which may be linked to 
the disruption or stabilisation of the lid region. This in turn has an effect on the binding affinity 
of the nucleotide based ligands to each mutant as described previously. The consequences for 
using these mutations to look solely at the influence of the lid position over the binding of ADP 
and AMPPNP is that the results obtained are not based solely on the position of the lid since 
many other changes are occurring to the binding site. This is reflected in the ΔCp values 
observed, as previously described, which cannot be explained by a simple movement of the 
ATP ‘lid’ alone. Since the mutations are still influencing the position of the lid it suggests that 
not only is the lid position important for the binding of nucleotide based ligands but that the 
position of the lid is also linked to a wider ranging and more subtle series of changes across the 
ligand binding site that alters binding affinity of the ligand during the binding and hydrolysis 
cycle. 
 
 
3.4 Conclusions 
 
 There is strong evidence to suggest that the preferred binding state of the ligand to 
the NT Hsp90 domain is the -3 charge state. ADP shows strongest binding affinity while in this 
charge state and the transition of AMPPNP from the -3 to the -4 charge state coincides with a 
drop in binding affinity. The change in binding affinity has been clearly demonstrated by ITC 
and the presence of a protonation event on the ligand and not on the protein has been 
confirmed by both 1H and 31P NMR. Values for the pKa of both the bound and free states have 
also been confirmed as being at pH 6.5 and pH 8 respectively. 
The ΔCp of binding was also determined by ITC for each ligand. Previously predicted 
values for the ΔCp  were compared to the actual values and variations from this were described 
in terms of conformational changes associated with the ATP ‘lid’ region moving between an 
‘open’ and ‘closed’ conformation and the likelihood of the apo state being in equilibrium 
between open and closed. The ΔCp data suggests that ligand binding may lead to a change in 
equilibrium position of the lid with ADP favouring a ‘lid open’ conformation while binding of 
AMPPNP favours a ‘lid closed’ conformation. Further investigation of the lid region was 
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undertaken using two mutants, T22I stabilising the ‘open’ lid conformation and T101I 
destabilising the ‘open’ conformation. The nature of the conformational changes within the 
mutants was also investigated through NMR observing the shifts associated with each mutant 
in various ligand bound states. These mutants revealed changes in all thermodynamic 
characteristics and ΔCp values in a way that supported the overall hypothesis that binding of 
AMPPNP favoured a ‘closed lid’ conformation while ADP binding favoured an ‘open lid’ 
conformation. Studies involving the mutants also suggested that movement of the lid was not 
an isolated event but concurrent with a subtle rearrangement of the region around the 
nucleotide binding site that alters the ligand binding affinity and is also reflected by the change 
in heat capacity that cannot be explained by the change in buried surface area due to the lid 
movement alone. 
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4 NMR Structural Investigation 
 
4.1 Introduction 
 
Within this chapter a detailed analysis by NMR of the N-terminal domain of Hsp90 is 
presented.  Building upon the pre-existing backbone assignment of the N-terminal domain of 
Hsp90 undertaken by Salek et. al.[15] a series of standard NMR experiments were performed 
to allow the assignment of the side chains of the domain in the apo, ADP and AMPPNP bound 
forms. Although crystal structures have been solved for the full length in the presence of both 
AMPPNP and p23[7] and of the isolated N-terminal domain in the adp bound state[8] it is far 
from clear how the N-terminal domain of Hsp90 behaves in solution with and without ligands 
and in the absence of specific co-chaperones. Of particular note is the position of the ATP ‘lid’. 
The lid has been seen in the open conformation in the isolated N-terminal domain crystal 
structure and with ADP bound while in the full length compact form in the presence of 
AMPPNP and p23 the lid has been seen closed over the ligand binding site. What is not clear is 
whether this lid behaviour is dependent upon co-chaperone binding and how much of the 
capability of conformational change is localised to the N-terminal domain or whether a larger 
proportion of the chaperone is required to facilitate these movements. The position of the lid 
region in the apo state in solution is also unclear, although as mentioned in the previous 
chapter it may occupy a position between open and closed. Studies by NMR can be used to 
answer some of these questions and give a greater understanding of the movement of this 
highly dynamic protein. The response of Hsp90 to ADP and AMPPNP ligand binding was 
observed using chemical shifts from the side chain assignments and using H/D exchange data. 
A study into the Hydrogen/Deuterium (H/D) exchange parameters of the N-terminal domain of 
Hsp90 was undertaken monitoring exchange on the backbone amide bond. This was 
performed in the apo state and in the ADP and AMPPNP ligand bound states to report upon 
the relative flexibility and accessibility of each amino acid within the protein in each form. 
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4.2 Sample preparation, data acquisition and processing. 
 
Protein samples of the N-terminal domain of Hsp90 were prepared as described in 
Chapter 2 using either 15N-ammonium sulphate and 12C-glucose or 15N-ammonium sulphate 
and 13C-glucose. This resulted in either singly or doubly isotopically labelled proteins suitable 
for NMR data acquisition.  
Data was collected using spectrometers operating at 700 and 800 MHz using 
experimental parameters described in Chapter 2. Processing of the free induction decay (FID) 
datasets utilised NMRPipe scripts[58] as described in Chapter 2. Processed data was then 
analysed using CCPNmr software[59].  
Backbone resonances for the N-terminal domain were taken from published data from 
the group [15] and were used as a basis from which to assign the side chains of the N-terminal 
domain. HNCA, HNCOCA, HNCACB and HNCOCACB experimental assignments were used to 
uniquely identify the Cα and Cβ carbon resonances of each side-chain. These resonance 
assignments were used in conjunction with assigned 15N-edited TOCSY-HSQC (TOWNY-HSQC) 
data (unpublished work) to facilitate the side chain assignment. The ADP and AMPPNP 
backbone assignments are not published but were available in house (Salek and Williams 
personal communication). 
Assigning the side chains of a protein involves defining the unique carbon/proton 
chemical shift associated with each CH group within the side chain. Carbons with a single 
proton bound to them such as the CαH of most amino acids (bar glycine) or the CγH in Leucine 
will generate one resonance. Carbons with two protons attached to them, such as in the case 
of the H-Cβ-H group in Leucine or Glutamate will generate two C-H resonances. The 
resonances from a CH2 group may be distinct if the chemical environments of each proton are 
different. If the chemical environments are very similar, however, these two signals may be 
degenerate. Methyl groups as found in Leucine, Isoleucine, Valine, Alanine and Methionine will 
generate only one distinct C-H resonance due to the freedom of rotation around the central 
carbon. This free rotation means all protons are occupying an equivalent average chemical 
environment. Side chain amines and aromatic groups beyond the Cβ were not assigned. 
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4.3 Aliphatic resonance assignment of the side chains of the apo 
N-terminal domain of Hsp90 
 
Assignment was undertaken using CCPN analysis software[59]. The general method used 
for side chain assignment is described below using residue Leu50 to illustrate the procedure. 
Using previously assigned 1H15N-HSQC and 15N-edited NOESY-HSQC and TOWNY-HSQC spectra, 
the proton chemical shifts associated with the Cα-H and often the Cβ-H through the 
connectivity to their own amide N-H bond can be identified. This is shown in Figure 4.1A where 
the Cα-H resonance can be observed in the TOWNY-HSQC spectrum however no Cβ-H 
resonance can be seen. 
 The assigned HNCA and HNCOCA spectra can be used to identify the Cα chemical shift 
of the amino acid in question. Once identified, the Cα chemical shift from the HNCA can be 
cross referenced with the Cα-H proton chemical shift identified through the 1H15N-
HSQC/TOWNY-HSQC spectra. This provides chemical shift coordinates for each component of 
the Cα-H bond. This set of coordinates corresponds to a resonance detected on the constant 
time 13C-HSQC (CT-13C-HSQC) spectrum recorded for the apo N-terminal domain of Hsp90. This 
peak on the CT-13C-HSQC spectrum can then be unambiguously assigned (Figure 4.1B). 
 If a TOWNY-HSQC peak or peaks are visible for the Hβ atom then the process 
described for locating the Cα-H resonance  CHSQC-CT peak can be repeated. The HNCACB and 
HNCOCACB spectra can be used to identify the carbon chemical shift and the TOWNY/15N-
NOESY spectra can be used to identify the proton chemical shift. Often however only a single 
resonance for the Cβ-H will be visible in the TOWNY-HSQC spectrum where two would be 
expected, or none at all as is the case with Leu50. When no proton chemical shift is visible 
from the TOWNY-HSQC data then two alternative experiments can be used to find the 
carbon/proton linkages between the atoms within a single side chain. Two experiments were 
used to look at this – an HCCH-TOCSY experiment was used to observe the connectivity of two 
proton chemical shifts with respect to a single carbon chemical shift. Thus if the chemical shift 
for one carbon/proton pair is known, such as the Cα/Hα bond, then from this the proton 
chemical shifts of all other Cx-H nuclei in that side chain can be determined.   A CCH-TOCSY 
experiment was used to observe the connectivity of two carbon chemical shifts with respect to 
a single proton shift. Thus using the known proton/carbon chemical shifts for the Cα/Hα bond 
the carbon shifts for all other Cx-H bonds within the side chain can be determined.  In each 
case linkages within the same bond, e.g. Hα to Cα and back to Hα or Cα to Hα and back to Cα 
result in a self cross-peak occurring on the diagonal (Figure 4.2). 
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Figure 4.1 The side chain assignment of the CA atom of residue Leu50. A: The 15N-HSQC peak is marked and the 
associated TOWNY peak corresponding to the HA atom has been identified giving its proton resonance. B: The 
carbon CA resonance has been identified in the HNCA spectra allowing the intersect to identify the 13C-HSQC peak 
corresponding to the CA-H group. 
   
The combination of these two techniques is therefore very powerful for determining 
the proton and carbon chemical shifts of all bonds within the side chain of any given amino 
acid. The combination of these two techniques does not reveal, however, which proton shift 
matches to which carbon shift and in order to establish the exact combination of each 
proton/carbon chemical shift pair for each C-H bond along the side chain the slices through the 
3D spectra are observed. A match must be found (compare Figure 4.3A with 4.3B) where the 
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self peak for the given atom is on the diagonal and cross peaks are observed to the already 
identified CαHα resonance and to C-H groups further along the chain. Indeed the most certain 
way of identifying correctly matching C and H shifts is to find matching peak patterns in other 
3D slices of the experiment. This procedure can be carried out with both HCCH and CCH-TOCSY 
experiments to identify exact proton and carbon chemical shifts for each C-H pair along the 
side chain. Although often this can be inferred from known chemical shift ranges for each 
atom type it cannot be guaranteed and often the ranges overlap so much as to be impossible 
to judge. It is also possible that within each spectra, either HCCH-TOCSY or CCH-TOCSY, that 
there will be excessive overlap of peaks. This makes determining which peaks correspond to 
the specific CαHα bond under investigation, and which belong to a neighbouring bond with 
similar carbon and proton chemical shifts, very difficult. In order to resolve some of these 
issues the various proton/carbon resonance pairs can be compared to the CHSQC-CT to 
observe whether a cross peak actually exists here. In order to aid assignment of resonance 
pairs to atoms within a side chain, the resonance values were compared to the expected range 
of resonances  for each group type within each amino acid. E.g. Normally to distinguish the 
leucine Cβ from the leucine Cγ within a single side chain the presence of two Hβ peaks at a 
single carbons shift for Cβ, but not the Cγ shift, was used. However if the Hβ peaks were 
degenerate or only one could be found then the characteristic shift range for a leucine Cβ was 
used to identify it from the Cγ. The expected ranges for each atom type were taken from the 
Biological Magnetic Resonance Data Bank (BMRB), http://www.bmrb.wisc.edu/.  
Figure 4.2 shows the HCCH and CCH-TOCSY slices from an initial CαHα start point. 
Panel A shows the CCH-TOCSY experiment followed by possible cross peaks generated from 
the linkage between the Cα atom and other carbon atoms in the Leu50 side chain marked in 
blue. The known carbon chemical shift of the Cβ atom is shown marked in black. Panel B shows 
a similar situation with the HCCH-TOCSY. Here the blue horizontal lines mark possible cross 
peaks from any given hydrogen atom on the side chain to the Hα through the Cα atom. 
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Figure 4.2 Identifying the CH resonances along the side chain. A: The CCH-TOCSY spectrum shown here identifies 
the Cα-Hα peak marked on the diagonal. The second upper line marks the known Cβ chemical shift obtained from 
the HNCACB experiment.  In the right hand panel possible carbon chemical shifts for the remaining carbon atoms 
are marked in blue. B: The HCCH-TOCSY spectrum shown here identifies the Cα-Hα peak on the diagonal. Here 
the proton chemical shift is obtained from the 13C-HSQC spectrum. No Hβ proton chemical shift  is known but the  
right hand panel marks in blue possible proton chemical shifts for each of the C-H groups in the side chain. 
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Figure 4.3 Identifying the carbon resonance from the HCCH-TOCSY spectrum. A: Marked in blue are the possible 
proton shifts corresponding to C-H groups along the side chain as determined from the cross-peaks to the Cα-H 
resonance marked on the diagonal . B: Marked in black are two resonances that show cross-peaks to the carbons 
identified previously thus confirming that the peaks in A do correspond to protons in the same side chain. The 
carbon ‘slice’ at which this match occurs corresponds to the carbon chemical shift of that atom, in this case the 
Cβ. C: Each diagonal peak is marked from the HCCH-TOCSY experiment to identify a corresponding 13C-HSQC peak 
for each Cβ-H pair. In this case the carbon chemical shift identified can be cross-checked against the known Cβ 
carbon chemical shift from the HNCACB spectrum. 
Figure 4.3 shows a case where two cross peaks on the diagonal are observed. These 
are marked in Figure 4.3B. Both diagonal peaks at this carbon slice have a cross-peak that 
matches that seen for (Cα-H)Hα. This matching set of resonances adds to the evidence that 
these resonance belong to the same side chain. Both diagonal peaks show the same pattern of 
cross-peaks as that seen for the Cα. Specifically this distinctive pattern of two peaks with 
 
168 
different proton resonances but at the same carbon resonance are characteristic of a H-C-H 
arrangement i.e. as observed in the Cβ of this Leucine where each proton bound to the same 
carbon inhabits a slightly different environment. Once the correct carbon resonance has been 
identified through matching of proton resonances the diagonal peaks marked can then be 
used to locate the corresponding peaks in the CT-13C-HSQC spectrum. This is demonstrated in 
Panel C where the known Cβ carbon chemical shift from the HNCACB spectrum supports the 
Cβ chemical shift determined via the HCCH-TOCSY spectrum. 
 
Figure 4.4 Identifying the proton resonances from the CCH-TOCSY experiment. A: Proton resonances are 
identified from cross-peaks back to the Cα-H group. B: A proton slice is identified where a diagonal peak has the 
correct pattern of cross-peaks marked in blue to belong to the same side chain. C: A second proton slice is 
identified where the diagonal peak has the correct pattern of cross-peaks to belong to the same side chain. This is 
expected since there are two separate protons associated with the CB atom. D: Each identified diagonal peak 
from B and C is marked to identify two 13C-HSQC peaks. These peaks can be checked against the known carbon 
resonance from the HNCACB spectrum. The 13C-HSQC peaks also match those identified by the HCCH-TOCSY 
experiment. 
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In an analogous situation to the HCCH-TOCSY experiment, the CCH-TOCSY experiment 
shows cross-peaks which give the carbon chemical shifts within the side-chain. Moving through 
the proton slices of the CCH-TOCSY spectrum, new diagonal peaks are found with cross-peaks 
that match those seen for the initial CαHα group. Such matches identify the relevant 
connected proton resonance. In Figure 4.4 panel A, a cross-section is taken at the proton 
chemical shift corresponding to the CαHα. Four distinct cross-peaks have been identified and 
marked with a horizontal line in blue. Figure 4.4 panel B shows a slice in the CCH-TOCSY 
spectrum where a diagonal peak matches one of the previous cross-peaks and all other cross-
peaks also match. The proton resonance at which this slice occurs defines the proton chemical 
shift for this C-H group. Figure 4.4 panel C shows another slice at which the same situation 
occurs. This defines the second proton chemical shift for the second H bonded to the Cβ atom. 
Panel D then shows these proton/carbon chemical shift coordinates on the CT-13C-HSQC 
spectrum and how these relate to the known Cβ carbon chemical shift from the HNCACB 
spectrum.  
A comparison of panel C from Figure 4.3 and panel D from Figure 4.4 show that the 
same two peaks are identified using each method. This gives some confidence of the correct 
assignment of these peaks. 
The complimentarity of the methods as described allows the detection of both proton 
and carbon resonances for the entire side-chain beginning with the CαHα alone. The 
redundancy of these methods, while best used in conjunction, also allows the use of only one 
set of data if the overlap in the other is too great to resolve peaks accurately in any region. This 
can be seen to some extent in Figures 4.5, 4.6 and 4.7 where the regions in the HCCH-TOCSY 
where in the CγHγ, Cδ1Hδ1 and Cδ2Hδ2 resonances are identified more clearly through the 
CCH-TOCSY spectrum than from the HCCH-TOCSY spectrum. 
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Figure 4.5 Identifying the Cγ-H resonance using both the CCH and HCCH-TOCSY spectra. A: A proton slice is 
identified in the CCH-TOCSY experiment where the diagonal peak shows the correct cross-peak pattern to belong 
to the side chain in question marked in black. B: A carbon slice is identified in the HCCH-TOCSY experiment where 
the diagonal peak shows the correct cross-peak pattern to belong to the side chain in question. C: When marked, 
both diagonal peaks from A and B correspond to the same 13C-HSQC peak. Once identified the chemical shift 
range of this peak can be used to identify it as the Cγ-H group of Leu50. 
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Figure 4.6 Identifying a Cδ1-H resonance using both the CCH and HCCH TOCSY spectra. A: A proton slice is 
identified in the CCH-TOCSY experiment where the diagonal peak shows the correct cross-peak pattern to belong 
to the side chain in question marked in black. B: A carbon slice is identified in the HCCH-TOCSY experiment where 
the diagonal peak shows the correct cross-peak pattern to belong to the side chain in question. C: When marked, 
both diagonal peaks from A and B correspond to the same 13C-HSQC peak. Once identified the chemical shift 
range of this peak can be used to identify it as the Cδ1-H group of Leu50. 
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Figure 4.7 Identifying a Cδ2-H resonance using both the CCH and HCCH TOCSY spectra. A: A proton slice is 
identified in the CCH-TOCSY experiment where the diagonal peak shows the correct cross-peak pattern to belong 
to the side chain in question marked in black. B: A carbon slice is identified in the HCCH-TOCSY experiment where 
the diagonal peak shows the correct cross-peak pattern to belong to the side chain in question. C: When marked, 
both diagonal peaks from A and B correspond to the same 13C-HSQC peak. Once identified the chemical shift 
range of this peak can be used to identify it as the Cδ2-H group of Leu50. 
 Systematic assignment of all aliphatic regions of all residues visible in the NHSQC was 
undertaken. A summary of all Apo assignment data is tabulated in Appendix A. A summary of 
the assigned data is shown in Table 4.1. 
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Assigned Apo  
 H C 
% Side Chain protons 74%  
% Side Chain non-protons  60% 
%H/C α 90% 95% 
%H/C β 81% 94% 
%H/C γ 80% 64% 
%H/C δ 63% 55% 
%H/C ε 27% 25% 
Table 4.1A summary of the degree of assignment of the resonances associated with the side chains of the N-
terminal domain of Hsp90. The % assigned for proton and carbon resonances is shown for the apo states. 
 
 
4.4 Assignment of the side chains of ADP and AMPPNP bound 
Hsp90 
 
 An overlay of the CT-13C-HSQC spectra for the apo, ADP and AMPPNP bound forms of 
the N-terminal domain of Hsp90 reveal an overall very similar peak distribution. As observed 
for the NHSQC spectra, the CT-13C-HSQC spectra show some peaks which do not shift in 
response to a change in ligand bound state suggesting no change in chemical environment. 
However, a significant number do shift implying a change in their chemical environment upon 
ligand binding (Figures 4.8 and 4.9). It is already known that ligand binding to the N-terminal 
domain of Hsp90 causes movement of the backbone and so movement of the side chains is 
not unexpected. Observations of which side chains move may allow a better picture of the 
conformational changes occurring in response to ligand binding to be formed. 
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Figure 4.8 An overlay of the CT-13C-HSQC spectra collected for the Apo N-terminal domain of Hsp90 (black) and 
the ADP bound N-terminal domain of Hsp90 (red) showing overall similarity but with some notable differences. 
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Figure 4.9 An overlay of the CT-13C-HSQC spectra collected for the Apo N-terminal domain of Hsp90 (black) and 
the AMPPNP bound N-terminal domain of Hsp90 (blue) showing overall similarity but with some notable 
differences. 
A systematic review of all amino acids allows the transfer of peak assignments from 
the apo dataset to either the ADP or AMPPNP bound dataset. The high similarity between the 
spectra of the apo and ligand bound domain allows direct transfer of assignments in cases 
where no movement has occurred. All the assignments for any given side chain are considered 
together and reference to both HCCH and CCH-TOCSY spectra is used to confirm that the cross-
peak pattern is consistent throughout. This is seen for Val163 in Figures 4.10, 4.11 and 4.12. 
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Figure 4.10 A: The identified apo Cα-H peak of Val163 overlays exactly with a peak recorded for the ADP 13C-HSQC 
constant time experiment. B: Confirmation that the peak in the ADP spectrum is consistent with it belonging to 
residues Val163 was obtained by inspection of the corresponding  CCH-TOCSY spectrum. The pattern of cross-
peaks identified (marked in blue) is consistent with the known values of Val163. 
 
Figure 4.11 A: The identified apo Cβ-H peak of Val163 overlays exactly with a peak recorded for the ADP 13C-HSQC 
constant time experiment. B: Confirmation that the peak in the ADP spectrum is consistent with it belonging to 
residues Val163 was obtained by inspection of the corresponding CCH-TOCSY spectrum. The pattern of cross-
peaks identified (marked in blue) is consistent with the known values of Val163. 
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Figure 4.12 A: The identified apo Cγ1-H and Cγ2-H peaks of Val163 overlay exactly with the peaks recorded for 
the ADP 13C-HSQC constant time experiment. B: Confirmation that the peaks in the ADP spectrum are consistent 
with them belonging to residues Val163 was obtained by inspection of corresponding CCH-TOCSY spectrum. The 
pattern of cross-peaks identified (marked in blue) is consistent with the known values of Val163. In this case both 
methyl groups have very similar proton resonances but differing carbon resonances. 
Where some movement of the peak has occurred, the position of the new peak can be 
identified in a number of ways depending upon the situation. The entire side chain is 
considered together to allow matching of cross-peak patterns in the HCCH and CCH-TOCSY 
spectra. If the peak shift is small then the most likely closest peak can be confirmed or ruled 
out by comparing their cross peaks in the HCCH and CCH-TOCSY spectra to the pattern from 
the apo dataset. Additional information on the Cα and Cβ carbon chemical shifts was obtained 
from HNCA and HNCACB spectra for the AMPPNP dataset. The ADP dataset lacked any HNCA 
and HNCACB spectra and was therefore assigned by comparison to both the apo and the 
AMPPNP CHSQC-CT, HCCH and CCH-TOCSY spectra. In the case of Thr95 in the ADP bound 
state as displayed in Figure 4.13 the movements are relatively small. The apo peak is marked 
with a ‘*’ while the cross hairs are centred on the most likely candidate for the displaced peak 
in Panel A. Panels B and C below it display the CCH and HCCH-TOCSY spectra respectively 
corresponding to the proposed ‘new’ peak position for Thr95. The alignment of the cross peaks 
on the horizontal markers in each case suggests that the ‘new’ peak is the correct one. This 
was repeated for all carbon atoms within the side chain in a similar fashion. 
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Figure 4.13 A: The identified apo CA-H of Thr95 does not overlay exactly with the peak recorded for the ADP 13C-
HSQC constant time experiment. A: The apo peak is starred (*) and the closest candidate for the shifted peak in 
the ADP spectrum is marked with a cross-hair in black. B: The corresponding cross-peak pattern in the CCH-TOCSY 
experiment matches that expected for Thr95. C: The corresponding cross-peak pattern in the HCCH-TOCSY 
experiment matches that expected for Thr95. Any deviation from the marked lines might indicate proton shifts in 
the other side chain atoms however the number of peaks is characteristic of a Thr residue. 
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A summary of the side chain assignments for the apo, ADP and AMPPNP bound states 
is shown in Table 4.2. A table of the assignments for the ADP and AMPPNP bound states can be 
found in Appendices B and C respectively.  
Assigned Apo  ADP  AMPPNP  
 H C H C H C 
% Side Chain protons 74%  73%  71%  
% Side Chain non-protons  60%  57%  50% 
%H/C α 90% 95% 85% 85% 81% 71% 
%H/C β 81% 94% 81% 81% 79% 66% 
%H/C γ 80% 64% 81% 65% 78% 62% 
%H/C δ 63% 55% 29% 55% 61% 53% 
%H/C ε 27% 25% 25% 25% 25% 25% 
Table 4.2 A summary of the degree of assignment of the resonances associated with the side chains of the N-
terminal domain of Hsp90. The % assigned for proton and carbon resonances is shown for each of the apo and 
ligand bound states.  
 Figure 4.14 shows the 13C-HSQC of the apo state of the N-terminal domain of Hsp90. In 
order to show details of the final assignment, key areas have been highlighted by the red 
boxes shown. These designated areas refer to the labelled panels in Figures 4.15 – 4.19. 
Figures 4.15 – 4.19 show the assigned 13C-HSQC peaks for the N-terminal domain in the apo 
state. These figures are representative of the apo assignment but not exhaustive. For a full list 
of assignments and a complete diagram in the apo, ADP and AMPPNP bound states please see 
the supplementary data CD. 
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Figure 4.14 Diagram of the CT-13C-HSQC spectrum of the N-terminal domain of Hsp90 in the apo state. The red 
boxes relate to diagrams 4.15 – 4.16 which show a labelled assignment of the appropriate area. 
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Figure 4.15 Assigned 13C-HSQC spectrum for the N-terminal domain of Hsp90 in the apo state. Refer to figure 4.14 
for location information for each of the detailed figures shown here. 
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Figure 4.16 Assigned 13C-HSQC spectrum for the N-terminal domain of Hsp90 in the apo state. Refer to figure 4.14 
for location information for each of the detailed figures shown here. 
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Figure 4.17 Assigned 13C-HSQC spectrum for the N-terminal domain of Hsp90 in the apo state. Refer to figure 4.14 
for location information for each of the detailed figures shown here. 
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Figure 4.18 Assigned 13C-HSQC spectrum for the N-terminal domain of Hsp90 in the apo state. Refer to figure 4.14 
for location information for each of the detailed figures shown here. 
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Figure 4.19 Assigned 13C-HSQC spectrum for the N-terminal domain of Hsp90 in the apo state. Refer to figure 4.14 
for location information the detailed figure shown here. 
4.5 Using the CHSQC spectra  
The assigned CHSQC spectra for the apo state, the ADP state and the AMPPNP state 
were compared and peaks that showed chemical shift differences in the different ligand bound 
states were identified. The peak shifts could be divided into two categories; those where the 
shifts were small and those where the shifts were large. The side chains show a far greater 
sensitivity than the backbone amide groups to changes in their local environment which may 
indicate conformational changes within the protein reflected in their changes in chemical shift 
upon ligand binding. This is expected as rearrangement of residue side chains would be vitally 
important for the functional conformation of the protein but would not necessarily be 
reflected by movement of the amide resonances depending on the flexibility and size of the 
side chain involved. Initially all identified changes in chemical shift induced by ligand binding 
were identified for the ADP and AMPPNP bound state. These shifts were then mapped onto 
the crystal structure for the ADP bound N-terminal domain (Figure 4.20). The combined shift 
was calculated in a similar manner to the combined proton/nitrogen shifts (see equation 3.2) 
using the following equation:  
Combined proton/carbon shift = Proton shift + (Carbon shift / 9)   (4.1) 
Shifts above 0.01 were considered to show a small shift while values above 0.05 were 
considered to be a large shift. 
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Figure 4.20 Comparison of all identified side-chain chemical shift changes induced by ligand binding in the N-
terminal domain of Hsp90. Residues were identified using the 13C-HSQC spectra and plotted onto the known ADP 
bound crystal structure. Left: Shifts induced upon ADP binding. Right: Shifts induced upon AMPPNP binding. In 
each case large changes in chemical shift are shown in orange while small changes in chemical shift are shown in 
blue. The ATP ‘lid’ is circled in green. PDB of the ADP bound state (1AMW) used for diagrams. 
 From Figure 4.20 it can be seen that a large number of shifts can be observed across 
the entire protein in both ligand bound states. More chemical shift changes can be observed in 
the long helix in the AMPPNP bound state than in the ADP bound state. In contrast more shifts 
can be seen in the ATP ‘lid’ in the ADP bound state than in the AMPPNP bound state. A similar 
number can be seen in each ligand bound state in the β-sheet at the back of the binding 
pocket. Larger shifts (in orange) appear to be mostly, but not exclusively, closer to the ligand 
than smaller shifts (shown in blue). The overall pattern of peak shifts implies a great deal of 
flexibility within the N-terminal domain, however, from Figure 4.20 it is hard to identify ligand 
specific influences over the protein. 
The bigger shifts are likely to be caused by a more significant change in environment 
and thus are of interest when thinking about how ligand binding influences the conformation 
of the N-terminal domain. In order to more clearly look at ligand induced changes to the 
protein, the large shifts only were first considered (Figure 4.21) followed by focusing on the 
large shifts induced that were unique to each ligand bound state (Figure 4.22). 
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Figure 4.21 Comparison of the side-chain chemical shift changes induced by ligand binding in the N-terminal 
domain of Hsp90. Residues were identified using the 13C-HSQC spectra and plotted onto the known ADP bound 
crystal structure. Comparisons were made between the apo state and the ADP bound state (red) and between 
the apo state and the AMPPNP bound state (blue). PDB of the ADP bound state (1AMW) used for diagrams. 
 Residues where a majority of resonances in a side chain showed a significant chemical 
shift were plotted onto the known crystal structure. From Figure 4.21 it is clear that the 
residues which are substantially shifted by the binding of either ADP or AMPPNP are widely 
dispersed, most are localised to the back of the binding pocket within the β-sheet and to the 
flanking helices surrounding the ligand binding pocket. There are also some notable shifts 
within the lid as shown in Figure 4.21 circled in green.  A large number of chemical shift 
changes occur that are common to both the AMPPNP and ADP bound state, suggesting that 
many of the changes occurring are due to accommodating any ligand binding. 
A more detailed picture of the specific changes that occur upon either ADP or AMPPNP 
binding can be identified by looking at the shifts that are seen in the presence of one ligand 
but not the other. These shifts are summarised in Figure 4.22 and Table 4.3. 
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AMPPNP Phe8 Ile45 Gly83 Tyr146   
  Glu33 Lys48 Gly118 Arg166   
  Leu34 Gln55 Tyr125 Gly170   
  Asp40 Glu59 Leu129 Leu173   
  Ala41 Lys73 Ile137 Arg174   
  Leu42 Asp79 Gln145 Ala202   
ADP Thr5 Glu76 Ser109 Ser138 Phe156 
  Leu15 Ser80 Ala110 Asn141 Glu165 
  Ile29 Met84 Ala112 Asp142 Phe176 
  Arg32 Ile90 Phe128 Asp143 Gln181 
  Ser36 Phe104 Ala131 Glu149 Glu187 
  Ile66 Ala107 Val134 Gly153 Tyr203 
Table 4.3 A summary of the uniquely shifted residues identified upon the binding of AMPPNP and ADP to the N-
terminal domain of Hsp90. 
 
Figure 4.22 Unique shifted residues associated with ligand binding identified by comparing the CHSQC spectrum 
of the apo state with the spectra of the ADP and AMPNP bound states as plotted on the crystal structure. A: The 
unique chemical shifts induced by ADP binding. B: The unique shifts induced by AMPPNP binding. 
 A comparison of panel A and B of Figure 4.22 reveals some distinct differences 
between the binding of ADP and AMPPNP to the N-terminal domain of Hsp90. The binding of 
ADP uniquely shifted residues predominantly in the lower section of the long helix, the ATP 
‘lid’ region, the flanking helix just behind the lid and the lower section of the β-sheet and one 
or two shifts at the top of the β-sheet and in the connecting loops. The binding of AMPPNP 
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shows uniquely shifted residues predominantly in the long helix, at the top of the β-sheet , one 
residue in the ATP ‘lid’ and a few residues in the helix directly following the ATP lid. The 
differences between the two ligands suggests that ADP causes disruption to the lower portion 
of the domain while AMPPNP interacts more with the upper portion of the domain. The 
movement within the β-sheet suggests that ADP may move deeper into the bottom back of 
the pocket while AMPPNP is then orientated more towards the top of the pocket. This is 
consistent with the chemical shift differences observed in Chapter 3 that suggest that the β-
sheet is sensitive to the ligand position. 
 The residues which move uniquely in the ATP ‘lid’ region in the ADP bound protein and 
in the helix preceding the long helix are consistent with the lid being in an ‘open’ state when 
bound to ADP as is shown in the crystal structure used for Figure 4.22. The chemical shift 
changes induced by ligand binding may suggest that ADP leads to a ‘lid open’ conformation as 
the movement apart of these two regions as the lid moved, would alter their chemical 
environment. The chemical shift changes within the lid seen in Figure 4.20 indicate that upon 
ligand binding, either ADP or AMPPNP, the ATP ‘lid’ moves suggesting that the ‘ground-state’ 
of the lid is not close to either ligand bound state. The unique changes in chemical shift in the 
ATP ‘lid’ region in the AMPPNP bound protein are limited to Gly118. No unique shifts are 
observed in the first helix of the lid in contrast with the ADP bound state.  
This may suggest that ADP causes a significant change in environment of the first helix 
by a tight association with the main body of the protein, as seen by the unique changes in 
chemical shift seen in the helix that precedes the long helix. AMPPNP in contrast only shows 
unique shifts in Gly118 within the ‘lid’ region. These unique changes in chemical shift are 
consistent with the apo state of the ‘lid’ being neither open nor closed and the binding of the 
ligand moving it from one state to another. The mutual changes in chemical shift also support 
this as the large numbers of shifts across the lid suggest that it is highly flexible in all states. 
 
 
4.6 H/D exchange experiments 
 
 The use of hydrogen/ deuterium exchange experiments to monitor the accessibility of 
backbone amide groups is well documented [73-76]. Under normal conditions the proton on 
the backbone amide will freely exchange with the surrounding solvent. If the amide is 
protected, either due to its location within the folded structure of a protein or due to specific 
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non-covalent interactions such involvement in a hydrogen bond, then the proton exchange 
with the solvent will be limited. Thus changes in proton accessibility under different conditions 
can inform on conformational changes caused by that particular set of conditions. 
 In a 15N-HSQC experiment the detected signal is that of backbone amide (NH) group of 
each amino acid. Under normal circumstances this signal is a composite of all protein 
molecules present in the sample. When deuterated solvent is introduced into the sample, such 
as by the addition of 50% D2O, then amide proton exchange in the solvent will result in a mixed 
population of protonated and deuterated amide groups. Deuterated amide groups do not 
contribute to the overall amide signal detected by NMR thus as more amide groups exchange 
hydrogen for deuterium the signal intensity will decrease.  Once an equilibrium with the 
solvent has been achieved then signal intensity decrease will cease. 
 As previously mentioned some amide bonds will be more shielded from exchange than 
others. These groups will decrease less rapidly and will take longer to achieve equilibrium with 
the solvent. In this series of experiments a 300 µL sample of the N-terminal domain of Hsp90 in 
the apo state at a concentration of 600 µM in 50 mM Tris was diluted with 300 µL of 50 mM 
Tris dissolved in D2O. All experiments were undertaken at pH8. A 15N-HSQC spectrum was 
recorded every 15 min for the first 10.5 h, then every half hour for 11.5 h then every hour for 
the final 25 h. The process described for determining the peak intensity decay for the apo N-
terminal domain of Hsp90 was repeated for samples of the protein pre-incubated with ten-fold 
excess ADP or AMPPNP. 
 Peak heights were determined using NMRPipe. All spectra were initially processed 
identically using NMRPipe. A pseudo 3d spectrum was then constructed using each individual 
spectrum from the time course experiment as a spectrum slice with the NMRPipe script 
‘series.com’. Once processed, each peak was selected and overlapping peaks were identified 
within the peak list and labelled as belonging to the same cluster. The height of each peak in 
the pseudo 3d data series was then determined using the NMRPipe script autoFit.tcl. This 
script generated a ‘synthetic’ spectrum and a ‘difference’ spectrum for each ‘slice’ of the 
pseudo 3D data. From the synthetic spectrum the peak height was determined for each peak 
within the peak list. From the decay of a peak height across the pseudo 3d slices the rate of 
decrease for each peak was then determined. The ‘difference’ spectrum contains the original 
data minus the ‘synthetic’ data and thus acts as a check on the quality of the synthetic 
spectrum. Due to data handling limitations within the NMRPipe software the analysis of each 
data set was undertaken in three independent sections comprised of approximately 30 spectra 
each. Each set was then combined allowing for scaling factors between the sets. Allowance 
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was also made for the increase in intensity due to the increase in the number of scans at later 
time points.  
 
 
4.7 Fast exchange or no exchange 
 
 This method of measuring H/D exchange allows determination of rates for amides with 
a medium to slow exchange rate. Some peaks will show no discernable change in intensity 
over the time course of the experiment. These peaks are either in very fast or very slow 
exchange. It is necessary to determine whether a peak fully exchanges before the first 
experiment or whether no exchange occurs over the time course of the experiment. In order 
to determine whether a peak is in very fast or very slow exchange its intensity compared to a 
peak that is known to have a medium rate of exchange was found. The ratios of the target 
peak to the peak in medium exchange were determined in an unquenched sample. This was 
repeated using five peaks in medium exchange. This set of five ratio values were then 
compared to the same ratios determined in the quenched sample. Where the difference 
between these ratios was small, the peak was determined to be in slow exchange. Where the 
ratios were very different this indicated that the peak was in very rapid exchange and thus 
reached equilibrium with the bulk solution before the first spectrum was recorded. 
 For each ligand bound state, five residues that showed clear proton exchange were 
selected. For the apo state residues Leu31, Asp40, Ala41, Phe63 and Asn91 were selected. For 
the ADP bound state residues Glu33, Se36, Phe63, Met116 and Lys191 were selected. For the 
AMPPNP bound state residues Ser35, Phe63, Asn91, Arg133 and Ile190 were selected.  All 
peaks selected as ‘reference peaks’ were chosen for their high initial intensity close to the 
unquenched sample values  and their subsequent rapid yet measureable decrease in intensity 
suggesting that they are neither in very fast or very slow exchange.  
 For every peak in a control 15N-HSQC spectrum containing no D2O its peak height was 
determined using CCPN software. The average ratio of ‘reference peak’ / ‘peak height’ was 
calculated for the five reference peaks. For every peak in the first H/D exchange spectrum the 
ratio of the reference peak to the peak height was also determined using CCPN software. 
 A comparison of these two reference values was then used to determine whether a 
peak was in very fast or very slow exchange. The use of ratio values obtained from each 
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spectrum ensured that only relative values between two peaks were being considered thus 
negating the need to adjust for differences in overall intensity between the two spectra. If a 
peak was in very slow exchange then the peak height ratio would remain close to its 
unquenched value. If a peak was in very rapid exchange then the peak height ratio in the first 
exchange spectrum would be far higher than in the unquenched spectrum. Thus any peak that 
showed a significant ratio increase between the control and first dataset was inferred to be in 
very rapid exchange. This ratio comparison was used on the apo, ADP and AMPPNP bound 
states of the N-terminal domain of Hsp90. This is seen in Figures 4.23, 4.24 and 4.25. 
Peaks deemed to be in very fast exchange for the apo N-terminal domain of Hsp90 
were Asn21, Asn26, Leu93, Thr95, Ile96, Gly118, Val122 and Lys178. Peaks deemed to be in 
very fast exchange for the ADP bound N-terminal domain of Hsp90 were Phe8, Ala10, Glu11, 
Lys27, Glu28, Ile29, Leu160, Glu162 and Arg169. Peaks deemed to be in very fast exchange for 
the AMPPNP bound N-terminal domain of Hsp90 were Arg32, Asn92, Ala017, Asp113, Gly154, 
Leu160, Arg169 and Trp148. 
 A comparison of the decay rate (intensity unit delay s-1) for each amide in each state 
was undertaken. Where a peak for an amino acid was visible in one or two but not the 
remaining datasets the value for that peak in the missing set was set to a nominal negative 
value. Since a negative decay rate is impossible this value merely highlights that no peak was 
present in subsequent graphical analysis. Where rapid proton exchange had been identified by 
ratio comparison the ‘measured’ decay rate was very small as all proton exchange had already 
occurred before the first measurement. To identify these residues the rate was replaced with a 
value of ‘3x10-5’ in each case. This value was not chosen for its accuracy but due to it exceeding 
all other measurable rates and thus allowing easy identification of a ‘rapid decay rate’ in 
subsequent graphical analysis.   
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Figure 4.23 Using the apo N-terminal domain of Hsp90, the ratio of peak heights for each residue was determined 
against five 'reference peaks' in an unquenched and a D2O quenched sample. The difference in signal between 
the quenched and unquenched samples was then plotted. Those with a large difference in ratios indicated that 
the peak was in very rapid exchange. 
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Figure 4.24 Using the ADP bound N-terminal domain of Hsp90, the ratio of peak heights for each residue was 
determined against five 'reference peaks' in an unquenched and a D2O quenched sample. The difference in signal 
between the quenched and unquenched samples was then plotted. Those with a large difference in ratios 
indicated that the peak was in very rapid exchange. 
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Figure 4.25 Using the AMPPNP bound N-terminal domain of Hsp90, the ratio of peak heights for each residue was 
determined against five 'reference peaks' in an unquenched and a D2O quenched sample. The difference in signal 
between the quenched and unquenched samples was then plotted. Those with a large difference in ratios 
indicated that the peak was in very rapid exchange. 
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4.8 A comparison of the proton exchange rates for the apo, ADP 
and AMPPNP bound states of the N-terminal domain of Hsp90 
 
 The decay rate of an amide proton after quenching with D2O is dependent upon its 
accessibility to the solvent and whether it is involved in any hydrogen bonding networks such 
as present in both α-helical and β-sheet secondary structures. Conformational changes 
including disruption to secondary structure can both influence the rate of proton exchange. 
Thus the difference in the decay rate between the apo, ADP and AMPPNP bound states is a 
potentially good method of monitoring/inferring structural changes induced by ligand binding 
and indentifying different responses to each ligand. 
Residues 1 – 21: 
 
Figure 4.26 Decay rate of each amino acid residue amide proton intensity from residue 1 - 21 in intensity units S-1 
for each of the three states – apo (blue), ADP bound (red) and AMPPNP bound (green). Negative bars represent a 
lack of data for that construct at that residue. Values of 3x10-5 represent residues that exchange very rapidly 
before the first data point is measured. 
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The initial 21 amino acids correspond to the first strand and helix of the N-terminal 
domain of Hsp90. The β strand shows a high degree of protection in all ligand bound states 
with the exceptions of residues 2, 8 and 15 which show very rapid exchange in the two ligand 
bound forms in contrast to the apo state. 
The first half of the α-helix shows a considerable increase in exchange rate in the 
ligand bound states (Figure 4.26). ADP and AMPPNP induce a high exchange rate in Thr13 and 
Gln14 respectively. These two amino acids are located on the α-helix with the amide bond 
facing towards the main bulk of the protein. The difference between the two ligands suggests 
a slightly different position of the helix caused by each to allow solvent exposure of the 
relevant amide protons to the solvent. Residue Leu15 shows an equal change in 
exposure/exchange for both ligands. The latter half of the helix however shows a degree of 
protection against proton exchange in all states. This may indicate a degree of uncoiling of the 
first two turns of the helix induced by the binding of ADP and AMPPNP but a retention of the 
secondary structure towards the end of the helix. Following the helix the loop from residue 21 
again has increased exchange as anticipated for an unstructured region. These results are 
consistent with increased flexibility in the first strand/helix induced by ligand binding and may 
be linked to the ‘strand swap’ event that occurs in the full length protein. 
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Residues 26 – 51: 
 
Figure 4.27 Decay rate of each amino acid residue amide proton intensity from residue 26 - 51 in intensity units S-
1 for each of the three states – apo (blue), ADP bound (red) and AMPPNP bound (green). Negative bars represent 
a lack of data for that construct at that residue. Values of 3x10-5 represent residues that exchange very rapidly 
before the first data point is measured. 
 
No data was available for residues 22 – 25 in any of the datasets due to the inability to 
resolve peak overlap. Residues 26 – 29 corresponds to a coiled section of α-helical structure 
just prior to the start of the long α-helix (Figure 2.27). This suggests that ligand binding 
destabilises this structure compared to the apo state thus increasing the accessibility and rate 
of exchange. The long α-helix runs from residues 29 – 48. The first four residues (29 – 33) show 
some accessibility followed by a region of fairly low accessibility suggesting strong secondary 
structure. The exception is residue Ser36 which shows considerably more accessibility in the 
ligand bound states than the apo state. Ser36 points towards the strand/helix formed by the 
first 21 residues which show increased flexibility in the ligand bound states. If these two 
regions interact then destabilising of one could lead to destabilising of the other. Asp40 and 
Ala41 show increased protection in the ligand bound states compared to the apo state. These 
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two residues form part of the long helix directly opposite the ligand binding site thus 
interaction with the ligand via the water network may lead to stabilisation of this region, 
preventing proton exchange. The latter half of the long helix shows a low exchange rate under 
all conditions with a slight increased rate in the ADP bound state.  
 
Residues 52 – 79: 
 
Figure 4.28 Decay rate of each amino acid residue amide proton intensity from residue 52 - 79 in intensity units S-
1 for each of the three states – apo (blue), ADP bound (red) and AMPPNP bound (green). Negative bars represent 
a lack of data for that construct at that residue. 
Residues 52 – 56 from a short helix showing low exchange in all states (Figure 4.28). Residues 
57 – 62 form an exposed loop region that shows a low accessibility in the apo state and 
AMPPNP bound state but a higher exchange and thus greater flexibility in the ADP bound 
state. Phe63 shows a roughly equal exchange rate between all three states, it is positioned on 
the N-terminal end of the first beta strand and is fairly exposed to solvent. Residues 64 – 72 
comprise a β-strand that forms part of the binding pocket for the ligand. Exchange is seen in 
the apo and ADP bound state but not the AMPPNP bound state. This suggests that the 
AMPPNP bound state leads to a rearrangement of the strand or reduced flexibility that 
decreases solvent exposure of the amide protons in this region. AMPPNP binding may promote 
 
200 
a stronger association with the C-terminal β-strand that otherwise might be somewhat flexible 
at the extreme terminus of the protein. It has already been suggested in chapter 3 that in the 
AMPPNP bound state there is a distinct arrangement of the ligand within the pocket caused by 
the protonation of the terminal phosphate, this could lead to an increased stability within this 
region of the binding site. Residues 73 – 79 form a β-strand that is central to the β-sheet of the 
N-terminal domain. This region shows a low proton exchange rate for all states as is 
anticipated for a secondary structure region that is not disrupted by ligand binding.  
Residues 80 – 98: 
 
Figure 4.29 Decay rate of each amino acid residue amide proton intensity from residue 80 - 98 in intensity units S-
1 for each of the three states – apo (blue), ADP bound (red) and AMPPNP bound (green). Negative bars represent 
a lack of data for that construct at that residue. Values of 3x10-5 represent residues that exchange very rapidly 
before the first data point is measured. 
 
Residues 80 to 98 comprises a loop, a short helix and then a loop leading into the ATP 
‘lid’. The initial loop region from 80 – 85 shows a high degree of proton protection in all states, 
despite the lack of secondary structure (Figure 4.29) however given its location in the interior 
of the protein it is likely more shielded from exchange. Residues 86 – 93 form a small two turn 
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helix that flanks the binding site. This region is most stabilised in the ADP bound state and 
destabilised by the apo and AMPPNP bound states. Residues 93 to 97 show most exchange in 
the ADP bound state with the exception of residue 96 which shows most exchange in the apo 
state. This is close to the hinge lid suggesting that the presence of ADP and AMPPNP stabilise 
this region in different ways with the ADP bound state being most exposed. The high exchange 
of residue 96 in the apo state suggests that it is accessible until ligand is bound. 
Residues 103 – 130: 
 
Figure 4.30 Decay rate of each amino acid residue amide proton intensity from residue 103 - 130 in intensity units 
S-1 for each of the three states – apo (blue), ADP bound (red) and AMPPNP bound (green). Negative bars 
represent a lack of data for that construct at that residue. Values of 3x10-5 represent residues that exchange very 
rapidly before the first data point is measured. 
Residues 99 – 123 comprises the ATP ‘lid’ as detailed earlier. In the apo state and the 
ADP bound state the exchange rate is relatively slow across the lid suggesting that the addition 
of ADP has a minimal effect on the accessibility or protection of the lid backbone residue 
protons (Figure 4.30). In the AMPPNP bound state two residues show a dramatic increase in 
proton exchange rate. These residues, Ala107 and Asp113, are located at the tip of the ATP 
‘lid’ region. Residues 124 – 130, form a short helix following the ATP ‘lid’. They show slightly 
more accessibility in the apo bound state than in either of the ligand bound states at residues 
126 and 127. These two residues form part of an α-helix in the ADP bound crystal structure. 
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Their accessibility in the apo state suggests that ligand binding is required to stabilise this 
section of secondary structure. 
Residues 131 – 161: 
 
Figure 4.31 Decay rate of each amino acid residue amide proton intensity from residue 131 - 161 in intensity units 
S-1 for each of the three states – apo (blue), ADP bound (red) and AMPPNP bound (green). Negative bars 
represent a lack of data for that construct at that residue. Values of 3x10-5 represent residues that exchange very 
rapidly before the first data point is measured. 
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Residues 131 – 161 form three strands of the β-sheet that comprises the back of the 
binding pocket. Much of this section has limited or slow proton exchange with some notable 
exceptions (Figure 4.31). Residues Arg133 and Val134 are located at the end of the β-sheet and 
are only flanked on one side by a strand of equal length, they show a high rate of proton 
exchange in all three states with the exception of Val134 AMPPNP bound where not data was 
available. Residues 135 – 143 show high stability and low proton exchange corresponding to 
the first of the β-strands in the sheet and the beginning of the loop connector. Residue 144 
shows high exchange corresponding to its location on the outside of the loop. No data is 
available for the ADP bound state. This is followed by a region of high protection 
corresponding to the second β strand from 145 – 153. The notable exception here is the high 
accessibility of residue Trp148 in the AMPPNP but not the ADP bound state with no data 
available for the apo state.  The side chain of Trp148 points in towards the binding pocket. 
AMPPNP binding may cause a rearrangement of the binding pocket  compared to the binding 
of ADP; this might interact with the Trp side chain leading to it influencing the amide proton on 
the reverse side of the β-sheet. 
Residue Gly154, at the start of a beta strand, shows a large difference in accessibility 
between AMPPNP bound and the other two states yet curiously Gly153 shows no such 
behaviour despite both being part of the same loop region. Thr157 shows a high degree of 
accessibility compared to its neighbouring residues, however it is located in the β strand 
directly opposite Trp148. This proximity may indicate that any effect upon Trp148 might 
disrupt the hydrogen bond between the two residues thus making Thr157 more accessible to 
proton exchange or may indicate a more direct response to ligand binding. ADP presumably 
causes less disruption in this area compared to AMPPNP only influencing the amide of Thr157 
but not managing to influence Trp148. 
 Leu160 is located at the end of a beta strand exposed to the bulk solvent but only 
shows a high degree of proton accessibility in the AMPPNP bound state suggesting that the β-
sheet hydrogen bond network is disrupted in this bound state only. This matches the trend for 
AMPPNP to induce chemical shift changes at the top of the binding pocket as seen earlier in 
this chapter. The neighbouring residue, Asp161, is part of a loop region extending from the β-
strand and is slightly less accessible in both ligand bound forms compared to the apo state. 
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Residues 162 – 186: 
 
4.32 Decay rate of each amino acid residue amide proton intensity from residue 162 – 186 in intensity units S-1 for 
each of the three states – apo (blue), ADP bound (red) and AMPPNP bound (green). Negative bars represent a 
lack of data for that construct at that residue. Values of 3x10-5 represent residues that exchange very rapidly 
before the first data point is measured. 
Residues 162 – 169 form a loop between two beta strands exposed to the solvent. This 
accessibility however is not reflected in the apo and AMPPNP bound state which shows a very 
limited exchange until the end of the loop region where rapid exchange is then observed. This 
may indicate some degree of association between the early portion of the loop and the β-
sheet. ADP however seems to lead to a high rate of exchange suggesting that this loop is more 
flexible in the ADP bound state (Figure 4.32). Residue Arg169 shows a high accessibility in both 
ligand bound states with no data available for the apo state. The β-strand then shows a low 
exchange rate in all states with marginally faster exchange in the presence of ADP. Lys178 
marks the end of the β strand and the start of the loop region containing one helix turn 
reflected by the increase in H/D exchange. A high exchange rate is also seen for Gln181 just 
prior to the helix turn. Residues 182, 183 and 185 show a high degree of protection as 
expected due to their involvement in an α-helix. Residues 184 and 186 show a decreased 
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degree of protection in all states which is unexpected due to the hydrogen bonding network 
provided by the α-helix turn.  
Residues 187 – 207: 
 
Figure 4.33 Decay rate of each amino acid residue amide proton intensity from residue 187 - 207 in intensity units 
S-1 for each of the three states – apo (blue), ADP bound (red) and AMPPNP bound (green). Negative bars 
represent a lack of data for that construct at that residue. Values of 3x10-5 represent residues that exchange very 
rapidly before the first data point is measured. 
The final short α-helix is formed of residues 187 – 196. The first three residues show 
very low proton exchange with slightly higher accessibility in the ADP bound state (Figure 
4.33). In strong contrast, residues 190 and 191 show a very high rate of proton exchange in all 
states despite their location in the middle of an α-helix, although no data is available for the 
AMPPNP bound state of 191. Residues 192 – 196 then show a relatively high level of 
protection, however, some exchange is still occurring suggesting that this helix is not as highly 
stabilise as others that are located more centrally within the N-terminal domain. Residues 199 
to 207 comprise the extreme C-terminal β strand which shows a high degree of protection in 
the apo and AMPPNP bound states most likely due to the hydrogen bonds formed with the 
neighbouring β strand as part of the binding pocket β-sheet. Protection of alternate amide 
groups as might be expected in a β-strand structure is not seen. In contrast in the ADP bound 
state this strand shows a far higher accessibility suggesting an increased level of flexibility. This 
region appears to be highly variable in its accessibility. This is reflected by the side-chain 
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chemical shift changes observed in this region earlier in this chapter suggesting that it 
responds flexibly to ligand binding.  
Figure 4.34 highlights the amino acids where the binding of ligand, either ADP or 
AMPPNP, leads to a change in H/D exchange pattern observed compared to the apo state. 
Figure 4.34A shows the residues where both ligands cause a similar change in exchange and 
possible exposure compared to the apo state, either increasing or decreasing its accessibility to 
H/D exchange. From this figure it is clear to see that there are a few key areas that show 
changes and that these areas are mostly located around the edge of the binding site. These 
regions are likely associated with the general response of the domain to ligand binding 
reflecting the way the protein accommodates the ligand within the binding site. It would be 
generally expected that in the ligand bound state the rate of protein unfolding would be 
slower and the protein more stable thus leading to a lowered exchange rate. Therefore 
increased exchange rates observed in the ligand bound state are particularly interesting.  
Conformational flexibility of the back-bone, as reflected by the change in chemical 
shift resonances, has been observed upon ligand binding and exploited in Chapter 3.  It was 
additionally seen in the first half of this chapter that changes in chemical shift of the side-
chains were observed for a great number of residues across the domain. Although some of 
these shifts were very small, they occurred in response to both ADP and AMPPNP ligand 
binding. This suggests an inherent flexibility in response to ligand binding even within stable 
secondary structural elements. Small chemical shift changes would not necessarily indicate a 
change in gross conformation, and thus not be as informative on the gross conformational 
changes induced by ligand binding, but may suggest sufficient flexibility in the protein overall 
to facilitate the increased H/D exchange observed.  
The first strand and helix, comprising the first 20 amino acids, shows an increase in 
accessibility. This region is involved in the strand swap event and so it seems likely that ligand 
binding may cause the N-terminal domain to adopt a conformation whereby this ‘strand swap’ 
event is favoured even in the absence of a second N-terminal domain with which to dimerise. 
This increased flexibility may denote a decrease in the strength of the secondary structure 
elements that keep the N-terminal strand and helix associated with the main body of the 
protein.  
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Figure 4.34 Changes in the H/D exchange pattern on the N-terminal domain of Hsp90 induced by ligand binding plotted onto 
the crystal structure. Orange residues show an increased exchange while blue residues show a decreased exchange. A: The 
changes in H/D exchange pattern caused by both the binding of ADP and AMPPNP. B: The unique changes in H/D exchange 
pattern caused by the binding of ADP. C: The unique changes in H/D exchange pattern caused by the binding of AMPPNP. 
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The long helix shows two regions of increased exchange at the top and bottom of the 
helix and a region of increased protection in the middle close to the ligand. The region of 
increased stability involves residues Ala40 and Ala41 which are known to be involved in an 
extend water network that interact with the adenine group of the ligand through van der 
waals forces (see Chapter 1). The regions of increased exchange involve residues that are not 
directly involved in ligand binding. The involvement of Ala41 with the binding of the ligand 
may lead to a distortion of this long helix leading to a weakening of the α-helical structure 
towards the ends of the helix and the exposure of the amide groups of these residues to the 
solvent. Ala41 also showed a change in chemical shift upon binding of AMPPNP as described in 
the first half of this chapter. Residues Ile90 (which also showed a chemical shift change in its 
side chain resonances in the 13C-HSQC upon ADP binding) and Leu93 show an increased 
protection from exchange. Between these two residues, Asn92 is involved with a direct link to 
the ribose group of the ligand and is one of the few direct contacts with it. This direct contact 
may lead to a stabilising of the region and thus increased protection for Ile90 and Leu93. The 
influence of Asn92 may also be felt by Ile96 explaining the increase in protection of this 
residue as well.  
There are three residues in the β-sheet at the back of the binding pocket that show an 
increase in exchange; Ala2, Thr157 and 169R. None of these residues are involved in the 
binding of the ligand either directly or indirectly however they are all located either at the end 
of a β-strand (Ala2 and Arg169) or at the very edge of the β-sheet (Thr157). The side chain of 
Phe156 is known to show a chemical shift change in the presence of ADP and this movement 
of the aromatic group could influence the accessibility of the Thr157 amide even if its own 
amide remains stable. It is has already been detailed in Chapter 3, and earlier in this chapter, 
that the binding of ligand causes a series of chemical shifts detected by NMR that map to this 
β-sheet. This suggests that ligand binding causes a rearrangement of the back of the binding 
pocket, the increase in exchange at the periphery of the β-sheet reflecting perhaps a decrease 
in the stability of the edge of it caused by movement in the middle where the ligand sits. 
The unique shifts associated with the binding of ADP to the N-terminal domain of 
Hsp90 can be mapped to two main regions (Figure 4.34B). The first location is the extreme C-
terminus of the domain and the preceding helix. The second location involves the β-sheet 
involving residues Ile66 and Ile77 which are also close to the C-terminal region and the loop 
that connects the long helix to the β-sheet from residues 57-62. It is known that residues Ile66 
and Glu76 both show a chemical shift change in the 13C-HSQC spectra as detailed earlier. It is 
also known that Gln181, Glu187 and Tyr203 all show chemical shift changes in the 13C-HSQC 
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spectra. These residues are all close to or on the expected interface between the N-terminal 
and middle domains of the Hsp90 molecule. The increase in exchange here, and the chemical 
shift change seen in the 13C-HSQC, suggests an increased flexibility in this region or a 
destabilisation of structure. It is known that during the chaperone cycle the binding of ATP is 
associated with an association of the N-terminal and middle domains. The data here suggests 
that the interface is disrupted in the presence of ADP perhaps indicating a role in the 
dissociation of the domains and the resetting of the cycle. Asn91 shows a decrease in 
exchange that may again be due to the stabilising influence of Asn92 directly bound to the 
ligand. Thr13 is located on one of the helices that flank the nucleotide binding site and which 
also shows additional exchange in panel A. This suggests that ligand binding influences the 
whole helix causing a weakening of the proton protection and so allowing increased H/D 
exchange. Thr13 shows one way in which ADP differs slightly in the degree of disruption to the 
helix compared to AMPPNP. Thr13, Gln14 and Leu15 are all part of the same helix after the 
first strand. Both Thr13 and Gln14 may be influenced by Leu15 which is known to show a 
chemical shift change upon ADP binding. The binding of ligand may influence the middle of the 
β-sheet thus placing the periphery of the sheet under strain that allows increased solvent 
accessibility. The reverse of this is seen in the final residues Val134 where increased protection 
is observed. Val134 is located within the middle of the β-sheet and displays a chemical shift 
change in the 13C-HSQC upon ADP binding; if ligand binding leads to a rearrangement of this 
region, previously indicated by NMR shifts, then this could lead to a stabilisation of the 
structure and thus increased protection for the amide proton from exchange. 
Figure 4.34C shows the unique changes in H/D exchange associated with the binding of 
AMPPNP to the N-terminal domain of Hsp90. The pattern of exchange accessibility is distinctly 
different to that of the ADP bound state. Again residues at either end of the long helix (Lys48 
and Arg32) show increased accessibility suggesting that the helix is under strain thus 
weakening the hydrogen bonding network at the ends. Chemical shift changes in the side-
chains of residues Glu33, Leu34, Asp40, Ala41, Leu42, Ile45 and Lys48 under AMPPNP bound 
conditions support the exchange data observed for this helix. Residue Phe200 also shows an 
increased accessibility however the large degree of accessibility seen in this region in the 
presence of ADP is not reflected in the presence of AMPPNP. This suggests that the AMPPNP 
does not lead to any destabilisation in this region. This fits with the idea that the binding of 
ligand before hydrolysis promotes the association of the N-terminal and middle domains and 
thus a destabilisation of the interface is not required. Indeed the region from Asn26 – Ile29 
shows an increase in protection in this strand of the β-sheet suggesting an increased stability 
in this region.  Trp148 and Leu175 are located in the middle of the β-sheet and show an 
increased accessibility suggesting a disruption of the β-sheet hydrogen bonding network that 
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leads to the amide bond protection. Arg174 shows a chemical shift change upon AMPPNP 
binding which might explain the increased accessibility observed for Leu175. Such a disruption 
could be caused by a movement of the AMPPNP ligand against the back of the binding pocket 
as has already been suggested by NMR data in Chapter 3 where shifts are observed across the 
β-sheet in response to pH in the AMPPNP bound state and in both ligand bound states of the 
T22I and T101I earlier in that chapter. 
Three residues of note that show an increase in accessibility are Ala107, Asp113 and 
Asn92. As previously mentioned, Asn92 is bound directly to the adenine base of the ligand 
upon binding and may be implicated in the stabilisation of this binding site flanking helix. The 
increased accessibility of the amide group in the AMPPNP bound state only, coupled with the 
decreased accessibility of the surrounding helix, suggests a more specific influence upon Asn92 
that is ligand dependent. Residues Ala107 and Asp113 are only influenced in the AMPPNP 
state and are the only residues within the ATP ‘lid’ region that show any shift at all. The crystal 
structure here is shown in the ‘lid open’ position however in the ‘lid closed’ position Asn107 
and Asp113 would fold up and end up in very close proximity to Asn92. If the binding of 
AMPPNP lead to the stabilisation of the ‘closed’ state, the close proximity of these residues 
could lead to a disruption in the secondary structure thus leading to an increase in proton 
exchange. This could be consistent with the idea that in the isolated N-terminal domain of 
Hsp90, the binding of AMPPNP leads to the stabilisation of the ATP ‘lid’ in the closed state 
while ADP does not. 
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5 Thermodynamics of the extended molecule of 
Hsp90. Nucleotide ligands binding to the N551 
and full length constructs 
 
5.1 Introduction 
The thermodynamics of binding of ligands ADP, AMPPNP, adenosine and adenine to the 
isolated N-terminal domain has already been reported in Chapter 3. However, as was 
discussed in Chapter 1, the presence of the middle domain is known to have an influence over 
ATP hydrolysis due to the requirement of Arg380 on the catalytic loop of the middle domain 
for efficient terminal phosphate cleavage.  It is known that the conformational changes 
induced by ligand binding and hydrolysis within the N-terminal domain of Hsp90 must, in some 
way, be propagated to the rest of the chaperone molecule. It is also known that during the 
conformational cycle of Hsp90, the N-terminal and middle domains move closer to one 
another and that there is a structural rearrangement, including the reorientation of the 
catalytic loop of the middle domain containing Arg380. This series of changes causes the γ-
phosphate of the AMPPNP ligand to be positioned so as to contact the catalytic residue Arg380 
as shown in the full-length crystal structure [7]. This contact has also been demonstrated as 
being significant for full ATPase activity as detailed in Chapter 1. There have, however, been no 
previous studies as to whether this influence of the middle domain on the kinetics of the 
reaction also extends to the thermodynamics of initial binding. 
In order to study the influence of the middle domain over the N-terminal domain and 
ligand binding, a construct containing both the N-terminal and middle domains was used. The 
N551 construct, comprising of the first 551 amino-acid residues of Hsp90, is shown in Figure 
5.1. Key features shown in Figure 5.1 include the N-terminal helix and strand involved in the 
strand-swap event, the ATP ‘lid’ closed over the ligand binding site, residue Arg380 from the 
middle domain catalytic loop and the two ends of the long linker that joins the two domains 
although that proved  too flexible to resolve in the crystal structure. 
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Figure 5.1 The N551 construct illustrated from the full length crystal resolved by Ali et al. [7] The N-terminal 
domain is shown in green while the middle domain is shown in blue. Key features are labelled. Diagram taken 
from PDB file 2CG9. 
The N551 construct is 50kDa in size and is thus at the limit of what is possible to study 
by conventional NMR techniques. As the protein being studied increases in size, the rate of 
tumbling decreases leading to significant peak broadening. This peak broadening leads to a 
decrease in achievable resolution in the data and of signal intensity. These losses of signal and 
resolution makes the study of large proteins far harder by solution state NMR than that of 
smaller ones.  
Within this chapter the thermodynamics of the N551 construct were studied using ITC 
under ADP, AMPPNP and adenosine bound conditions. The ΔCp was recorded across a 
temperature range of 10 – 25°C. The thermodynamics was then compared to the isolated N-
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terminal domain of Hsp90. Thermodynamic analysis of the full-length Hsp90 chaperone was 
also undertaken by ITC under ADP, AMPPNP and adenosine bound conditions. The ΔCp was 
recorded across a temperature range of 10 – 25°C. 
Due to the high expression of the N551 construct and subsequently high yields of pure 
protein, the use of TROSY NMR was possible. This allowed optimisation of sample preparation 
conditions and a comparison of the different ligand bound states of the N551 construct. The N-
terminal domain spectra overlaid well with the N551 spectra and this allowed exploitation of 
the N-terminal backbone assignments to look at the N-terminal domain peaks identified within 
the N551 construct, and associated shifts induced by ligand binding. 
 
 
5.2 The thermodynamics of binding of ADP, AMPPNP and 
adenosine to N551 show marked differences from those of 
binding to the N-terminal domain 
 
Titrations were undertaken between the N551 construct of Hsp90 and the ligands ADP, 
AMPPNP and adenosine in 20 mM Tris at pH8 across a temperature range from 10°C – 25°C. 
Protein concentration was 50µM in the cell with ligand concentrations of 1 mM for ADP, 1.5 
mM for AMPPNP and 1.5 mM for adenosine in the syringe. 
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Protein:  N551 Ligand: ADP pH: 8  ΔCp: -1.52  kJ mol-1  K-1 
Temp (C) Stoichiometry (N) Kd (µM) Error (µM) ΔH (KJ mol-1) Error (+/-) TΔS (kJ mol-1) ΔG (kJ mol-1) 
10 1.02 ± 0.01 4.03 ±0.19 -93.93 ±0.76 -64.61 -29.32 
10 1.01 ± 0.01 5.62 ± 0.63 -76.65 ± 1.78 -48.19 -28.46 
15 1.05 ± 0.01 6.92 ±0.23 -96.69 ±0.69 -68.15 -28.54 
15 1.09 ± 0.01 5.26 ± 0.31 -75.19 ± 0.86 -46.04 -29.14 
20 1.01 ± 0.01 10.46 ±0.34 -97.027 ±0.82 -69.08 -27.95 
20 1.04 ± 0.03 13.12 ± 1.40 -90.00 ± 3.20 -62.55 -27.44 
25 1.06 ± 0.01 23.11 ±0.64 -122.56 ±1.44 -95.77 -26.49 
25 1.06 ± 0.05 27.70 ± 3.42 -103.60 ±6.79 -77.59 -26.00 
Table 5.1 Summary of binding data for the ITC experiments of ADP binding to the N551 construct of Hsp90. Titrations undertaken in 20 mM Tris, 5 mM Mg2+, pH 8. 
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From Table 5.1 it is clear to see that the temperature-dependence of binding of ADP to 
the N551 construct shows a similar trend to that of the N-terminal domain of Hsp90. The Kd 
increases with temperature, with weaker binding arising from a more favourable enthalpy 
change at higher temperature outweighed by a less favourable entropy change. In comparison 
to the N-terminal domain binding parameters however, it is clear to see that the Kd is smaller 
in the presence of the middle domain than in its absence. The difference at low temperatures 
is around a factor of two (4.03µM compared to 8.76µM); however, as temperature increases 
the difference does as well until at 25°C there is a factor of four (27.7µM compared to 
115.75µM) separating the binding affinities of the two constructs of Hsp90. 
Protein:  N551 Ligand: AMPPNP pH: 8  ΔCp: -0.28  kJ mol-1  K-1 
Temp 
(C) 
Stoichiometry 
(N) 
Kd (µM) Error 
(µM) 
ΔH  
(KJ mol-1) 
Error 
(+/-) 
TΔS  
(kJ mol-1) 
ΔG  
(kJ mol-1) 
10 0.93 ± 0.02 45.05 ±1.83 -44.60 1.07 -20.22 -23.56 
15 1.05 ± 0.02 70.42 ±2.67 -45.44 1.25 -22.55 -22.91 
20 1.07 ± 0.03 110.0 ±4.65 -46.11 1.64 -23.67 -22.22 
25 1.11 ± 0.04 121.36 ±5.55 -41.00 1.91 -18.59 -22.35 
30 0.96 ± 0.09 181.00 ±11.53 -53.848 5.96 -32.14 -21.71 
Table 5.2 Summary of binding data for the ITC experiments of AMPPNP binding to the N551 construct of Hsp90. 
20 mM Tris, 5 mM Mg2+, pH 8. 
It is found that the binding constants for AMPPNP when bound to the N551 construct 
of Hsp90 shows marginally smaller binding than the same ligand binding to the N-terminal 
domain of Hsp90 alone (Table 5.2). The difference between the two affinities is only 10µM, but 
within the same order of magnitude, at both 10°C and 20°C with a consistently more 
favourable enthalpy values by around 10kJ mol-1 and a consistently more favourable entropy 
value of around -10kJ mol-1 K-1 at each temperature.  
Protein:  N551 Ligand: Adenosine pH: 8  ΔCp: -9.70  kJ mol-1  K-1 
Temp 
(C) 
Stoichiometry 
(N) 
Kd (µM) Error 
(µM) 
ΔH  
(KJ mol-1) 
Error (+/-) TΔS (kJ 
mol-1) 
ΔG  
(kJ mol-1) 
10 1.06 ± 0.12 68.82 ±3.81 -55.16 7.11 -35.58 -22.58 
15 1.01 ± 019 108.89 ±4.95 -87.11 17.06 -65.26 -21.85 
20 1.00 ± 0.35 154.82 ±6.02 -155.14 55.52 -133.69 -21.45 
Table 5.3 Summary of binding data for the ITC experiments of adenosine binding to the N551 construct of Hsp90. 
20 mM Tris, 5 mM Mg2+, pH 8. 
It can be seen that the binding affinity for adenosine binding to the N551 construct is 
comparable to that for the N-terminal domain at 10 and 15°C temperatures (Table 5.3). As the 
temperature was increased to 20°C the binding affinity increased with both constructs. 
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However, binding to the N551 construct was higher than to the N-terminal domain alone. The 
change in entropy shows similar values between binding to the N-terminal domain and the 
N551 construct at 10°C. As temperature increases, both constructs show an increasingly 
negative change in enthalpy term; however, the binding of adenosine to N551 is significantly 
more enthalpically favourable than binding to the N-terminal domain at the same 
temperature.  
Figure 5.2 shows a comparison of the thermodynamic parameters of binding for the N-
terminal to all ligands (top) compared to the N551 construct (bottom) at 15°C. From this figure 
it is very clear to see that the presence of the middle domain changes the enthalpy/entropy 
profiles of adenosine and AMPPNP the most with less influence over the binding of ADP. 
Adenosine shows an increase in magnitude of both entropy and enthalpy but also a difference 
in their proportions leading to less difference between the two values. AMPPNP binding shows 
an increase in the entropy with respect to the enthalpy leaving a similar Gibbs free energy 
overall in comparison to the N-terminal domain.  
 
Figure 5.2 Comparison of the ΔH, TΔS and ΔG values for the N-terminal domain under adenosine, ADP and 
AMPPNP bound conditions against the N551 construct bound to the same ligands. 20 mM Tris, 5 mM Mg2+, pH 8, 
15°C. 
 
217 
The heat capacities of binding of ADP, AMPPNP and adenosine to the N551 construct: 
 
Figure 5.3 ΔCp plot of ADP, AMPPNP and adenine binding to the N551 construct of Hsp90. 20 mM Tris, 5 mM 
Mg2+, pH 8. 
 Figure 5.3 shows the plots used to determine the ΔCp values. A comparison of the heat 
capacity data for the N-terminal domain of Hsp90 and the N551 construct yields the following 
results shown in Table 5.4. 
Ligand N-terminal domain (J mol-1  K-1) N551 construct (J mol-1  K-1) 
AMPPNP +286 -280 ±60 
ADP -900 -1500 ±140 
Adenosine +600 -9700 ±2700 
Table 5.4 Comparison of the ΔCp values calculated for various ligands binding to the N-terminal domain of Hsp90 
compared to the N551 construct as determined by ITC at pH 8 in 20 mM Tris, 5 mM Mg2+. 
From Table 5.4 it is clear that there are some significant differences between the ΔCp 
values determined for the same ligand with the different protein constructs. In the case of 
ADP, the result is an increase in magnitude of the ΔCp with the N551 construct compared to 
the N-terminal domain; however, both ΔCp values are negative. In the case of the ligands 
AMPPNP and adenosine there is a change in sign between the ΔCp values determined for the 
N551 construct compared to the N-terminal domain from positive to strongly negative.  The 
implications of this will be discussed later. 
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5.3 The binding of ADP, AMPPNP, adenosine and adenine to the 
full length Hsp90 molecular chaperone molecule 
 
 ITC titrations between the full length Hsp90 molecular chaperone and the ligands ADP, 
AMPPNP, adenosine and adenine were undertaken across the temperature range 10 – 25°C. 
An initial concentration of 30µM protein in the calorimeter cell was used in each case. The 
ligands were used at the following initial concentrations in the syringe: ADP at 1 mM, AMPPNP 
at 1.5 mM, adenosine at 1.5 mM and adenine at 1.5 mM. Using the full length protein the 
chaperone is assumed to form a dimer via the C-terminal domain. The presence of a 
stoichiometry of 1 in all experiments suggests that the binding to the two N-terminal domains 
of the dimer is sufficiently independent and that the ligand can bind as easily to one as to the 
other. 
Protein:  Hsp90 Ligand: ADP pH: 8  ΔCp: -1.53  kJ mol-1  K-1 
Temp (C) Stoichiome
try (N) 
error Kd 
(µM) 
Error 
(µM) 
ΔH (KJ 
mol-1) 
Error 
(+/-) 
TΔS (kJ 
mol-1) 
ΔG  
10 1.05 0.01 1.75 ±0.12 -78.58 1.25 -47.39 -31.19 
15 1.07 0.01 4.13 ±0.22 -85.10 1.07 -55.46 -29.64 
20 1.1 0.02 6.49 ±0.41 -87.86 1.65 -58.75 -29.13 
25 1.04 0.07 13.25 ±1.27 -116.27 10.21 -88.32 -27.95 
30 1.04 0.05 15.20 ±1.05 -101.17 6.28 -73.19 -27.98 
Table 5.5 Summary of binding data for the ITC experiments of ADP binding to the full length Hsp90 molecular 
chaperone molecule. 20 mM Tris, 5 mM Mg2+, pH 8. 
The binding of ADP to the full length Hsp90 molecule shows no increase of binding 
affinity compared to the N551 construct (Table 5.6). Again it has four times the affinity as for 
the N-terminal domain alone. Both enthalpy and entropy terms for the binding of ADP to the 
full length molecule are more negative than binding to the N-terminal domain of Hsp90 or the 
N551 construct suggesting that perhaps the addition of the C-terminal domain has an effect on 
ligand binding thermodynamics. However, the increased complexity of the system, taking into 
account the high flexibility of the chaperone dimer and therefore the increased number of 
degrees of freedom of the protein, may account for this.  
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Protein:  Hsp90 Ligand: AMPPNP pH: 8     
Temp (C) Stoichiome
try (N) 
error Kd (µM) Error 
(µM) 
ΔH (KJ 
mol-1) 
Error 
(+/-) 
TΔS (kJ 
mol-1) 
ΔG  
10 1.02 0.27 67.52 ±11.76 -55.69 17.64 -33.09 -22.60 
15 1.01 3.15 160.26 ±63.45 -196.82 648.94 -176.02 -20.80 
20 1.04 0.96 144.93 ±111.95 -38.96 48.74 -17.42 -21.54 
Table 5.6 Summary of binding data for the ITC experiments of AMPPNP binding to the full length Hsp90 molecular 
chaperone molecule. 20 mM Tris, 5 mM Mg2+, pH 8. 
The binding of AMPPNP to the full length Hsp90 molecule shows a slightly lower 
affinity than the N551 construct (Table 5.7); however, the affinity is still stronger than for the 
N-terminal domain alone. The low heats obtained for the ITC experiments and the limited 
supply of full length protein have led to the large errors in the calculated Kd values at higher 
temperatures and so an accurate ΔCp cannot be determined. The ΔH and TΔS terms are both 
more negative in the full length protein than in the N551 construct. This is, however, to be 
expected with the increased size of the protein and the large degree of flexibility associated 
with the chaperone molecule. It should be noted again, the large error at higher temperatures 
does not allow accurate analysis of the enthalpic and entropic contributions. 
Protein:  Hsp90 Ligand: Adenosine pH: 8     
Temp (C) Stoichiome
try (N) 
error Kd (µM) Error 
(µM) 
ΔH (KJ 
mol-1) 
Error 
(+/-) 
TΔS (kJ 
mol-1) 
ΔG  
10 1.07 0.48 71.94 ±6.49 -141.38 66.40 -118.94 -22.43 
15 1.02 0.11 58.69 ±3.62 -43.39 5.19 -20.03 -23.36 
Table 5.7 Summary of binding data for the ITC experiments of adenosine binding to the full length Hsp90 
molecular chaperone molecule. 20 mM Tris, 5 mM Mg2+, pH 8. 
 The measurement of the binding of adenosine to the full length Hsp90 molecule was 
made more difficult by the small heats involved and could only be determined at low 
temperatures (Table 5.8). From this we can see that the presence of the full length molecule 
leads to no change in binding affinity at 10°C; however, the binding affinity is increased by a 
factor of two from 108 µM to 58 µM at 15°C. At 10°C the ΔH and TΔS values are more negative 
compared to the N551 construct while at 15°C, less negative ΔH and TΔS values are observed. 
The high error associated with the ΔH and TΔS values at 10°C do not allow for much analysis of 
the thermodynamic parameters. The smaller error at 15°C perhaps suggests a more reliable set 
of figures and suggests that in the presence of adenosine, the full length chaperone shows less 
negative ΔH and TΔS values than with the N551 construct.  
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Figure 5.4 ΔCp plot of ADP binding to the full length Hsp90 molecular chaperone. 20 mM Tris, 5 mM Mg2+ pH 8. 
The ΔCp value for ADP binding to the full length Hsp90 molecule, -1.53 kJ∙mol-1∙K-1, is 
very similar to that determined for the N551 construct (Figure 5.4). This suggests that the 
addition of the C-terminal domain of Hsp90 does not lead to any significant changes in the 
change in exposed surface area that occur on binding nucleotide, and that the difference 
between the ΔCp values for the full length protein and the N-terminal domain alone are due to 
the middle domain and its interactions with the N-terminal domain. 
 
 
5.4 NMR of the N551 construct of Hsp90 
 
TROSY spectra were collected of the N551 construct at a concentration of 150 µM. 
Perdeuteration of the sample was required to minimise noise within the spectrum and reduce 
relaxation through non-amide protons. Surprisingly good spectra were obtained with good 
peak dispersion suggesting that the two domains were tumbling somewhat independently 
rather than as one large unit. This is shown in Figure 5.5A. 
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Figure 5.5 A: 15N-TROSY spectra of the apo N551 construct of Hsp90 (purple). 50  mM Tris 50 mM NaCl pH 7.5 25°C 
800 MHz. B: 15N-TROSY spectra of the apo N551 construct of Hsp90 overlayed with the 15N-HSQC spectra of the N-
terminal domain of Hsp90 (blue). 
A comparison of the N551 spectrum with that of the N-terminal domain reveals that 
many of the N551 peaks overlay exactly and others are sufficiently close to identify as having 
undergone a small chemical shift (Figure 5.5B). The closeness of the match suggests that the 
presence of the middle domain has minimal influence over the gross conformation of the N-
terminal domain in the apo-state, but does have a subtle effect. The presence of the long 
flexible loop connecting the N-terminal and middle domains would allow each domain the 
possibility of independent movement. This distance between the two large globular domains 
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could allow each one to tumble in an independent fashion, thus reducing the peak broadening 
effects caused by the increased size of the protein.  
5.4.1 Comparison of the N551 domain and the N-terminal domain of Hsp90 and 
identification of peak shifts 
 
 The overlay of the chemical shift changes of the N-terminal domain with the N551 
construct mapped onto the crystal structures of the N551 construct (Ali et al.[7]) as seen in 
Figure 5.6 shows that although the spectrum for the N-terminal domain overlays well, there 
are some resonances that show a chemical shift change in response to the addition of the 
middle domain. These shifts were identified using the existing backbone assignments for the 
N-terminal domain. Shifts within the central region of the spectrum were not considered as 
they overlapped too much, with resonances arising from the middle domain and are thus 
impossible to identify unambiguously. The presence of a small number of strong peaks in this 
central region in all bound states in the mutant protein, suggests the formation of some 
unstructured regions however the exact nature and identity of this possible local unfolding is 
not clear. 
 
Figure 5.6 Residues in the N-terminal domain of apo-state N551 construct which show different chemical shifts 
compared to the isolated apo N-terminal domain. Residues showing a chemical shift change are shown in orange. 
The N-terminal domain of the N551 construct is shown in dark grey. The middle domain of the N551 construct is 
shown in light grey. An expanded view is shown and labelled in the right hand panel. The catalytic residue 
(Arg380) from the catalytic loop of the middle domain is shown in blue for reference. Diagram taken from PDB 
file 2CG9. 
From Figure 5.6 it is clear that the shifts can be divided into two categories. The first 
includes residues Arg32, Arg46, Ser49, Met105, Gly118, Val201 and Tyr203. These shifts are all 
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close to the interface between the N-terminal and middle domains, suggesting that the two 
domains do interact, at least transiently, with one another in the apo state. A transient 
association is suggested on the basis that permanent association would lead to significant peak 
broadening in the NMR spectra recorded that was not observed. The second set of shifts 
includes residues Phe63, Arg65, Glu71, Glu76, Arg78, Asp79, Ile82, Leu93, Lys139, Tyr 184 and 
Leu207. These shifts all map either to the back β-sheet of the binding pocket or to the far end 
of the long helix close to the binding pocket. These regions are not in direct contact with the 
middle domain suggesting that the association at the known domain interface leads to a series 
of small structural changes within the binding pocket.  
5.4.2 Comparison of the N551 domain and the N-terminal domain of Hsp90 and 
identification of peak shifts in the AMPPNP bound state 
 
 A TROSY spectrum was recorded of the N551 construct bound to AMPPNP (Figure 5.7). 
A comparison to the N-terminal spectrum bound to AMPPNP was undertaken.  
 
Figure 5.7 15N-TROSY spectrum of the N551 construct bound to AMPPNP (green) overlaid with a 15N-HSQC 
spectrum of the N-terminal domain alone bound to AMPPNP (blue). 15N-TROSY recorded in 50 mM Tris, 50 mM 
NaCl, 5 mM MgCl2+ at pH 7.5, 700 MHz. 
Shifts were identified where the N-terminal domain spectrum differed from the N551 
spectrum and these were plotted onto the crystal structure (Figure 5.8). 
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Figure 5.8 Shifts in residues in the N-terminal domain of the N551 construct compared to the isolated N-terminal 
domain in the AMPPNP bound state. Residues with a chemical shift change are shown in orange. The N-terminal 
domain of the N551 construct is shown in dark grey. The middle domain of the N551 construct is shown in light 
grey. An expanded view is shown and labelled in the right hand panel. Catalytic residue Arg380 from the catalytic 
loop of the middle domain is shown in blue for reference. Diagram taken from the PDB file 2CG9. 
 The chemical shift differences observed for the N551 construct compared to the N-
terminal domain of Hsp90, both in the AMPPNP-bound state, revealed a similar pattern to that 
observed for the apo state. The presence of peak shifts at the domain interface suggests that 
the two domains, at least transiently, associate with one another as the peak broadening does 
not suggest a permanent association. More residues were significantly shifted in the AMPPNP-
bound state than for the apo state but these shifts mostly mapped to the same regions 
observed before. Leu160, Ala152 and Gln144 show shifts in a region previously undisturbed at 
the far end of the β-sheet indicating some link to the binding of AMPPNP. It has already been 
noted that the presence of the middle domain has an influence over the β-sheet (Figure 5.8) 
and as this region is at the top of the β-sheet and close to the edge of the binding pocket. A 
different response to ligand binding than that seen in the N-terminal domain alone is not 
unreasonable and may indicate an explanation for the increased binding affinity observed for 
AMPPNP binding to the N551 construct compared to the N-terminal domain alone.  
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5.4.3 Comparison of the N551 domain and the N-terminal domain of Hsp90 and 
identification of peak shifts in the ADP bound state 
 
 A TROSY spectrum was recorded of the N551 construct bound to ADP (Figure 5.9). A 
comparison to the N-terminal spectrum bound to ADP was undertaken.  
 
Figure 5.9 15N-TROSY spectrum of the N551 construct bound to ADP (blue) overlaid with an HSQC spectrum of the 
N-terminal domain alone bound to ADP (red). 15N-TROSY recorded in 50 mM Tris, 50 mM NaCl, 5 mM MgCl2+ at 
pH 7.5, 700MHz. 
Shifts were identified where the N-terminal domain spectrum differed from the N551 
spectrum and these were plotted onto the crystal structure (Figure 5.10). 
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Figure 5.10 Shifts in residues in the N-terminal domain of the N551 construct compared to the isolated N-terminal 
domain in the ADP bound state. Residues with a chemical shift change are shown in orange. The N-terminal 
domain of the N551 construct is shown in dark grey. The middle domain of the N551 construct is shown in light 
grey. An expanded view is shown and labelled in the right hand panel. Catalytic residue Arg380 from the catalytic 
loop of the middle domain is shown in blue for reference. Diagram taken from PDB file 2CG9. 
 From the plotted data it can be seen that there is far more variation between the two 
constructs in the ADP bound state than was evident in the apo state. Once more the peak 
shifts mostly map to two distinct regions; the interface with the middle domain and the β-
sheet at the back of the binding pocket. Again the presence of peak shifts at the domain 
interface suggests that the two domains, are transiently associated with one another as the 
peak broadening does not suggest a permanent association. There are, however, more shifts in 
the β-sheet and along the long helix that flanks the binding site than were observed for the 
N551 construct in the apo state. The ADP bound state shows more shifts overall than in the 
AMPPNP bound state with slightly more shifts located in the β-sheet and long α-helix. The 
exception to this peak distribution pattern is a small number of shifts seen in the loop regions 
that connect the β strands together to form the sheet, such as Gly81, Ile82, Asn141, Gln144, 
Phe156, Val163 and Asn164. 
 The pattern of peak shifts when N551 is bound to ADP suggests that the presence of 
the middle domain influences the way ADP binds to the N-terminal domain. The ITC has 
already shown that ligand binding is enhanced by the presence of the middle domain. The 
chemical shifts observed indicate that binding enhancement involves small conformational 
changes across the binding site within the N-terminal domain and are not limited to the N-
terminal domain/ middle domain interface.  The presence of shifts across the back of the 
binding pocket in the β-sheet may suggest that this region is important for the strong binding 
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of ligand and that the presence of the middle domain may help in orientating the β-sheet 
correctly.  
 
5.4.4 Missing peaks are observed when the N551 domain spectra are compared to 
the N-terminal domain spectra 
 
An overlay of the spectra for the N551 construct and N-terminal domain reveals that 
some peaks are missing in the spectrum for the N551 construct when compared to the 
spectrum for the N-terminal domain (Figure 5.11) such as Asn21, Gly81, Val74, Ser138, 
Asn141, Ile172, Leu173 and Arg174. The perdeuteration of the protein, necessary for increased 
resolution as previously mentioned, requires that backbone amide deuterium atoms exchange 
with protons within the buffer prior to recording the TROSY spectrum. Incomplete back 
exchange of the backbone amide protons would lead to those residues not being detected on 
the TROSY spectrum. Incomplete back-exchange can arise from increased protection of the 
amide proton, either through its location in the centre of a globular domain, or through its 
involvement in secondary structural elements that provide protection via the formation of 
hydrogen bonds, such as in stable α-helices or β-sheets.  
In order to recover these backbone TROSY peaks the protections of the amide deuterons 
must be relaxed either by allowing solvent access to the centre of the globular domain or by 
disrupting the secondary structural elements. This can be achieved by partial unfolding of the 
protein to disrupt the overall tertiary structure and the secondary structural elements that 
were previously protecting the amide/proton bond and allowing proton/deuteron exchange.  
Partial unfolding can be achieved by dialysis into a high concentration of guanidinium 
chloride (GndCl), a known denaturing agent, followed by dialysis back into a suitable refolding 
buffer with no GndCl present. The process of fully unfolding and refolding a protein can be 
detrimental to the final folded protein structure; however, the more complete the unfolding 
the more complete the proton back exchange can be.   
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Figure 5.11 The apo 15N-TROSY spectrum for the N551 construct (purple) overlaid with an 15N-HSQC spectra of the 
N-terminal domain alone in the apo state (blue). Note some peaks present in the N-terminal spectrum but not in 
the N551 spectrum circled in red. Spectra recorded in 20 mM Tris, 5 mM Mg2+ pH 8, 700MHz.  
 
Protein folding was monitored by circular dichroism (CD) spectroscopy to monitor the 
presence of α-helical and β-sheet content in the native folded state, a partially unfolded state 
in the presence of different concentrations of guanidinium chloride and the refolded state 
after dialysis out of various concentrations of guanidinium chloride.  
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Figure 5.12 CD spectroscopy trace of the N551 construct of Hsp90 at 25°C. Data recorded from 260 – 195 nm 
every half nm. 
From Figure 5.12 we can see the distinctive double trough trace with minima at 208nm 
and 222nm characteristic of a protein containing α-helical content. The shallow transition, as 
opposed to a local maximum between the troughs, is within the region where a minimum 
caused by β-sheet content would be expected (216nm). Thus the average signal contributed by 
both α-helical and β-sheet structures leads to a shallow transition between the two minima as 
is observed. Immediately following purification, and therefore at 0mM GndCl, the protein is 
fully folded. 
Dialysis overnight of the N551 construct into 1M or 2M GndCl was undertaken in order 
to partially unfold the protein. Partial protein unfolding was confirmed by CD as show in Figure 
5.13A and 5.14 A. Full unfolding in 4M GndCl was tried but caused protein precipitation when 
refolding was attempted. 
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Figure 5.13 CD spectroscopy trace of the N551 construct of Hsp90 at 25°C. Data recorded from 260 – 195 nm 
every half nm. A. Trace recorded in the presence of 1M GndCl. B. Trace recorded after removal of 1M GndCl by 
dialysis. 
Figure 5.13 A shows the CD trace recorded for the N551 construct in the presence of 1 
M GndCl. Figure 5.13 B shows the CD trace recorded for the N551 construct following refolding 
after 1 M GndCl is dialysed out of solution. When compared to the initial trace (Figure 5.12) 
two effects can be observed. The first is the disruption by the GndCl of the ability of the CD to 
detect a signal from the protein without being overwhelmed by the signal generated by the 
GndCl at low wavelengths. This is seen by the lack of data from 209 – 195 nm due to a signal 
channel overload. The second is that following removal of GndCl (Figure 5.13 B) the trace 
resembles that of the original protein (Figure 5.12) suggesting that fully refolded protein has 
been recovered. 
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The unfolding/refolding procedure was repeated with 2M GndCl as shown in Figure 
5.14. 
 
Figure 5.14 CD spectroscopy trace of the N551 construct of Hsp90 at 25°C. Data recorded from 260 - 195nm every 
half nm. A. Trace recorded in the presence of 2M GndCl. B. Trace recorded after removal of 2M GndCl by dialysis. 
From Figure 5.14 a similar effect is seen using 2 M GndCl as in Figure 5.13 using 1 M 
GndCl. Again a comparison of the refolded trace with the 0 mM GndCl trace (Figure 5.14) 
shows that refolding does occur. Given that greater unfolding is likely to lead to greater 
backbone amide exchange and that unfolding is likely to be greater in the presence of 2 M 
GndCl than 1 M GndCl, 2 M GndCl was chosen for the partial unfolding/refolding of the N551 
construct. 
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Having confirmed that dialysis into 2 M GndCl overnight followed by dialysis into 0 M 
buffer overnight results in a folded protein, an NMR 15N-TROSY spectrum was recorded. A 
comparison with the previous 15N-TROSY spectrum was used to determine whether partial 
unfolding had resulted in the full back exchange of previously missing peaks. 
 
Figure 5.15 Overlaid 15N-TROSY spectra of the N551 construct and the N551 construct following 
unfolding/refolding by GndCl. Peaks that have been recovered through back exchange following partial unfolding 
are circled in red. Spectra recorded in 50 mM Tris, 50 mM NaCl, pH 7.5 25°C.  
 From Figure 5.15 it is clear to see that peaks previously identified as missing from the 
overlay with the N-terminal domain spectrum have reappeared. These peaks are shown in 
Figure 5.16 and all map either to the interior of the N-terminal domain or known secondary 
structural features which might act to prevent amide back exchange under normal conditions. 
Several other peaks that cannot be attributed to the N-terminal domain have also appeared. 
These peaks are likely to originate from protected regions within the middle domain. 
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Figure 5.16 A plot of the peaks appearing in the N-terminal domain of the N551 construct after partial unfolding 
and refolding of the protein. Appearing peaks are plotted onto the ribbon representation of the crystal structure 
solved by Ali et al.[7]. Diagram taken from PDB file 2CG9 
 
 
5.5 Discussions on the thermodynamics and conformational 
changes of the larger constructs of Hsp90 
 
As observed by ITC, the binding of N551 to ADP shows a binding affinity around four 
times higher than that seen for the N-terminal domain alone. The thermodynamic profile, 
however, looks very similar, with the enthalpy and entropy values varying only a little between 
the two different constructs used. Both the N-terminal data and the N551 data show negative 
ΔCp values; however, the value for the N551 construct is 600 J∙mol-1∙K-1 more negative than the 
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N-terminal data alone. The similar enthalpy/entropy profile suggests that the presence of the 
middle domain enhances the binding affinity of the ligand but without altering the overall 
gross arrangement of the ligand within the binding pocket. A similar change in ΔCp is 
associated with the binding of AMPPNP to the N551 construct with slightly more favourable 
ΔH and TΔS values. 
It is known from the crystal structure [7] that the N-terminal domain and the middle 
domain associate with one another in the AMPPNP ligand bound state. It is possible that this 
may also occur in the ADP bound state, however, no crystal structure has been solved in this 
state. The NMR data presented here, however, does suggest that under all ligand bound 
conditions and in the apo state there is some association between the N-terminal and middle 
domains. With both ADP and AMPPNP, the ΔCp value for binding to the N551 construct is 600 
J∙mol-1∙K-1 more negative than that observed for the N-terminal domain alone consistent with a 
common reason behind this decrease in ΔCp in both ligand bound states. 
As has been previously detailed, the ΔCp  can be influenced by a number of potential 
contributions, including the association of two protein surfaces, a change in the hydration of a 
protein and the associated displacement of water molecules or a conformational change such 
as local un/folding. The association of the N-terminal domain and middle domain leads to the 
burial of a large amount of surface area which will have an influence on the ΔCp.  The burial of 
surface area due to domain association can be computed from the known structure of full-
length Hsp90. 
The surface area of the interface between the N-terminal domain and the middle 
domain of Hsp90 was calculated using NACCESS software[77] and the pdb file 2CG9. This pdb 
file contains two Hsp90 strands in a dimer and two p23 monomers. The pdb file was altered to 
contain a single Hsp90 strand including just the N-terminal and middle domains (residues 1 – 
551 - NM) and excluding the C-terminal domain. This file was then used to create two further 
pdb files containing either just the N-terminal domain (residues 1 – 207 - N) or just the middle 
domain (residues 208 – 551 - M). The N-terminal domain was bound to ADP and coordinated 
to magnesium, neither of which were removed from the file. 
NACCESS was used with the default settings of a 1.4 Å probe together with the default 
van der Waals radii file. An analysis of the total surface area of the NM, N and M files was 
performed. Additionally this was broken down into non-polar and polar components. The 
surface area difference between the values for N+M and NM revealed the surface area of the 
interface between the N-terminal and Middle domains of the chaperone protein. This is 
summarised in Table 5.5. 
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Construct Total surface area  (Å) Non-polar surface area  
(Å) 
All polar surface area  
(Å) 
N 11789.6 7081.3 4708.3 
M 18838.3 10719.3 8199.3 
NM 28114.1 16325.4 11786.7 
Difference: 
 NM-(N+M) 
-2516.1 -1475.2 -1040.9 
Table 5.8 A comparison of the accessible surface areas of the N-terminal domain (N), the middle domain (M) and 
the N551 construct (NM). 
 Using  equation (3.3) the expected ΔCp value due to the burial of surface area between 
the two domains was calculated as -1.37 kJ∙mol-1∙K-1 . This is twice the difference observed in 
the ΔCp between the N-terminal domain and the N551 construct binding to the nucleotide 
ligands. 
This value of -1.37 kJ∙mol-1∙K-1 is twice as large as that expected from the previously 
determined ΔCp values for both ADP and AMPPNP binding to the N551 construct. To explain 
this discrepancy it must be considered that some process, in addition to the association of the 
domains, is opposing the contribution to the ΔCp that is made by the burial of surface area. 
This process is probably the same for both ADP and AMPPNP binding suggesting that it is not a 
part of the chaperone cycle that is driven by specific ligand binding or hydrolysis.  
Whatever is influencing the ΔCp value occurs upon ligand binding in the transition from 
the free to the bound state. The NMR 15N-TROSY data collected already supports the 
association of the N-terminal domain with the middle domain; however, the spectra also 
reveal an influence upon the β-sheet at the back of the binding pocket. This is most likely not 
due to direct interactions with the middle domain, judging by the crystal structures previously 
mentioned [7]. It is possible, that whatever is occurring in this region of the N-terminal domain 
may account for the ΔCp discrepancy between that predicted and observed. 
The 15N-TROSY data do suggest one alternative possibility for the ΔCp discrepancy 
observed. Looking in detail at the central region of the spectra one would expect to see several 
sharp peaks corresponding to the unstructured long linker between the two domains. As this 
loop is believed to be unstructured one would expect the peaks arising from it to be identical 
in all states. A diagram showing the central region of the overlaid 15N-TROSY spectra in the 
apo, ADP and AMPPNP bound states is shown in Figure 5.17. The contour levels have been 
greatly increased so as to only show very intense peaks that are most likely to arise from the 
unstructured loop region and are less likely to arise from the unassigned middle domain. It is 
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known that the long linker is not essential for function, as detailed in the introduction. 
However it cannot be explicitly seen in the crystal structure[7] and has not been assigned by 
NMR.  The fact that the loop is not essential does not preclude some minor involvement in the 
chaperone cycle that has previously not been detectable. 
 
Figure 5.17 An overlay of the TROSY spectra for the apo (red), ADP (blue) and AMPPNP (green) states of the N551 
construct. Spectra recorded in 50 mM Tris, 50 mM NaCl, 5 mM Mg2+, pH 7.5. Circled in red are intense peaks that 
show shifts between the three different states but that do not match to any known N-terminal peak. 
The circled peaks do not match any assigned N-terminal domain peak and show 
differences between the ligand bound states, yet are also very intense, suggesting they are 
from an unstructured region of protein. This may indicate that the flexible loop in some way 
responds to the binding of ligand in a specific fashion. Using equation 5.1 it can be predicted 
that the exposure of 448 Å of non-polar surface area or the burial of 1025 Å of polar surface 
area would result in a +600 J∙mol-1∙K-1  ΔCp change. Using the estimate that one amino acid has 
an accessibly surface area of 100 Å[78] this either leads to the burial of 4 polar amino acids or 
the exposure of 10 apolar amino acids or to suitable combinations therein to add up to a total 
ΔCp predicted value of -600 J∙mol-1∙K-1. If the linker were to form any sort of secondary 
structure in the apo state that was disrupted by the binding of ligand, or, alternatively, if the 
binding of ligand induced the formation of secondary structure, or even simply association of 
part of the linker with either of the structured domains, this would lead to a change in the 
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buried surface area and also a change to the ΔCp.  Alternatively, if the linker were to associate 
with the back of the β-sheet in the N-terminal domain in the apo state and that this was 
disrupted by a change in ligand bound state, this could also lead to a change in the buried 
surface area and also a change to the ΔCp.  
From Figure 5.17, 9 peaks have been identified that could belong to the long linker but 
which also show differences between the ligand bound states. This number is within the range 
that could explain the ΔCp discrepancy described earlier and is roughly the correct number to 
account for the number of shifts observed in the ligand bound state in the β-sheet. One thing 
to note is that intense peaks are always unstructured and flexible and so the circled peaks 
indicate an effect of ligand binding upon some residues in the long linker region. If secondary 
structure was formed or lost, a change in peak intensity would also be expected but currently 
such peaks are not easily identifiable. As such the peaks involved in any linker region role may 
not be limited to the circled peaks. With current data it is not possible to determine which 
residues are involved in any secondary structure formation or association with either of the 
domains present in the construct.  However, the existence of intense peaks from a potentially 
unstructured region of the protein that show specific changes upon ligand binding, potentially 
suggests a previously unknown role for the long linker region. 
The ITC titrations between the N551 construct and the nucleotide based ligands ADP, 
AMPPNP and adenosine have revealed that the presence of the middle domain increases the 
binding affinity for all ligands compared to the N-terminal domain alone. This effect is most 
prominently observed with ADP. The use of the full length protein shows no significant change 
in binding affinities of the ligands compared to the N551 domain, suggesting that the addition 
of the C-terminal domain, and therefore the ability to dimerise, does not significantly alter the 
binding properties of the nucleotide to the N-terminal domain and that the N-terminal domain 
and middle domain contribute most towards defining the binding thermodynamics of the 
nucleotide. 
NMR spectra have been obtained for the apo, ADP and AMPPNP bound states. The 
quality of the spectra and the lack of peak broadening suggest that the two domains do not 
permanently associate with one another under any ligand bound state. An analysis of the peak 
shifts observed in the N551 construct in comparison to the known peak positions of the N-
terminal domain suggest two things. The first is that there is some contact at the 
domain/domain interface, as shifts are observed in this region. The second is that the presence 
of the middle domain leads to changes in the β-sheet at the back of the binding pocket. These 
changes in the binding pocket may give some indication as to how the binding affinity for the 
ligands is increased, and that it is due to altered interaction with this region of the binding 
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pocket that leads to increased binding affinity. What is not clear, however, is how the middle 
domain influences this region of the N-terminal domain.  
The presence of the middle domain also has a dramatic influence on the ΔCp recorded 
for all ligands. The effect on the ΔCp for ADP and AMPPNP is the same, suggesting a common 
process; however, the burial of surface area alone does not correctly account for the change in 
heat capacity observed. Here it is tentatively suggested that the discrepancy between 
observed and predicted ΔCp values could be attributed to the long linker between the N-
terminal domain and middle domain. This is based upon the intense peaks, most likely 
corresponding to a mostly unstructured region in the central portion of the spectrum showing 
specific differentiation between ligand bound states. This suggests that the linker may have a 
previously unforeseen influence upon ligand binding, either by the formation of some ordered 
structure, or by an association with the N-terminal domain. 
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6 Discussion 
  
In the course of this thesis the response of the molecular chaperone Hsp90 to ligand 
binding has been studied in detail. The thermodynamics of nucleotide-based ligand binding 
have been investigated and the conformational changes induced by ligand binding within the 
N-terminal domain have been studied. Additionally the influence of the middle domain and the 
presence of the full length protein upon ligand binding was investigated. Throughout the 
course of these studies it has become increasingly obvious that Hsp90 is a highly dynamic 
protein that can respond specifically to the binding of ligands that differ by only one phosphate 
group and that this difference in response is shown both in the thermodynamics of ligand 
binding and in the conformational changes observed. 
The molecular chaperone Hsp90 is driven by ATP binding and hydrolysis as already 
described in Chapter 1. The binding site has been studied in some detail both here and 
elsewhere; however many of the previous studies undertaken at atomic resolution focus on 
the static structure and have only touched upon the dynamic changes in structure induced by 
nucleotide ligand binding. The two known crystal structures [7;8] show two distinct 
conformations of the N-terminal domain of Hsp90 in two different ligand-bound states; 
however, these two structures were obtained under very different circumstances. One is in the 
ADP bound state in the isolated N-terminal domain while the other is in the AMPPNP bound 
state but with the full length protein and in the presence of p23. Distinct differences can be 
seen between these two states, however, dissecting the influence of elements other than the 
nucleotide is not trivial. In the isolated N-terminal domain with ADP bound the ‘ATP lid’ is seen 
in the open position and the first twenty amino acids are in a strand and helix that are close 
into the main structure. In contrast in the AMPPNP-bound structure ‘ATP lid’ is seen in the 
closed position over the ligand. Whether this is induced by the different ligand binding, by the 
presence of p23 or by the presence of the remainder of the protein and its dimer partner is 
unclear. Additionally the N-terminal strand and helix are seen to associate with the N-terminal 
domain of the other half of the dimer, but again whether this is due to the presence of the 
different ligand or due to the presence of the other elements mentioned is unclear.  
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6.1 The thermodynamics of ligand binding 
 
Investigation of the effects of ligand binding were assessed by ITC measurement. This 
was done in a systematic way by binding the adenine ring system and effectively building out 
the adenosine fragment to adenosine, ADP and finally ATP/AMPPNP. Binding of adenine to the 
isolated N-terminal domain revealed that much of the binding affinity arose from the adenine 
ring system that, from the crystal structure, appears to sit on the β-sheet at the back of the 
binding pocket. The addition of the ribose group to form adenosine and the addition of the 
first two phosphate groups was then observed to increase the affinity to a small degree, but to 
within the same order of magnitude as that achieved by the adenine ring alone. The presence 
of the third phosphate group led to a decrease in binding affinity back to a level that was 
equivalent to that of the adenine base alone. The binding of the adenine ring to the binding 
pocket is mostly mediated by water molecules with van der Waals bonds between the ring and 
Met84 providing the only direct contact. The addition of the ribose ring leads to an additional 
direct contact between Asn92 and the ring. The first two phosphate groups also add more 
direct and indirect contacts including those to Phe124, Lys98 and Asn37. The addition of the 
third phosphate leads to no additional direct contacts in the N-terminal domain. Therefore 
whatever influences there are upon the binding affinity, therefore must occur through a large 
number of water intermediates rather than depending solely upon direct bonds. It is this lack 
of direct bonds that may well be the key to the dynamic response of the protein to the ligand. 
It has previously been noticed by Nilapwar [17] et al., that the binding of AMPPNP to the 
N-terminal domain of Hsp90 is sensitive to pH with a decreasing affinity as pH increases. Here 
it has been established that ADP is insensitive to pH and that the change in affinity with 
respect to pH for AMPPNP is due to a single protonation event. This protonation event has 
been identified by NMR as being due to the protonation state of the γ-phosphate group in 
AMPPNP. Protonation on the protein was ruled out by 15N-HSQC NMR data and positive 
identification of protonation on the γ-phosphate was achieved using direct monitoring of the 
phosphorus atoms by 31P-NMR 1D spectroscopy. 
The determination of the heat capacity was also used to great effect in investigating the 
conformational changes induced by ligand binding through use of the thermodynamic 
measurements alone. The implications of these heat capacity measurements will be discussed 
later. One very interesting point to note, which is something rarely seen in protein/ligand 
binding events, is the difference in sign between the binding of two very similar ligands, ADP 
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and AMPPNP, to the same binding site, suggesting that each ligand plays a distinct and very 
important role in the Hsp90 chaperone cycle. 
 
 
6.2 Assignment of the side chain resonances of the N-terminal 
domain of Hsp90 
 
The necessity for a side chain assignment of the N-terminal domain is clear since armed 
with these data a more detailed understanding of the conformational changes of the protein 
can be achieved and structural determination can be attempted. Knowledge of the side chain 
assignments allows shifts in response to different conditions, ligand binding, pH or otherwise, 
to be monitored. Chemical shifts correlated with a known crystal structure has already been 
shown to be a powerful combination; however, side chain shifts are far more sensitive to side 
chain protonation events and interactions with the ring currents of aromatic residues than 
backbone shifts. The side chain assignments here presented will allow a much more detailed 
study of the dynamics and flexibility of the N-terminal domain of Hsp90 to be undertaken. 
Comparisons of shifts under different conditions can now be undertaken and a more sensitive 
response measured through observation of side chain interactions. Movement of the side 
chain resonances will provide additional information than the chemical shifts observed for 
backbone resonances alone as side-chain movement often occurs during conformational 
changes. Having assignments for the side chain resonances also allows for future structural 
determination through the use of carbon and nitrogen edited NOESY experiments.  
Already a comparison of the side chain resonances in the apo, ADP and AMPPNP bound 
state has been undertaken in Chapter 4, revealing a more detailed look at the regions of the 
protein which respond to ligand binding and possible conformational changes that may occur. 
Details of this are discussed below. 
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6.3 Conformational changes in the N-terminal domain 
 
The chaperone molecule Hsp90 is an incredibly dynamic protein and goes through a 
large series of conformational changes during ligand binding and hydrolysis. As previously 
detailed, the large scale conformational changes can be identified by the crystal structures. 
However, elucidating the detailed and dynamic behaviour of the protein in solution is key to 
understanding the overall function of Hsp90 and how it is driven. The response of the N-
terminal domain of Hsp90 to different ligands has been observed by NMR within this thesis. As 
detailed previously, particular interest was taken of the first 20 amino acids and the likely 
position of the ATP ‘lid’ region in any given state. It was also interesting to note the changes in 
conformation in regions of the protein not linked to large conformational changes, as indicated 
by chemical shifts in the NMR spectra, particularly in the flanking helices around the entrance 
to the binding site and across the β-sheet at the back of the binding site. 
 
6.3.1 The ATP Lid 
 
 The movement of the lid from an ‘open’ to ‘closed’ position is not disputed here, 
however the impetus for the change from one state to the other is not clear. The movement of 
the lid marks one of the most dramatic known conformational changes within the N-terminal 
domain. Chapter 3 details the use of ITC to compare the recorded heat capacity change upon 
binding of ADP and AMPPNP to the N-terminal domain. Given the knowledge of the two 
potential positions (open or closed) predictions of the expected heat capacity change could be 
made and compared to the recorded values. This is possibly due to the dominant influence of 
the change in surface area buried upon the heat capacity change. A comparison of the 
predicted and actual heat capacity changes lead to the interpretation that as anticipated ADP 
led to the lid adopting an ‘open’ conformation while AMPPNP led to a ‘closed’ position. What 
became clear was that the assumed position of the apo was not as close to the ‘closed’ 
position as was initially anticipated. The data presented here is consistent with the apo state of 
the lid being in equilibrium between the open and closed forms described. 
 H/D exchange information was used to probe the flexibility of each amino acid and 
from these data it can be seen that the accessibility of the lid is different in each case as 
detailed in Chapter 4. The results agree with previous information to suggest that ADP leads to 
a ‘lid open’ conformation and that AMPPNP leads to a ‘lid closed’ conformation.   
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The side chain assignments can be used to probe with greater sensitivity the 
conformational changes that occur in different ligand bound states of the N-terminal domain. 
Here unique shifts are observed in the ADP-bound state within part of the lid and within a 
section of the protein that is close to the lid but only when the lid is in the open state. In the 
AMPPNP bound state, unique shifts are observed in a position of the long helix that would 
come into contact with the lid only if it were in a closed state.  
Overall all evidence seems to point to a dynamic movement of the ‘ATP lid’ between 
an open and closed position in the apo state with the binding of ADP or AMPPNP moving it to 
the expected open or closed positions respectively.  This confirms that binding of ligand alone 
is sufficient to cause specific movement of the ‘lid’ region and that the presence of the middle 
domain or the partner N-terminal domain is not required for lid movement, nor is the 
presence of any co-chaperones such as p23. 
 
6.3.2 The N-terminal helix and strand 
 
The first 20 amino acids of the N-terminal domain of Hsp90 consist of a β-strand and 
an α-helix that are involved in a strand swap event during the chaperone cycle with the N-
terminal domain of the opposite monomer. Observation of the side chain chemical shifts of 
the AMPPNP and ADP-bound states of the N-terminal domain show some chemical shifts in 
this region suggesting that the environment of the side chains has changed. Of the shifts 
observed, more residues are affected in the AMPPNP bound state than in the ADP bound 
state. The strand swap event is associated with the start of the chaperone cycle and so a 
greater degree of movement seen in the AMPPNP bound state, also mimicking the start of the 
cycle, may indicate a loosening of the association of the N-terminal strand and helix with the 
main body of the protein induced by ligand binding. The smaller number of shifts observed in 
the ADP bound state suggests that the environment of the helix and strand has changed a little 
but not as significantly as in the AMPPNP bound state. This pattern of shifts is reflected in the 
H/D exchange data where the first 20 amino acids show a far greater accessibility to H/D 
exchange in each of the ligand bound states than in the apo state. However the AMPPNP 
bound state contains more residues that exchange than the ADP bound state. 
Whether a full dissociation occurs without the presence of the second N-terminal 
domain, or whether the association with the main body of the protein is simply weakened, is 
unclear. From this information it can be seen that both ligands induce chemical shifts that 
suggest a weakening of the association of the N-terminal strand with the main body of the 
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protein. AMPPNP mimics ligand bound state at the start of the chaperone cycle and the large 
number of chemical shifts in the region may suggest that the ligand either induces the strand 
swap or favours it significantly. The ADP bound state mimics the end of the chaperone cycle 
and the decrease in observed chemical shifts in this region suggests that the ligand, while not 
favouring a fully associated form, does not favour the ‘strand swapped’ state as much as at the 
beginning of the cycle. This may be an indication that the ADP bound state is involved in 
resetting the cycle.  
 
6.3.3 The β-sheet at the back of the binding pocket 
 
In all of the 2D NMR experiments observing chemical shift changes, one feature seen 
was the presence of shifts located in the β-sheet. These shifts appear to show some 
differentiation depending on which ligand is bound to the protein yet the contact with this 
region is with a group, the adenine ring, that is common to all the ligands observed.  
This suggests that the position of the adenosine group of the ligand within the binding 
site is flexible and determined by the interaction of the phosphate groups with the protein. It 
has already been established that the majority of the binding affinity is provided by the 
adenine ring yet it is also clear from this that the position of the adenine ring varies depending 
on the ligand. The contacts between the adenine ring and the protein are mostly water 
mediated with the exception of van der Waals forces between the ring and Met84 and a direct 
contact with Asp79. The movement of the ligand as reflected by the shifts on the β-sheet, does 
not correspond to a dramatic drop in affinity suggesting that the water molecules that line the 
binding site buffer the ability of the ligand to bind to a certain extent, while still allowing for 
small variation such as that observed between ADP and AMPPNP at physiological pH. This 
buffering effect may allow conformational changes in the protein while still permitting the 
binding of the ligand under physiological conditions. 
It could be theorised that small differences in the ligand, such as the presence of a third 
phosphate group in AMPPNP, might interact with the mouth of ligand binding site as 
supported by chemical shifts of resonances in these regions. However this interaction 
propagates through the ligand causing a shift in the positioning of the adenine ring of the 
ligand with a subsequent influence over the binding pocket via the β-sheet that is greater than 
would be anticipated based on just the difference in interaction at the terminal phosphate site. 
This propagation of movement may indicate a path by which the binding of two such similar 
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ligands as ADP and AMPPNP can induce such drastically different conformational changes 
within the N-terminal domain of Hsp90. 
 
 
6.4 The influence of the middle and C-terminal domains 
 
While previous work has shown the importance of the middle domain and the dimer for 
ATPase activity, the thermodynamics of binding had not been investigated before. The 
addition of the middle domain to form the N551 construct leads to an increase in affinity for 
both ADP and AMPPNP binding although the greatest influence is observed with ADP binding. 
This is despite the presence of the Arg380 residue in the catalytic loop of the middle domain 
which contacts the γ-phosphate. This suggests that Arg380 is involved primarily with efficient 
hydrolysis of ATP and does not contribute significantly to the binding affinity of the ligand. It 
was observed in Chapter 4 that the interface between the N-terminal domain and the middle 
domain became more accessible with a greater level of H/D exchange observed. This might 
indicate that ADP facilitates a conformation that interacts favourably with the middle domain 
and leads to the stabilisation of a structure where ADP binding is enhanced.  
The binding of adenosine to the N551 construct shows a decreased binding affinity 
when compared to the N-terminal domain alone. Although the adenine ring of adenosine 
contributes most towards the binding affinity it has already been noted that it is the presence 
of the phosphate groups that differentiates the conformational changes induced by the 
different ligands. In the smaller construct it might be easier for the adenine to exert sufficient 
influence over the domain to provide good binding contacts without the aid of the phosphate 
groups in the larger ligand. In the larger protein construct it might be less favourable for the 
small adenosine molecule to exert its influence over the entire protein to allow it to bind as 
tightly as in the N-terminal domain alone. 
The full length Hsp90 chaperone showed a similar binding affinity for ADP as the N551 
construct, while the binding of AMPPNP was slightly weaker than for the N551 construct. This 
suggests that the C-terminal domain has very little influence over the binding of ligand and is 
consistent with a weak transient N-terminal dimerisation. 
The NMR undertaken on the N551 construct shows much promise with good dispersion 
seen despite the size of the protein. The precise overlay with the N-terminal domain spectra 
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has allowed the identification of a number of the N551 peaks, and subsequently observed 
chemical shift differences between the N551 and N-terminal constructs. Shifts are observed 
for both ligands across the β-sheet at the back of the binding pocket. This influence over the β-
sheet may indicate a path by which the middle domain has influence over the binding of ligand 
as previously described. 
The heat capacity data from the N551 construct shows that both the binding of ADP and 
AMPPNP are around 600J∙mol-1∙K-1 more negative than anticipated from predicted surface area 
burial calculations. This suggests that the presence of the middle domain leads to a common 
event that occurs upon ADP and AMPPNP ligand binding leading to a ΔCp of 600J∙mol-1∙K-1. The 
NMR shows some very strong peaks that cannot be attributed to the N-terminal domain and 
due to their intensity may well belong to the unstructured, long linker between the two 
domains. However, most interesting to note is that these peaks, in a supposedly unstructured 
region, show ligand-induced specific chemical shifts. This suggests that there is some specific 
interaction or structure that is ligand-dependent and the formation or unfolding of which may 
explain the decrease in the change in heat capacity observed with both ligands. The linker 
region has previously been shown to be unnecessary for protein function.  Any interaction is 
then clearly not essential. Evidence presented here may indicate a role for this region, albeit a 
nonessential one, where previously nothing of import was thought to occur. Certainly this 
shows the importance of dynamic studies of the protein by NMR to identify such areas of 
interest where crystallography cannot resolve them due to the inherent flexibility of the 
region. 
 
 
6.5 Future Work 
 
 The study of Hsp90 is ongoing and this thesis suggests a number of avenues for future 
research. The solution state structure of the N-terminal domain has yet to be solved by NMR. 
It has been demonstrated that the apo state, the ADP bound state and the AMPPNP bound 
state are all subtly different and that these changes are due to the ligand alone rather than the 
influence of any co-chaperones or client proteins. Ascertaining the levels of conformational 
change due to ligand binding will be very important for future studies regarding Hsp90 
inhibition and its function within client protein activation and co-chaperone interaction. The 
position of the ‘ATP lid’ has yet to be definitively confirmed and the data here presented 
 
247 
suggests that the exact conformation of the β-sheet may have a significant role in determining 
ligand induced conformational change. 
The change in heat capacity data suggests that the two ligands induce different 
conformational changes within the protein. However they also suggest that the apo state is 
also flexible and, with particular regard to the position of the ATP ‘lid’, in a state of equilibrium 
between the open and closed forms. A growing body of evidence [5;9;22;40] suggests that 
Hsp90 moves through the cycle, not through a series of practically irreversible steps, but by 
favouring the forward equilibrium of each step. This makes solving the solution state structure 
of all three states important in order to ascertain how they relate to one another and to 
determine more detail about the equilibrium between the states. 
This thesis has also shown the feasibility of undertaking NMR spectroscopy on the 50 
kDa N551 construct comprising the N-terminal and middle domains. Good dispersion was 
observed in the 15N-TROSY spectra for the apo and both ligand bound states. Since good 
overlap was seen between the N551 and the N-terminal spectra many peaks in the larger 
construct could be identified. Further optimisation of the conditions used, potential selective 
labelling strategies and use of the information already acquired for the N-terminal domain 
alone could allow the backbone assignment of the larger construct. This in turn would provide 
a way of directly studying the N-terminal domain and middle domain interactions under 
different conditions. 
Overall this thesis highlights the immense degree of flexibility within the N-terminal 
domain and its ability to respond specifically to two nucleotide based ligands that differ by one 
phosphate group only. The conformational changes induced by ligand binding mostly appear 
to cause small changes in position however these changes are numerous enough that 
cumulatively they could cause the far greater and wide ranging changes observed in many of 
the crystal and EM structures. The one large conformational change observed is in the ‘ATP lid’ 
which here has been seen to move in response to ligand binding alone, but the influence of 
this, beyond the isolated N-terminal domain, is still a matter for discussion. The role of Hsp90 
in the cell is one of great complexity and involves the interplay of many different components 
from co-chaperone and client binding to ligand binding and hydrolysis. The dissection of the 
influence of each of these elements is key to understanding the overall mechanism of Hsp90 
action. With the work presented here our knowledge of the influence of the ligand over the 
protein has been greatly expanded. 
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Assigned side-chain CHSQC data for the apo, ADP and AMPPNP N-terminal domain of Hsp90 in 
CCPN format. 
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terminal domain of Hsp90. 
